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Abstract
Thin-layer chrom atography (TLC) is of g rea t im portance for the  pharm aceutical industry 
a s  a  sim ple, quick, and low cost analytical m ethod. C onsiderable effort h a s  been  m ade 
over the p ast d e c a d e s  to com bine the simplicity of TLC with the  selectivity and  
sensitivity of m ass  spectrom etry  (MS) detection. In the  pharm aceutical industry 
sensitivity is an especially  important factor, since the allowed impurity level of m ost 
drugs is under 0.1%.
The aim of the p resen t thesis  w as to develop m ethods for the  direct exam ination of 
pharm aceutical com pounds from TLC plates by m atrix-assisted lase r 
desorption/ionisation time-of-flight m ass  spectrom etry  (MALDI TOF MS). T he study 
w as  started  by com paring several ap p ro ach es  for the application of the  matrix for direct 
TLC-MALDI including a newly developed  electrospray  matrix deposition m ethod. This 
new  m ethod w as  found to be superior to the  o ther techn iques studied. It produced a 
stab le  signal, minimised analyte spreading, and  hence  allowed the  scanning  of a  TLC 
plate to obtain chrom atographic a s  well a s  m ass  spectral data . T he plotted m ass  
chrom atogram s a ssis ted  in spo t location, and  allowed the  calculation of Rr values. 
T h ese  show ed good ag reem en t with the  Rr values determ ined by UV detection. The 
d e c re a se  in m ass  resolution and m ass  accuracy  comm only observed  in TLC-MALDI 
TOF MS due to the  uneven nature of the  silica gel layer w as  corrected  by internal 
recalibration on se lec ted  matrix ions during the  scanning of the  TLC plate. To en h a n ce  
the  signals recorded directly from a  TLC plate the  u se  of an extraction solvent prior the  
matrix application w as explored. Further im provem ents in sensitivity w ere obtained by 
modifying a  robotic x-y-z axis motion system  to ac t a s  an  e lectrospray  deposition 
device and  by u se  of special Si 60 F254 HPTLC-MALDI targets. Using both a p p ro ach es  
sensitivities in the  high fmol range w ere obtained. To minimise matrix interference, 
which can  su p p ress  analyte signals, the  application of su sp en s io n s  of particles of 
different m aterials and s ize s  (Co-UFP, TiN, T i0 2, graphite and  silicon) onto elu ted  TLC 
p lates w ere investigated. The structural analysis of pharm aceutical com pounds w as  
achieved by post-source decay  -  m atrix-assisted laser desorption/ionisation (PSD - 
MALDI) m ass  spectrom etry  perform ed directly on the  se p ara ted  spo ts. TLC-MALDI MS 
is not only applicable to the qualitative analysis of pharm aceutical com pounds. The 
generation  of quantitative da ta  by using a structural analogue a s  an  internal s tan d ard  is 
a lso  described. Different ap p ro ach es to the  incorporation of the  internal s tandard  into 
the  TLC plate w ere tested . The m ost successfu l approach  w as  to develop  the  TLC 
plate in the  mobile p h a se  to which the  internal standard  w as added . G ood accuracy , 
precision, linearity and sensitivity w as obtained using this approach .
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The pharmaceutical industry has produced hundreds of new compounds for the market 
over the last decade. This development would certainly not have been possible without 
the corresponding improvements in analytical techniques, e.g. of vibrational 
spectroscopy (Raman and IR), column chromatography (GC and HPLC), planar 
chromatography (TLC and HPTLC), and hyphenated techniques of column or planar 
chromatography with mass spectrometry (MS).
Thin-layer chromatography (TLC) is of great importance for the pharmaceutical 
industry as a simple, quick, and low cost analytical method [reviewed in 1-5], 
particularly in three areas: (i) research and development of new drugs, (ii) 
manufacturing process of drugs, and (iii) detection of residues and monitoring of 
poisoning cases [6 ]. As an off-line method TLC offers the possibility o f analysing many 
samples simultaneously, and hence is often used in routine investigations. Even though 
high performance liquid chromatography (HPLC) is usually conducted as a 
complementary technique, with TLC the chances of observing the presence of 
unknowns is greater. In column chromatography unknowns might be missed due to non 
elution from the stationary phase or migration within the solvent front. TLC is also 
commonly performed as a cleanup step, which is simultaneously carried out with the 
separation, offering a further advantage to this relatively low technology technique.
To improve the sensitivity and to allow chemical identification of the compounds, 
considerable effort has been made over the past decades to combine TLC with MS 
[reviewed in 7-10]. Especially in the pharmaceutical industry sensitivity is crucial, since 
the allowed impurity level of most drugs is under 0 .1 % [1 1 ].
The whole range of modem ionisation techniques has, at one time or another, been used 
for coupling TLC to MS. From this whole range, there are essentially two modes of 
TLC-MS, which can be broadly categorised as either indirect or direct methods. In 
indirect methods, the analyte is removed from the TLC plate by scraping it off with the 
stationary phase, followed by extraction into a suitable solvent for MS analysis. In 
direct methods the TLC plate, or a large portion of it, is left undisturbed and introduced 
into the mass spectrometer for analysis. This increases the information available from 
the TLC plate. Chromatograms or images of the analyte spots on the TLC plate can be 
obtained. Furthermore, chromatographically overlapping analyte spots with different 
molecular weights can be fully resolved by MS detection.
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The following ionisation techniques have been applied to direct TLC-MS methods: fast 
atom bombardment (FAB) [12], liquid secondary ion mass spectrometry (LSI MS) [13], 
laser desorption (LD) [14] and matrix-assisted laser desorption/ionisation (MALDI) 
[15-25]. TLC-FAB MS and TLC-LSI MS normally require the use of a vacuum stable 
liquid matrix, e.g. glycerol. The liquid matrix provides extraction of the analyte from 
inside the TLC plate towards the top of the TLC plate where it can be desorbed during 
the analysis. In addition, the liquid matrix aids in soft ionisation of the analyte. 
However, liquid matrices cause analyte spreading in the plane of the TLC plate. TLC- 
LD MS is performed without the addition of a liquid matrix due to the greater 
penetration depth of a laser beam compared to an atom or ion beam. Even though TLC- 
LD MS provides high sensitivity and spatial resolution, it suffers from poor signal 
reproducibility and significant molecular fragmentation [15]. The latter disadvantage 
can be overcome by using an IR laser for desorption and an UV laser for ionisation, but 
this technique requires complex instrumentation [26]. The coupling o f TLC with 
MALDI can potentially overcome these drawbacks. TLC-MALDI MS has been shown 
to be useful for the analysis of a variety of biopolymers, including peptides and proteins 
[15-18], nucleotides [19], glycosphingolipids [20], lipopolysaccharides [21], and 
oligomers [22]. Low molecular weight compounds, such as dyes [16-17], drugs [23], 
metal acetylacetomates [24], and pesticides [25] have been also investigated. In recent 
years the interest in the use of TLC-MALDI MS for the direct analysis of TLC plates 
has increased [27].
The aim of the present thesis was to develop methods for the analysis of pharmaceutical 
compounds by direct TLC-MALDI TOF MS. The thesis is divided in ten chapters. 
Chapter 2 gives an overview of the evolution of TLC-MS, involving the different 
ionisation techniques employed, with special emphasis on MALDI mass spectrometry. 
Six main chapters follow, in which several issues for successful TLC-MALDI coupling 
are addressed:
Chapter 3 is concerned with the method used for the deposition of the MALDI matrix 
onto the TLC plate. The matrix facilitates the ionisation of the analyte molecules, 
separated on the TLC plate. The application of the matrix directly onto the TLC plate 
has to be done in such a manner that analyte spreading along the silica gel layer is 
avoided. Thus, the chromatographic integrity of the analyte spots is maintained. Several 
approaches for the application of the matrix for TLC-MALDI coupling have been
compared, including a newly developed electrospray deposition method. This 
electrospray method was found to be superior to the other techniques studied. It 
produced a stable signal, minimised analyte spreading and hence allowed the scanning 
of a TLC plate to obtain chromatographic as well as mass spectral data.
Chapter 4 discusses the requirement for efficient extraction of the analyte from the 
interior of the silica gel layer to increase the sensitivity. To enhance the signal recorded 
directly from a TLC plate the use of an extraction solvent prior matrix application was 
investigated. The porosity of the silica gel layer can also lead to problems. Ions starting 
from different points on the surface can have a slight variation in their flight times, and 
hence a decrease in the mass resolution of spectra recorded is observed, when a TOF 
analyser is employed. The mass measurement inaccuracies, typically obtained in TLC- 
MALDI TOF MS analysis, were corrected by internal recalibration on selected matrix 
ions during the MS scan.
In chapter 5 the generation and characterisation of an impurity profile of a 
pharmaceutical compound by TLC-MALDI TOF MS at the 0.1% level is reported. 
Mass chromatograms could be constructed down to 2.4 pmol spots of the impurity. 
Further improvements in sensitivity were achieved by using a special Si 60 F254 
HPTLC-MALDI target. Using this special target mass spectra in the high fmol range 
were obtained.
For the analysis of low molecular weight compounds, such as pharmaceuticals, strong 
matrix peaks can interfere with the analyte signal. Chapter 6 presents a study o f the 
minimisation of such matrix interference by applying suspensions of different materials 
and sizes (Co-UFP, TiN, Ti0 2 , graphite, and silicon) onto eluted TLC plates.
The combination of TLC with MALDI is not only applicable to the qualitative analysis 
of pharmaceuticals. Chapter 7 describes the generation of quantitative data by using a 
structural analogue as an internal standard. Different approaches to the incorporation of 
the internal standard into the TLC plate were investigated and are presented. The most 
successful approach was to develop the TLC plate in the mobile phase to which the 
internal standard was added. Good accuracy, precision, linearity and sensitivity could be 
obtained using this approach.
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In chapter 8 the use of post-source decay (PSD) -  MALDI, directly performed on TLC 
plates, is presented as a method to aid the identification of compound spots. Two 
matrices were tested for the TLC-PSD MALDI analysis of several small drug 
molecules, the organic matrix a-cyano-4-hydroxy cinnamic acid (a-CHCA) and the 
particle suspension matrix graphite.
The results presented in chapters 3 to 8  are finally concluded in chapter 9 and some 
possible suggestions for future studies were made.
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2.1 Thin-layer Chromatography - Mass Spectrometry
2.1.1 Introduction
Thin-layer chromatography (TLC) combined with mass spectrometry (MS) has a long 
and distinguished history dating back to the late 1960s, where much of the work 
involved scraping off the separated sample spot from the support (plastic, glass or 
aluminium backing) and subsequent analysis by MS (with or without extraction of the 
adsorbent). A detailed summary of the earlier TLC-MS work, including this indirect or 
off-line approach, can be found in the review by Busch [1].
A wide range of compounds, including small molecular weight compounds (drugs and 
metabolites, porphyrines, surfactants, toxins and dyes) and biomolecules (peptides, 
lipids, bile acids, oligosaccharides, polysaccharides and glycosides), have been analysed 
by TLC-MS. The whole range of ionisation techniques, has at one time or another, been 
used for the MS detection of TLC spots in a direct or indirect approach. An overview of 
the ionisation techniques applied to TLC-MS is given in Figure 2-1.
TLC - El MS - MS 
TLC - FAB MS - MS 
TLC - LSI MS - MS
TLC - MALDI MS
TLC - ESI MS
TLC - SALDI MS
20001960 1970 1980
Figure 2-1. Evolution of ionisation techniques in TLC-MS.
Here only the recent developments and applications will be described on the basis of the 
ionisation methods employed. For a more detailed coverage of this topic the reader is 
directed to several reviews [2-4].
2.1.2 Ionisation Techniques
TLC-EI MS. The use of the classical ionisation technique electron ionisation (El) [5-7], 
in conjunction with the ’’traditional” scrape and elute method in TLC-MS, is generally 
limited to the analysis of relatively non-polar and thermally stable compounds. The 
reasons are that polar involatile compounds have a strong adsorption to the silica gel 
layer, and hence high temperatures are required to evaporate them, and at these 
temperatures they decompose. One possibility to overcome this problem is the use of 
less adsorbent phases, such as polyamide TLC plates [8 ].
Recently Brzezinka et a l [9] have described the screening of biological samples for 
drugs and metabolites by indirect TLC-EI MS. The appropriate zone of the silica gel 
TLC plate was scraped off and extracted in methanol. The extracts were then transferred 
to the direct insertion probe of the mass spectrometer. Evaporation of the drug 
molecules were accomplished by a source temperature of 200°C. The gas-phase 
molecules were ionised by collision with unusually energetic electrons (100 eV), 
emitted from a heated filament. Typically, the radical cation M** as well as several 
fragment ions of the drug molecules were present in the recorded mass spectra. The 
formation of fragment ions was caused by the release of the excess energy of the radical 
cations.
TLC-CI MS. Chemical ionisation (Cl) [10-11] combined with TLC is considered as an 
alternative to TLC-EI MS for the analysis o f volatile samples. However, TLC-CI MS 
has not been widely used. The most comprehensive work in this area has been reported 
by Ramaley et a l [12-13], introducing a TLC-MS scanner. The instrument was based 
on thermal or laser desorption of analytes, separated or spotted on a TLC plate, into a 
gas stream, which carried the sample molecules into the ion source of a quadrupole 
mass spectrometer. Methane was used as Cl reagent gas to form protonated molecules 
[M+H]+ of the sample by proton transfer reactions between the highly acidic reagent gas 
CH5+ ions and the neutral sample molecules. The TLC plate was moved at a constant 
speed using stepper motors to enable the evaporation of all analyte spots present on the 
plate. Only low resolution chromatograms were obtained by this approach, due to 
redistribution of desorbed material within the TLC plate.
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TLC-LSI MS and TLC-FAB MS. The sputtering techniques, liquid secondary ionisation 
(LSI) [14-15] and fast-atom bombardment (FAB) [16-17] have been coupled to TLC to 
avoid the separate and discrete evaporation step, necessary in TLC-EI MS and TLC-CI 
MS. The sample molecules are transferred directly from the condensed-phase into the 
gas-phase, enabling the analysis o f polar, involatile, thermally unstable compounds, e.g. 
biomolecules. A variety of reports, including indirect and direct coupling methods by 
means of one- or two-dimensional images, are described in the literature [3].
Chang et a l [18] have described a TLC-FAB MS method that involved the transfer of 
an analyte spot within the silica gel layer to a FAB probe tip. After the TLC separation, 
the TLC spot was localised with UV fluorescence and removed from the backing by 
pressing the probe tip, covered with double-sided tape, onto the silica gel layer, as 




Figure 2-2. Transfer of the TLC spot to the FAB probe tip [18].
To extract the analyte from the absorbent and to aid in soft ionisation, a small amount of 
the FAB matrix, glycerol, was added to the removed spot. Desorption and ionisation of 
the sample was accomplished by irradiation with a fast neutral beam ( 6  kV xenon 
atoms). The exact mechanisms of the ion formation is not clear, however proton-transfer 
reactions are believed to play an important role [19]. The mass spectra of the antibiotic 
samples showed protonated molecules [M+H]+, as well as [M+Na]+ and [M+K]+ 
adducts. The matrix glycerol employed gave high background signals in the low mass 
range. However, no interference with the analyte signals were reported.
To enable the trace analysis of tetracyclines in bovine tissues and milk by TLC-FAB 
MS, Oka et a l [20-22] developed a technique to concentrate the analyte in the spot into 
a smaller area. The so called “trapezoid condensation technique” involves scraping a
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trapezoidal shape around the TLC spot followed by the application of the polar solvent 
methanol, causing the migration of the analyte towards the tip of the trapezoid. The 
procedure is presented in Figure 2-3. A FAB matrix is then applied to the condensed 
zone to enable direct MS analysis.
Mefluno!Suboctry phase
Medumol
From Qrigi* Sanpictpoc Condemed *one (QJ x 2mm) of simple
Figure 2-3. Procedure of the “trapezoid condensation technique” [20],
The acquisition of one-dimensional images of developed TLC plates by TLC-FAB MS 
was reported by Tamura et a l [23]. The insertion probe inlet of the mass spectrometer 
was modified to hold a 10 mm x 65 mm TLC plate, as shown in Figure 2-4.
From FAB gun




Figure 2-4. Design of the modified insertion probe inlet of a  FAB m ass spectrometer, allowing 
the scanning of a TLC plate in one dimension [23].
Since the incident particle beam was fixed, the various spots on the TLC plate were 
subsequently brought into focus by stepper motors, which moved the TLC plate along 
the y-axis. The obtained chromatograms exhibited reduced resolution due to diffusion
processes of the analyte caused by the liquid matrix; particularly if analysed a long time 
( 1 0  minutes) after application.
A similar approach was reported by Nakagawa and Iwatani [24] for the direct TLC-LSI 
MS determination of several drug metabolites. The design o f the movable direct 
insertion probe was similar to the type described by Tamura et a l [23]. The only 
obvious difference was the particle beam used for the deposition and ionisation process; 
an ion beam (cesium ions) was used, instead of a neutral beam.
Besides one-dimensional imaging, TLC-LSI MS has been successfully applied to record 
two dimensional images of a variety of compounds, including drugs, peptides, bile 
acids, diuretics and alkaloids [reviewed in 1, 25-27]. Busch et a l [27] first introduced 
such a mass spectrometer enabling the scanning of a TLC plate in the x- and y-axis. For 
the collection of the images in most experiments a gallium ion gun was employed due to 
its small beam diameter (1 pm). Thus, the spatial resolution could be readily improved 
compared to a cesium ion gun (20 pm) or an argon FAB gun. To minimise the 
limitation in the spatial resolution, arising from the liquid matrix, the phase-transition 
matrix threitol (melting point: ~ 71°C) was tested [26]. The matrix was applied to the 
TLC spot by means of spray deposition. The energy o f the primary ion beam in the 
mass spectrometer was sufficient to melt threitol precisely at the point of analysis, 
therefore providing a spatially discrete extraction.
TLC-LD MS. Another desorption-ionisation technique, which also allows the analysis of 
polar thermally unstable substances, is laser desorption (LD) [5-6]. Coupling to TLC 
has the advantage that no liquid matrix is required, and hence the spatial resolution for 
imaging of TLC plates is only limited by the incident laser beam. The imaging 
capabilities of such a technique has been shown for triphenylmethane dyes, distributed 
on a polymer membrane, using a laser-desorption based microprobe (LAMMA) [28]. 
The LAMMA instrument was equipped with a ultraviolet (UV) laser, focused to a spot 
size of 5 pm. The mass analysis was accomplished in a TOF analyser. The ions are 
believed to be desorbed and ionised with the UV laser due to excitation processes and 
individual electronic and photochemical reactions [29]. A thermal process was also 
suggested by transfer of the energy through substrate absorption followed by heating up 
of the sample layer [30]. The recorded mass spectra were dominated by molecular 
cations M*+ of the dye molecules and several fragment ions.
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The ionisation of a range of low molecular mass organic compounds directly from 
polyamide TLC plates was reported with this microprobe [31]. However, the polyamide 
stationary phase caused background ions in the low mass range of the recorded mass 
spectra. Furthermore, a high degree of fragmentation was obtained, due to the high laser 
power required for desorption of the analytes from such a material. The described 
fragmentation combined with poor reproducibility [32] encouraged the development of 
two-step laser mass spectrometry (L2 MS) for the surface analysis of TLC plates, since 
it also offers the advantage of no sample preparation.
TLC-L2 MS. The detection of various thermally labile biological molecules from silica 
gel TLC plates has been presented by Li and Lubmann [33] using L2 MS. In L2 MS the 
desorption and ionisation process is separated from each other. In the first step 
(desorption step), an infrared (IR) laser pulse is employed to ablate the analyte with the 
silica gel from the TLC support. The desorbed material is entrained in a supersonic jet 
of CO2 and transported towards a time-of-flight (TOF) mass analyser. The supersonic jet 
has three main functions [33]: (i) transport of the desorbed species away from the TLC 
plate to prevent sample condensation; (ii) cooling of the desorbed neutral molecules to 
avoid thermal decomposition, and (iii) increase in mass resolution of the recorded 
spectra by minimisation of the energy spread. The last point will be explained in more 
detail in section 2.2.4 of this thesis, where TOF mass spectrometry is discussed. In the 
second step (ionisation step), a pulse from a tuneable UV laser is used for resonance- 
enhanced multi-photon ionisation (REMPI) [5] of the neural gaseous molecules. In the 
resonance-two-photon ionisation (R2PI) [34], which takes place, the gaseous molecules 
in the ground-state, absorb one photon to reach their first excited-state. When they 
absorb a second photon, their internal energy is above the ionisation potential (IP) and 
dissociation of an electron occurs, resulting in the formation of radical cations. This soft 
ionisation scheme prevents extensive fragmentation, and therefore the recorded spectra 
are dominated by molecular ions, of those compounds that strongly absorb the selected 
ionisation wavelength. Since the ionisation wavelength is tuneable, it is possible to 
minimise the background level caused by the silica gel and to detect selectively analytes 
in unresolved TLC spots. The application of this technique has also been demonstrated 
for the determination of the drug naproxen [35] and the construction of one-dimensional 
images of small peptides, developed on a TLC plate [36].
13
TLC-MS-MS. Tandem mass spectrometry (MS-MS) [5-6, 37] applied in combination 
with TLC offers the advantage that structural information of the compounds of interest 
can be obtained and that the background noise is eliminated. In TLC-FAB MS and 
TLC-LSI MS the background noise is typically obtained due to the use of a liquid 
matrix, and in TLC-LD MS arising from the material of the TLC plate. A wide range of 
compound classes, including drugs and their metabolites, polymer additives, and 
glycolipids have been investigated in a direct or indirect approach [reviewed in 38]. For 
those compounds, which were not amenable by El, FAB or the related ionisation 
technique LSI was used. In the TLC-MS-MS experiments a molecular ion species of the 
analyte was selected in the first mass analyser, and thus separated from the interfering 
background ions. Excitation of the selected molecular ion species occurred in a collision 
cell with neutral gas molecules (usually He, Ar or Xe). The dissociated ions were then 
analysed in a second mass analyser. The only disadvantage of the tandem MS analysis 
was the higher sample quantity required compared to single stage TLC-MS.
TLC-MALDI MS. Matrix-assisted laser desorption/ionisation (MALDI), as a technique 
to ionise analytes separated on a TLC plate, has been examined by several groups in 
order to compensate for the limitations of the previously discussed ionisation methods. 
In comparison to LD, the sample preparation by MALDI involves the use of a matrix. 
However a greater versatility in the MS analysis is provided, by enabling the formation 
of larger ionic species from thermally labile non-volatile compounds with nearly no 
fragmentation. The fundamentals of MALDI mass spectrometry are separately 
discussed in section 2.2 of this chapter. Here, only the important features of direct TLC- 
MALDI coupling are covered. For the indirect TLC-MALDI approach (scrape and 
extract technique) the reader is directed to two recent publications [39-40].
As mentioned in the introduction (chapter 1) of this thesis, the challenge of direct TLC- 
MALDI coupling is the application of the matrix solution onto the TLC plate without 
causing planar diffusion. Several possible application procedures are described in the 
literature, and as the reader will see in chapter 3 of this thesis, have been investigated 
for their suitability in order to obtain chromatographic data.
In the original work, by Hercules and co-workers [32], the matrix solution was directly 
deposited on the separated TLC spot, using a pipette or syringe. Before matrix 
application, an extraction solvent was applied to the TLC spot to move the analyte
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molecules to the surface, thus enhancing the sensitivity. Once matrix and analyte were 
co-crystallised, portions of the TLC plate were introduced in the mass spectrometer for 
analysis. Although the technique enabled the construction of two-dimensional images, 
the shape of the TLC spots were altered due to spot diffusion, caused by the matrix 
deposition. Hence, a new technique [41] was introduced, which is presented in Figure 
2-5.
A. Matrix deposition
B.Drylng X  
matrix layer
Stainless steal
0 . Pressing F. MALDI analysis 
matrix lay er facing towards gel
C. Spraying ol extraction solution on TLC plate E. Stainless steel removed
Figure 2-5. Matrix deposition for direct TLC-MALDI analysis [41].
The new, very complex, technique involved pressing a previously prepared layer of 
matrix crystals into a pre-wetted TLC plate. The selection of the extraction solvent was 
based on its retardation factor (Rf) [42]. A high Rf value appeared to correlate to a high 
extraction efficiency. The signal intensity o f a selected analyte peak, recorded from a 
TLC plate, showed typically a maximum at mid Rf values, since too high extraction 
efficiencies caused analyte spreading. Several follow up studies were carried out, 
including the qualitative determination of pesticides [43], carcinogen DNA adducts 
[44], and the quantitative analysis of drugs [45].
Since sensitivity is an important factor for the usefulness of an analytical method, the 
same group has recently presented a TLC-MALDI hybrid plate [46]. The use of this
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special plate enabled, according to the authors, the recovery of 1 0 0  % of the deposited 
or developed analyte spot. This was achieved by eluting the separated analyte spot to an 
area, where the silica gel layer was removed and a matrix layer was created. With this 
hybrid plate the detection of the analyte in the rough and polar silica gel absorbent was 
avoided, and hence detection limits in the low femtomol range were obtained. Another 
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Figure 2-6. Pre-concentration of analyte spots for direct TLC-MALDI coupling to enhance
sensitivity [47],
Matusumoto et a l [47] pre-concentrated the analyte spot by scraping off the silica gel 
layer on one side of the TLC plate and development of the TLC plate in a second polar 
solvent, after a 90° rotation of the plate (an approach similar to two-dimensional TLC). 
Thus, the analyte migrated towards the edge of the silica gel layer and was 
simultaneously concentrated. This technique shows similarity to the “trapezoid 
condensation technique”, developed by Oka et a l [20]. Finally for MALDI analysis the 
matrix was directly applied on the edge of the silica gel layer at the position of the 
analyte.
Direct TLC-MALDI mass spectrometry has not only been applied to model compounds, 
“real” samples, such as the identification of unknowns in a synthesised organic mixture
[48], or biological material such as glycosphingolipids [49] or lipopolysaccharides [50], 
have also been successfully analysed. In the two latter applications, the biological 
samples were not only directly detected on the TLC plate, but also after heat transfer to
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a membrane. The sample preparation steps for the so called TLC blotting-MALDI MS 
experiments is explained in Figure 2-7. After the TLC plate was wetted in an extraction 



















Figure 2-7. Sample preparation for TLC-MALDI MS and TLC blotting-MALDI MS experiments
[49].
The direct TLC-MALDI MS experiments presented so far have all been obtained by 
employing a TOF analyser. Recent developments in MALDI have introduced the 
possibility of mass analysing ions, formed in an external ion source, in an ion trap or 
fourier transform ion cyclotron mass spectrometer. Further information about the 
different types of mass analysers used for MALDI, can be found in section 2.2.4 of this 
chapter. TLC-MALDI analysis of dyes in an ion trap mass spectrometer [51], as well as 
the determination of gangliosides in a fourier transform instrument [52] have been 
demonstrated.
TLC-SALDI MS. One disadvantage of using a matrix in TLC-MALDI is the matrix 
related background, occurring in the low mass range (below 500 m/z). Attempts to 
reduce these inference signals were reported by Cheng et a l using surface-assisted laser 
desorption/ionisation (SALDI) coupled to TLC [53-57]. In this technique the
appropriate zone of the TLC plate was in general covered with carbon particles 
(graphite, or carbon activated particles), suspended in glycerol, and introduced in the 
mass spectrometer, where the sample was irradiated with a UV laser. Using this 
methodology a variety of low molecular weight compounds could be detected, for 
example peptides [53-54], organic reactions products [55], polymers [56], and 
porphyrine derivatives [57]. A more detailed description of this technique can be found 
in chapter 6  of this thesis, where a similar approach was chosen for the analysis of 
tetracyclines.
TLC-ESI MS. Electrospray ionisation (ESI) [5-7, 58], another fairly new soft ionisation 
technique, was recently used for the detection of analytes, separated by reversed-phase 











Figure 2-8. TLC-ESI MS interface [59],
The extraction solvent (methano 1-water) was delivered through the central capillary tube 
to the analyte spot on the TLC plate. After a short time, the solvent extract was absorbed 
by capillary action in the absorbent material, placed in a further tube, surrounding the 
solvent delivery capillary. For mass spectrometric analysis, the analyte was extracted 
from the absorbent with an aliquot of solvent and directly injected in a triple-quadrupole 
mass spectrometer. The fine needle, which was held at a high potential (3-5 kV) 
produced a spray consisting of charged solvated aerosol particles, which evaporated and 
reduced their size till they were unable to “hold” the electrical charge on the rapidly 
decreasing surface area. The solvent clusters of the resulting single ions were removed 
by heating to 80°C. After ionisation of the sample molecules at atmospheric pressure,
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they passed several skimmers entering the high vacuum system of the analyser. Since 
the recorded mass spectra showed several abundant ions in the low mass range, 
produced from the material o f the TLC plate, which was also extracted, tandem MS was 
performed on the protonated analyte species. To minimise the spreading of the analyte 
during the extraction step, a hydrophobic barrier by means of melted wax was tested.
A newer TLC-ESI interface directly pumps the analyte extract in the ESI mass 
spectrometer [60-61]. The described extractor works similar to a HPLC pump valve and 
forms a strong sealing to the TLC support by cutting the absorbent layer. Qualitative 
and quantitative data were obtained with this set-up. Both TLC-ESI interfaces are at an 
very early stage and seem rather complex.
2.2 MALDI Mass Spectrometry
2.2.1 Introduction
The introduction of matrix-assisted laser desorption/ionisation mass spectrometry 
(MALDI MS) as a soft ionisation technique in the late 1980s by Karas and Hillenkamp 
[62-64] and by Tanaka et al. [65] has greatly helped to bring mass spectrometry into 
biomolecular science. MALDI MS enables the mass analysis of large, non-volatile and 
thermally labile compounds, such as proteins, oligonucleotides and synthetic polymers 
[6 6 ]. In the thirteen years since its introduction MALDI has become a standard method 
for the mass spectrometric analysis of biological macromolecules [67-68], due to its 
high sensitivity (attomole-range) [69], the accessible mass range (above 300 kDa) [6 6 ] 
and improvements in the resolution of time-of-flight (TOF) analysers [70-71]. Although 
MALDI is a powerful technique for the production of gas-phase ions from large 
molecules, the ion formation pathway remains still not fully understood. In a typical 
MALDI analysis, the analyte of interest is co-crystallised with an excess of a solid 
matrix, which has a strong extinction coefficient at the wavelength of the laser and 
hence directly absorbs the laser energy. The laser pulse induces desorption and 
ionisation processes of matrix and analyte molecules in a very dense plume, as shown in 
Figure 2-9.
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Figure 2-9. Schematic representation of the desorption/ionisation process. Matrix molecules 
absorb the laser energy, volatilise explosively and liberate the analyte ions to form the MALDI
The ions formed in the MALDI plume are extracted by a strong electric field into the 
field-free region of the TOF analyser, where they are separated according to their mass- 
to-charge (m/z) ratio. Depending on the polarity of the electric field, positive or 
negative ions are extracted. Each ion induces a current at the detector, which is then 
monitored as a function o f time yielding a mass spectrum. Several tens of mass spectra 
are summed up to improve the signal-to-noise ratio.
In the following sections, the experimental factors effecting the outcome of a MALDI 
spectrum are presented and the current knowledge on desorption-ionisation processes in 
the MALDI plume are discussed. A brief overview of the basic instrumentation 
currently available for TOF mass spectrometry is also given. This should give the reader 
an insight into the great diversity of MALDI TOF mass spectrometry.
2.2.2 Experimental Parameters in MALDI Mass Spectrometry
The number of parameters influencing the outcome of a MALDI experiment is 
enormous. Here, only the laser wavelength (A), the choice of matrix (B), and the sample 
preparation technique (C) are discussed, since they are considered to be the most 
significant [73].
plume [72].
A. Laser wavelength. The laser wavelength is a particularly important parameter in
MALDI. Traditionally MALDI uses ultraviolet (UV) fixed frequency lasers
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with nanosecond pulses. In the original work, Karas and Hillenkamp [62] employed a 
frequency-quadrupled Nd:YAG laser at 266 nm to detect proteins with molecular 
masses above 10 kDa embedded in nicotinic acid. Later, lasers emitting at 337 nm 
(nitrogen laser) and 355 nm (frequency-tripled Nd:YAG laser) [74] were used. 
Although all UV laser wavelengths have been successfully applied to MALDI MS, 
nitrogen lasers are found in most commercial instruments, since they are reliable and 
inexpensive. A nitrogen laser was also used in this work. In a parallel development, 
lasers in the infrared (IR) wavelength range have been applied: Er:YAG lasers emitting 
at 2.94 pm [75] and CO2  lasers, emitting at 10 pm [76]. The introduction of tuneable 
free-electron lasers (FEL) [77] and optical parametric oscillator (OPO) based systems
[78] have made the use of IR-MALDI very attractive, since they may be used in 
conjunction with ice as the matrix. The visible (VIS) wavelength range is not often used 
in MALDI due to a limited choice of good matrices. Dye compounds, e.g. rhodamine
6 G [79] or graphite plates [80] have been shown to be effective, when a frequency-
doubled Nd: YAG laser (532 nm) is employed.
B. Matrix. In addition to the selection of the laser wavelength, the matrix plays a key 
role in MALDI mass spectrometry. The functions of the matrix are characterised as 
follows [64, 81]:
• The high molar excess of the matrix (typically in the range of 1000 fold) 
provides separation of analyte molecules from each other, and therefore
reduces the intermolecular interactions between individual analyte
molecules.
• The energy deposition into the analyte molecules occurs through the matrix, 
thus the matrix must show a strong resonance absorbance at the applied laser 
wavelength. (In the case of particle suspension matrices, this is discussed 
extensively in chapter 6  of this thesis.)
• The matrix promotes analyte ionisation. (This will be described in detail in 
section 2.2.3 of this chapter.)
Besides this three properties, further requirements of the matrix, such as vacuum 
stability and compatible solubility with the analyte, are necessary. It is impossible to 
predict a priori if a compound is a good matrix or not, due to the limited understanding 
of the desorption-ionisation process. Thus, the discovery of new matrix materials with 
the desired properties has been a matter of empirical search [73]. There are several
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compounds, which have been used as MALDI matrices, however only a few compounds 
have established themselves as “common matrices”. Frequently used UV matrices are 
derivatives of benzoic acid, e.g. 2,5 dihydroxy benzoic acid (DHB) [82-84], and 
derivatives of cinnamic acids, e.g. a-cyano-4-hydroxy cinnamic acid (a-CHCA) [85]. 
For the analysis of oligonucleotides, 3-hydroxy picolonic acid (3-HPA) [8 6 ] is a 
potential matrix. Glycerol [87], succinic acid [8 8 ] and water [89] have been proven as 
useful IR matrices. The structures of some common UV and IR matrices, including 
those used in this work, are shown in Figure 2-10.
UV matrices IR matrices
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3-hydroxy picolinic acid 
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Figure 2-10. Structures, chemical names and abbreviations of common MALDI matrices. The 
abbreviations are usually used throughout this thesis.
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The mass spectral quality can often be improved by addition of a low molecular weight 
compound to the analyte-matrix mixture. On examination of the physio-chemical 
properties of these compounds, one can roughly distinguish between two different 
groups. The first group is embodied by substances, like fructose [90] or diamonium 
hydrogen citrate [91], which show no properties required for a matrix compound and 
hence are called as “matrix additives” or “co-matrices”. Fructose for example improves 
the mass spectral quality by decreasing the fragmentation rate of peptides and proteins. 
It is believed that the laser energy causes the pyrolysis of fructose molecules, which 
then absorb excess energy causing cooling during the desorption-ionisation process
[92]. A very well known representative of the second group is “super DHB” (DHBs), 
which is a mixture of 2,5-dihydroxy benzoic acid (DHB) and 2-hydroxy-5-methoxy 
benzoic acid (HMB) in the volume ratio 9:1 [93]. HMB is a compound, which has the 
properties of a matrix, and hence the resulting mixture of these two matrices is named a 
“binary matrix system”. In principal more then two matrices can be mixed together, 
however each compound added increases the possibility o f interference with analyte 
signals in the low mass range.
C. Sample Preparation Technique. A variety of different sample preparation 
techniques have been developed, since the introduction of MALDI mass spectrometry 
[62-65]. A summary of the most common sample preparation methods is given in Table 
2- 1.








Liquid matrix Chemical liquid 
Particle suspension
Special preparation Solid supports
The dried-droplet method [82], originally developed by Karas and Hillenkamp, is
nowadays used routinely in combination with the matrices DHB, DHBs and 3-
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HPA. A drop (lpl) of an aqueous matrix solution is mixed with a drop (lpl) of an 
analyte solution and dried. The resulting analyte-doped matrix crystals show typically a 
heterogeneous morphology, and therefore induce a lower mass accuracy, especially in 
linear TOF mass analysers.
Therefore the fast-evaporation method [94] was introduced to improve the mass 
accuracy and mass resolution of the MALDI measurements. Matrix and sample are 
handled separately: a drop (lpl) of the matrix solution (e.g. a saturated solution of a- 
CHCA in acetone) is applied to the target and is dried, and on top of it a drop (1 pi) of an 
aqueous analyte solution is deposited.
If the analyte is insoluble and it seems impossible to embed it in a matrix environment 
by the two previously described methods, the pellet method [95] is a possible solution. 
A mixture of finely ground matrix and analyte is pressed together in a hydraulic press.
There is a natural interest in the improvement of spectral quality by means of increased 
reproducibility and signal intensities. This enables the quantitative analysis of different 
compound classes by MALDI mass spectrometry. The sample preparation techniques, 
spin-coating [96], electrospray [97-99] and air-spray [100], have been developed to 
create a more homogeneous layer of equally sized matrix-analyte crystals, since even 
with the fast-evaporation method [94] a certain degree of heterogeneity within the 
MALDI sample is obtained, as revealed recently by mass spectrometric imaging [101]. 
Equally sized matrix-analyte crystals are believed to enhance the overall MALDI 
performance [102]. In spin-coating, a large volume (3-10 pi) of a premixed analyte- 
matrix solution is deposited on the target, yielding an even distribution of the analyte.
In the electrospray method [97-98] a small amount of the analyte-matrix mixture is 
electrosprayed from a HV-biased (3-5 kV) stainless steel capillary onto a grounded 
metal sample plate, mounted 0.5-3 cm away from the tip of the capillary. The diameter 
of the capillary, the flow rate, as well as the distance between the capillary tip and the 
table effects the size of the micro-crystals. Not only a mixture of analyte-matrix solution 
can be electrosprayed, Caprioli et al. [99] used this method to electrospray a matrix only 
solution onto tissue sections for molecular imaging of individual compounds distributed 
in the biological sample. An alternative, simple, low-cost sample preparation technique 
is the air-spray method [1 0 0 ], in which the pre-mixed matrix-analyte mixture is 
deposited onto a heated stainless steel target with a compressed air-brush device. The
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two latter presented sample preparation techniques have been further studied for matrix 
deposition onto TLC plates, as described in chapter 3 of this thesis.
Often only a small amount of the analyte is available and the addition of the matrix 
solution to the analyte decreases the analyte concentration. In this situation the use of 
matrix-precoated targets [103-104] is advantageous; an aqueous solution of the analyte 
is spotted directly onto a matrix-precoated target. Most efforts have been focused on the 
development of thin-layer matrix-precoated membranes, e.g. nitrocellulose, anion- and 
cation-modified cellulose, nylon, PVDF or regenerated cellulose dialysis membranes
[103]. This method offers the possibility of off-line coupling of MALDI to liquid 
separation techniques, such as capillary electrophoresis (CE) [105] or liquid 
chromatography (LC) [reviewed in 106-107].
The preparation of analytes with chemical liquids [63, 87] is rather straightforward. An 
appropriate molar ratio of the analyte is dissolved in an UV-absorbing liquid, e.g. o- 
nitrophenyl octyl ether [63] or an IR-absorbing liquid, e.g. glycerol [87]. The 
requirements for co-crystallisation and solubility, when employing solid matrices, are 
thus circumvented.
The addition of fine metal or carbon particles to a non-absorbing liquid (e.g. glycerol, 
liquid paraffin or ethylene glycol) is also a way of preparing samples for MALDI. The 
solid particles absorb the laser energy and assist in analyte desorption and the liquid 
dissolves and ionises the analyte. This concept offers more flexibility compared to a 
laser energy absorbing liquid or solid matrix. The use of such particle suspensions [108-
114] was first introduced by Tanaka et al. [65] and since then several combinations of 
particles and liquids have been used to analyse proteins, oligosacccharides, synthetic 
polymers, and dyes. Further information about this approach and its application in TLC- 
MALDI MS can be found in chapter 6  of this thesis.
An extension of the particle suspension technique is the solid support method [80, 106, 
115-116]. The laser energy absorbing particles are compressed or sintered to form an 
“active” MALDI support. A variety of materials, including Si, TiN, CuO, graphite, and 
carbon particles have been tested [80, 106]. However, best known is the use of porous 
silicon as sample support (desorption/ionisation on porous silicon or DIOS) [115-116]. 
This concept is very promising for practical applications, although current limitations
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are a limited mass range, poor reproducibility of the fabrication process, and surface 
contamination.
2.2.3 Desorption and Ionisation Mechanisms in UV MALDI
Investigation of the MALDI mechanism has been the focus of interest of a number of 
research groups. Several models explaining the desorption and ionisation processes 
occurring in the MALDI plume have been proposed, and these are discussed in the 
following section. Each is considered separately for simplicity reasons, although it 
certainly does not reflect reality, where they probably work in combination.
Desorption Mechanisms. A quasi-thermal desorption model was recently suggested 
by Hillenkamp and co-workers [117-118]. The first step involves a pressure-driven 
decomposition of the matrix-analyte material into smaller particles. The smaller 
particles consist of clusters and single molecules [119-120]. In a second step the clusters 
and individual molecules are thermally desorbed from the sample surface forming the 
MALDI plume. At the first few seconds, the MALDI plume is characterised by high 
density and high collision rates. After a few nanoseconds an explosive phase transition 
occurs, in which molecular gas-phase species of matrix and analyte are formed through 
expansional cooling. The initial velocities of ions formed in the plume are about 300- 
500 m/s [121], and such high initial velocities are assumed to indicate a soft desorption 
process.
Ionisation Mechanisms. The ionisation processes in MALDI mass spectrometry are 
less well understood then the desorption processes. Models for ion formation were 
summarised in a recent review by Zenobi and Knochenmuss [73] and discussed again 
more recently by the same authors [122] and by Karas et al. [123].
The current view is that several different pathways are contributing to the formation of 
ions, as summarised in Table 2-2.
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T a b le  2 -2 . P o s s ib le  p a th w a y s for MALDI ion form ation .
Primary ion formation Desorption of pre-formed ions 
Multi-photon ionisation 
Energy pooling 
Excited-state proton transfer 
Disproportionation reactions 
Thermal ionisation
Secondary ion formation Proton transfer 
Electron transfer 
Cationisation
The term primary ion formation stands for pathways in which gas-phase ions are 
created from neutral molecules or aggregates (often derived matrix species) in the 
MALDI plume. Many of these ions will undergo collisions, which is believed to be 
particularly important for the formation of analyte ions. These reactions will be 
described later in the section on secondary ion formation.
Primary ion formation. An important primary ion formation pathway is the desorption 
o f pre-formed ions [124]. In this mechanism the ions observed in the MALDI spectrum, 
e.g. peptide-metal adducts, are believed to be already present in the solid sample and are 
ejected as those in the gas-phase by the laser pulse.
The formation of matrix radical cations (M+*) by multi-photon ionisation is considered 
by many authors as a strong candidate for the UV-MALDI primary ionisation step, 
following the equation:
n (hv)M — — -----► M ^ + e
Ionisation of the matrix molecule can only occur if the absorbed energy given by the 
laser is higher then the ionisation potential (IP) of the matrix molecule. The IP of the 
common matrix DHB was recently determined as 8.05 eV [125]. This means, that three 
photons (each 3.7 eV) of a nitrogen laser (commonly used for MALDI experiments) 
would be required to ionise one DHB molecule, which is not possible with the laser 
irradiance typically used. Nevertheless, ionisation could occur via the described two- 
photon absorption and an assisting thermal step, as described by Allwood et al. in a
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photothermal model [126] or by energy pooling [125]. In the latter model two nitrogen 
photons are absorbed by two neighbouring matrix molecules, which go into the excited 
state (M*M*) and pool their energy to yield one matrix radical cation (M1"*) as follows:
2 (hv)2M ---------► M*M* ------- ► M + M**  ► M + M * + e“
This model is more likely, since clusters are known to be liberated from the MALDI 
sample [119-120].
The excited-state proton transfer pathway is also a frequently proposed MALDI 
ionisation model [127]. A single excited matrix molecule (M*) is presumed to be much 
more acidic compared to its ground state. An analyte or matrix molecule in the ground- 
state in the proximity of an excited matrix molecule can then accept the labile proton:
+ A ^  [M-H]- + [A+H]+
M 1 (hy) ► M* <\  + M > [M-H]' + [M+H]
Since this model only requires one nitrogen photon it is favoured. However, the 
knowledge of the local environment in the MALDI plume is still too small to frilly 
evaluate this approach [73].
Disproportionation reactions [128] have been suggested to explain the simultaneous 
formation of positive and negative ions in the MALDI experiment. Proton transfer of 
two coupled matrix molecules in the excited-state is believed to occur, following the 
equation:
2M 2  (hV') > MM** _______ ^  [M-H]‘ + [M+H]+
This reaction was found to be energetically accessible (5 eV) with two 337 nm photons
[128].
For particle suspension matrices thermal ionisation [65, 73, 111] is a very probable 
mechanism. The liquid is generally transparent to the laser radiation, which is absorbed 
by the particles. Smaller particles have been found to work better, since the reflection of 
the laser light is reduced and the enhanced surface area results in a higher absorbance 
efficiency of the laser light. Both factors are presumably responsible for the higher
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peak temperatures reached with smaller particles [65, 111].
Secondary ion formation. In the gas-phase proton transfer reactions [122] are 
believed to occur between matrix ions and neutral molecules (analyte or matrix 
molecules).
If non polar compounds with IPs lower then that of the matrix are analysed in MALDI, 
electron transfer reactions [129] between a matrix radical cation (M4-*) and an analyte 
molecule (A) can take place to form an analyte radical cation (A+#):
M ~ + A ----- — ------ ► M + A**
The secondary ionisation steps discussed so far involve the charge transfer in the gas- 
phase. For compounds that have an ionic character the release of pre-formed ions 
(cations) upon laser irradiation possibly contributes to the total ion yield [130]. The 
mechanism describing this pathway o f ion formation in MALDI is called cationisation
[130].
A uniform model for ion formation in MALDI was introduced in 2000 by Karas and co­
workers [123], and needs mentioning. The dominant ionisation process in this 
hypothetical “lucky survivor model” is considered to be the desorption of multiply 
charged clusters. After evaporation of neutral matrix molecules, the desolvated and 
highly charged analyte ions are neutralised or charge reduced by electron capture or 
proton-transfer reactions with reactive matrix species. Thus, only singly charged analyte 
ions are believed to have a chance to survive in the dense MALDI plume. The model 
was later extended in accordance to different compound classes and preparation 
techniques [131].
After ions have been formed in the MALDI source, they are accelerated towards the 
mass analyser. A common type of mass analyser coupled to MALDI sources is the TOF 
analyser, which will be discussed now.
2.2.4 Time-of-FUght Mass Spectrometry
The TOF mass analyser [132] is possibly the simplest analyser, and is ideally suited for
MALDI ion sources, due to its virtually unlimited mass range and the high duty
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cycle. Many reviews have been published, outlining its principles [133-135].
Linear TOF mass spectrometer. Essentially in a linear TOF instrument (Figure 2-11)
ions, which are generated by the laser pulse, are accelerated by an accelerating potential 
(V) as they enter the drift region (D). The kinetic energy the ions gain in the source 
region is given by:
v  1 2z-e-V = — m-v2
Where z = number of charges
e = charge of an electron
m = mass of an ion
v = velocity of an ion
The flight times (t) for the ions to reach the detector is proportional to the square root of 
their mass-to-charge (m/z) values, as shown below:
,  = -2  = o  m / zv  V 2 - e - V
D = length of the drift region
A mass spectrum is created because ions of different masses arrive at the detector at 
different times. Heavier ions arrive at the detector later than lighter ones, assuming the 
ions are singly charged.
Sample surface Extraction grid Detector
^  Ion source Drift tube
Figure 2-11. Basic schematic of a linear TOF m ass spectrom eter.
The main drawback of the linear TOF mass spectrometer, when used with continuous 
extraction, is the low resolving power achievable. Ions, depending on where they are 
formed, experience different acceleration potentials, and hence have slightly different 
kinetic energies. As a consequence poor mass resolution in the recorded mass spectra is 
obtained, since there is no energy focusing on a linear TOF mass spectrometer.
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Improvements in resolution as well as mass accuracy have been obtained in two ways: 
the introduction of delayed extraction (DE) in a linear TOF instrument by Brown and 
Lennon [136] in 1995 and the use of reflectron TOF mass spectrometers, which was in 
fact first described by Mamyrin et al. in the 1970s [137].
Delayed Extraction (DE). In this technique, a calculated time delay in the order of 
several nanoseconds is introduced after the laser has fired and before the extraction 
pulse is applied to the backing plate or the intermediate grid in a two-stage extraction 
source. This ensures that ions of particular energies are focussed when they are 
accelerated into the drift region, as shown in Figure 2-12.
Backing Intermediate Final
plate grid grid (grounded) Detector
Extraction Acceleration Drift region
region region
Figure 2-12. Schem atic representation of delayed extraction in a two-stage ion source: (A) Ions 
are formed with different kinetic energies after the laser pulse, (B) the difference in their initial 
kinetic energies results in different velocities, a s  presented in the spatial spread. (C) After the 
time delay the extraction field is switched on and the ions gain different acceleration potentials, 
so that (D) the ions will reach the detector at the sam e time.
During the time delay, the ions rearrange their positions according to their initial 
velocities, so that those with larger velocities, travelling in the direction of the drift 
region, will gain less energy from the extraction field when it is switched on. The only 
disadvantage of DE is its mass dependency: the optimum time delay is different with 
each mass. Thus, the optimisation of resolution across the entire mass range of 
relevance is not possible. In practice, the time delay is set to focus on the highest mass 
of interest, since lighter ions have got a smaller velocity spread.
Reflectron TOF mass spectrometer. The reflectron was introduced into TOF 
instruments to improve energy focusing and hence to significantly enhance the mass 
resolution. At the end of the drift region an “ion mirror” is introduced, over which an
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electric field is applied. Minor differences in kinetic energy of ions with the same m/z 
values are corrected, since ions of greater energy penetrate deeper in the reflectron than 
less energetic ions. This ensures that ions with different kinetic energies, but the same 
m/z values, arrive at the detector at the same time. The reflectron TOF mass 
spectrometer can also be used to gain structural information of the analytes using post­
source decay, as described below.
Post-Source Decay (PSD). Since a large portion of the molecular ions undergo 
intensive metastable decay in the drift region, before they enter the mass analyser, 
structural elucidation can be performed in a reflectron TOF mass spectrometer. Intact 
molecular ions, which gained sufficient internal energy during the desorption process, 
can release their excess energy by dissociation during their flight, i.e. metastable 
decomposition. This process is called post-source decay (PSD) [138-143] and its 
principles are illustrated in Figure 2-13. The product ions formed by PSD continue to 
travel through the drift region with the same velocity, but with a range of kinetic 
energies, since their mass has changed. Ions with a higher kinetic energy (i.e. heavier 
ions) penetrate deeper into the “ion mirror” than lighter ions and hence mass to charge 














n r */ / r / 
U1 U2
First field free drift path
Figure 2-13. Principles of PSD-MALDI TOF m ass spectrometry [142].
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Conventional reflectrons require several experiments to be performed with the “ion 
mirror” voltage optimised for each small sequence of the product ion spectrum. A 
complete PSD ion spectrum can be obtained by combining the small sequences 
together. This is not required when a curved-field reflectron is employed. This type of 
reflectron is able to disperse all PSD ions over the acquired spectrum with the same “ion 
mirror” voltage applied. A complete product ion spectrum can thus be acquired within a 
single step [144]. The use of this technique in combination with TLC-MALDI MS is 
described in chapter 8  of this thesis.
Latest developments. In the last 14 years MALDI has been coupled to both linear and 
reflectron TOF systems, operated with or without delayed extraction. The latest results 
report the successful coupling of MALDI sources with quadrupole-TOF systems (q- 
TOF) using orthogonal extraction conditions [145-146, reviewed in 147] and with TOF- 
TOF systems [148]. Both instruments allow tandem mass spectrometry (MS-MS) 
experiments to be carried out on MALDI generated ions. The precursor selection occurs 
in the first analyser (quadrupole or TOF) and the product ions produced by collision- 
induced dissociation (CID) are mass analysed in the second analyser, the TOF analyser. 
Using a TOF analyser as the precursor ion mass filter has the advantage of a high duty 
cycle and the disadvantage of transmitting high energy ions into the collision cell, thus 
obtaining product ion mass spectra, which can provide less structural information, than 
those obtainable from low energy collisions. Other mass analysers, such as fourier 
transform (FT) cells [149-150] and ion trap (IT) mass spectrometers [151-152] have 
been successfully coupled to external MALDI ion sources. High mass resolution spectra 
from a range of fragile biomolecules, such as oligonucleotides [149], gangliosides
[150], peptides [151], and oligosaccharides [152] could thus be recorded. In MALDI- 
FT-MS fragmentation and metastable decay of labile ions is a limiting factor, due to the 
relatively long time between the ionisation and detection (in the range of a few seconds 
instead of microseconds, normally obtained in MALDI-TOF-MS). Cooling of the hot 
ions with a high pressure gas [149-150] has been used to circumvent this disadvantage. 
In atmospheric pressure (AP)-MALDI-IT-MS the gas stream also assists in guiding the 
ions from the external source to the inlet system o f the analyser [151-152].
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Chapter 3
Preparation of TLC Plates for MALDI MS Analysis
43
3.1 Introduction
The key step to a successful TLC-MALDI TOF MS analysis is the application of the 
MALDI matrix onto the developed TLC plate, prior to introduction into the mass 
spectrometer, as indicated in chapter 2 of this thesis. Several techniques for the 
deposition of the matrix have been described in the literature. The earliest method for 
plate preparation, developed by Gusev et a l [1], involves pressing a previously 
prepared layer of matrix crystals into the TLC plate. Bristow and Creaser [2] reported 
the TLC-MALDI determination of dyes, using plates prepared by spraying the matrix 
solution onto the plate with a TLC reagent sprayer. An air-spray method was developed 
by Haddleton et a l [3] as a sample preparation method for the MALDI MS analysis of 
polymers. Electrospray for sample preparation in MALDI was first suggested by 
Axelsson et al. [4] and independently, at about the same time, by Hensel et a l [5]. In 
this technique, a small amount of matrix-analyte mixture is electrosprayed from a HV- 
biased stainless steel or glass capillary onto a grounded metal sample plate, mounted 0.5 
- 3.0 cm away from the tip of the capillary. A high degree of reproducibility was 
demonstrated for this sample preparation technique and it was shown to yield high 
quality quantitative data. Caprioli et a l [6 ] used electrospray matrix deposition to coat 
tissue samples during the MALDI based molecular imaging of peptides and proteins in 
biological samples.
In this chapter methods for the application of the matrix in TLC-MALDI TOF MS have 
been evaluated that allow the scanning of a TLC plate in order to obtain 
chromatographic as well as mass spectral data. The aim of this work was to develop a 
method for matrix deposition that is capable of being automated. This will allow routine 
use of the technique, and hence alternative approaches to the matrix pressing method [1 ] 
were tested. Preliminary work carried out showed that the use of a TLC reagent sprayer,
[2] or an air-spray [3], to coat the TLC plate with matrix crystals, caused spreading of 
the TLC spots and would therefore not be suitable for the acquisition of 
chromatographic data. Since it was felt that the fine droplets produced by electrospray 





The analyte tetracycline (compound A) was purchased from Sigma-Aldrich (Dorset, 
U.K.). Samples of known manufacturing impurities, epitetracycline (compound B), 
anhydrotetracycline (compound C) and compound D were supplied by Pfizer Global 
R&D (Sandwich, U.K.). The structures of these compounds are as shown in Figure 3-1. 
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Figure 3-1. Structures of tetracycline and some of its impurities.
The following MALDI matrices were evaluated for TLC-MALDI analysis of these 
compounds: a-CHCA, HABA and DHB [7-8]. The matrices were purchased from 
Sigma-Aldrich (Dorset, U.K.). The solvents, acetone, methanol, ethanol and 
dichloromethane used, were all HPLC grade. Trifluoroacetic acid (TFA) (AR grade) 
was typically added at 0 .1 % v/v to the matrix solutions.
The TLC plates employed were silica gel 60 F2 5 4 , 0.2 mm thickness and aluminium 
backed (Riedel-de Haen, Germany).
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3.2.2 Instrumentation
The time-of-flight (TOF) mass spectrometer employed in these investigations was a 
modified LaserTOF 1500 (SAI, Manchester, U.K.). This is a linear TOF instrument, 
equipped with a nitrogen laser (1=337 nm) and delayed ion extraction. More 
information about the instrument and its performance can be found in the appendix 
(chapter 10) of this thesis. The sample holder of this instrument was redesigned to allow 
TLC strips of approximately 64 x 2 mm to be fitted into a recessed slot. The sample 
probe and software were also modified to allow free movement along the z (vertical) 
axis, and software was developed that allowed the construction of mass chromatograms 
from the acquired data sets. Only the positive ion mode was used in this study.
3.2.3 TLC Separation
Tetracycline and its impurities were separated to the procedure described by Weng et al.
[9]. Before use, the silica gel plates were sprayed with an aqueous solution of disodium 
EDTA (10% w/w, adjusted to pH 9.0), dried horizontally at room temperature for 30 
minutes, and then in an oven for another 30 minutes (120°C). The TLC development 
tank was lined with filter paper and saturated with the mobile phase 
dichloromethane/methanol/water (53/35/6, v/v) for at least an hour prior to use. 
Typically, a 10 pi aliquot of a sample solution (20 mg/ml in methanol) was applied to a 
plate with a disposable spotting pipette. The plate was developed to a distance of 7.0 
cm, air dried at room temperature and the analyte spots were visualised under UV light 
(1=254 nm).
3.2.4 Application Techniques of Matrix Material
Method 1: Transfer of a previously prepared matrix crystal layer into the TLC plate. A 
homogeneous matrix crystal layer was created on a 25 x 25 mm aluminium plate by 
depositing 50 pi aliquots of a saturated solution of a-CHCA, dissolved in acetone, on it. 
Sample spots, cut from the TLC plate, were wetted with an extraction solvent (ethanol 
or methanol/water 1:1, v/v). The previously prepared matrix layer on the aluminium 
plate was then pressed into the TLC plate for 2 minutes, using a small press. After
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transfer, the aluminium plate was removed and thus the coated TLC spots were stuck to 
a MALDI target using double-sided tape.
Method 2: Brushing of a supersaturated matrix solution. A 50 x 2 mm strip of a 
developed (or uneluted) aluminium-backed TLC plate was mounted onto a MALDI 
target with double-sided tape. An extraction solvent (ethanol) was applied to the TLC 
spots. A hot supersaturated slurry of a-CHCA in acetone was then dabbed onto the TLC 
strip with a stiff brush. The prepared target was dried at room temperature for at least 30 
minutes before analysis.
Method 3: Electrospraying of a matrix solution. For matrix application via electrospray, 
an electrospray deposition device was constructed, as illustrated in Figure 3-2. This 
electrospray deposition device consisted of a syringe pump (Harvard 11), fitted with a 
25 pi syringe, which was connected via PTFE/PEEK tubing to a HPLC ‘zero dead 
volume’ fitting to a capillary steel needle, to which a high voltage (1-4 kV) was applied. 
The capillary needle was further threaded through a HPLC T-piece ‘zero dead volume’ 
fitting, through which dry nitrogen could be applied coaxial to the capillary tube. The 
TLC strip, which was attached to the MALDI target, was earthed and held horizontally 
during spraying and set at a distance of ca. 2-4 mm from the spray needle. The voltage 
and distance between the capillary needle tip and TLC plate were adjusted such that a 
stable Taylor cone was visible and remained stable.
A 50 x 2 mm strip of the developed (or uneluted) aluminium-backed TLC plate was 
stuck onto a MALDI target with double-sided tape. An extraction solvent (ethanol) was 
applied to the TLC spots, when required. Matrix concentrations were between 10-100 
mg/ml, depending on the matrix solubility. Two solvent systems were tested: solvent 
system A, methanol containing 0.1% TFA and solvent system B, methanol containing 
0.1% TFA/ water in the volume ratio 1:1. Typically, a 25 pi syringe was filled with 
matrix solution and electrosprayed at a rate of 150 pl/h while the TLC plate was moved 
at ca. 0.6 cm/min. The voltage applied to the capillary needle of the electrospray device 
was typically ~ 1.5 kV.
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Figure 3-2. Electrospray deposition device.
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3.3 Results and Discussion
3.3.1 Matrix Selection
The initial selection of matrix was based on examination of the analyte MS response 
observed from conventional stainless steel targets, during MALDI MS analysis [10-11]. 
A premixed solution of a matrix and sample solution (lpl), in a series of matrix to 
analyte ratios, was pipetted onto a stainless steel target. The matrix was selected on the 
following criteria: (i) solubility of matrix and analyte in similar solvents, (ii) absence of 
interfering peaks in the spectral regions of interest, and (iii) reproducible analyte signal 
intensity from laser spot to spot over the target (i.e. good crystal homogeneity). For 
tetracycline, all three matrices (a-CHCA, HABA and DHB) appeared suitable, based on 
the normal MALDI sample preparation procedure. However, the lower solubility of 
HABA (10 mg/ml in methanol) excludes its use for electrospray deposition. a-CHCA 
showed possible interfering peaks at m/z 423 [2M-H+2Na]+ and 439 [2M-H+Na+K]+, 
which made its use as matrix difficult, since mass spectral resolution appears to slightly 
deteriorate on TLC-MALDI coupling. This effect may be due to the uneven nature of 
the TLC plate surface, although it is not at present completely understood. (See chapter 
4 of this thesis for a fuller explanation of this phenomenon.)
Optimum matrix to analyte (tetracycline) molar ratios varied from 5:1 (HABA), 100:1
(a-CHCA) to 700:1 (DHB). This small excess of matrix to analyte is a reflection of the
low molecular mass of the analyte species, in contrast with the situation of large
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molecular weight analytes, such as bioploymers, where very large matrix excess is used
[12]. The mass spectrum obtained with the use of a-CHCA at a molar ratio to 
tetracycline of 100:1 showed considerable matrix suppression effects [13].
3.3.2 Com parison of Matrix Application Techniques
Method 1: Pressing. The indirect means of matrix deposition, by pressing a 
predeposited matrix layer into a wetted TLC plate, has been reported to work 
successfully by Gusev et al. [14]. This is not consistant with the studies presented here; 
the procedure was found to be extremely difficult, and only small sections of the silica 
gel plate could be handled. Therefore a developed TLC plate was cut up into small 
sections 1.5 x 1.5 cm. The silica gel plate was quite fragile and frequently cracked 
during the procedure. Mass spectrometric analysis of successfully prepared TLC spots 
showed areas of localised analyte-doped matrix crystals, but the number of points, from 
which analyte signals were obtained, was insufficient to allow chromatographic 
information to be obtained from a spot.
Method 2; Brushing. Deposition of matrix material by brushing a supersaturated 
solution of matrix into a TLC plate showed some incorporation of analyte-doped 
crystals and did yield analyte mass spectra. Figures 3-3 to 3-6 show mass spectra from 
TLC spots obtained from the analysis of tetracycline and some of its known 
manufacturing impurities. The TLC procedure was as described in the experimental 
section. Figure 3-3 shows the mass spectrum obtained from epitetracycline retardation 
factor Rf = 0.11. The [M+H]+ ion can be clearly observed at m/z 444.8. Figure 3-4 
shows the mass spectrum of tetracycline, itself Rf = 0.25, the [M+H]+ ion at m/z 445.3. 
Two unknown impurities at Rf values of 0.34 and 0.60 are shown in Figures 3-5 and 3- 
6 , respectively. The pre-treatment of the TLC plate with disodium 
ethylenediaminetetraacetic acid solution was necessary for the improvement of the 
separation of tetracyclines from the impurities. Without the pre-treatment, streaking was 
observed on the plate, due to the interaction of the basic moieties of tetracycline with 
metallic impurities in the silica. However, this procedure frequently contributed to the 
enhancement of signals from sodium and potassium adducts of tetracycline (m/ 467 and 
483, respectively) and its impurities, which complicates the interpretation of the mass 
spectra.
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Figure 3-3. Mass spectrum of epitetracycline (ETC, Rf 0.11), from an a-CHCA matrix applied
using the brushing method.












Figure 3-4. Mass spectrum of tetracycline (TC, Rf value 0.25), from an a-CHCA matrix applied
using the brushing method.
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Figure 3-5. Mass spectrum of unknown impurity in tetracycline (Rf 0.34), from an a-CHCA 
matrix applied using the brushing method.
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Figure 3-6. Mass spectrum of unknown impurity in tetracycline (Rf 0.60), from an a-CHCA 
matrix applied using the brushing method.
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Because of the cation adducts, the close range of molecular weights of potential 
impurities, and deterioration of resolution on TLC-MALDI coupling, unambiguous 
identification of the impurities on the basic of assignment of the [M+H]+ mass peaks 
proved challenging. In such a situation, only the use of good quality impurity reference 
standards would enable conclusive identification or the use of MS-MS techniques, as 
presented in chapter 8  of this thesis.
The procedure worked well only with volatile solvents, such as acetone, and in such 
cases lateral spreading of analyte species was minimal. MALDI MS analysis of targets 
prepared in this way showed analyte signals from localised areas on the TLC plate. 
However, it was difficult to produce consistent results in terms of signal intensity, since 
the procedure did not yield a consistent loading of matrix on the TLC plate. Since the 
analyte signals from the TLC plates prepared by the brushing method are localised, they 
are not obtained from a sufficient number of points on the TLC plate to generate 
chromatographic information from TLC spots. A degree of skill is needed to prepare a 
good plate, and the method does not seem to lent itself to automation. Therefore it was 
not investigated further.
Method 3: Electrospraying. For tetracycline the best data from plates prepared by 
electrospray were obtained using DHB as the matrix (100 mg/ml in solvent system B). 
It was found that a single spray pass was sufficient. A second pass showed either no 
improvement in signal intensity or a deterioration in the signal obtained, possibly 
because the initial layer of the crystals which is co-crystallised with analyte would be 
redissolved by the second pass of matrix solution.
Using the modified instrument, chromatographic data were successfully obtained from 
TLC plates, directly spotted with three replicated tetracycline spots, each of 100 and 1 
pg, prepared using the electrospray method. Figure 3-7 and 3-8 show summed mass 
chromatograms over the range m/z 440-460 for three tetracycline spots of 100 pg 
(Figure 3-7) and 1 pg (Figure 3-8). Typical mass spectra obtained for 100 and 1 pg 
tetracycline spots are shown in Figure 3-9 and 3-10, respectively. The ultimate limit of 
detection for tetracycline (localised signals) is however much lower at 1 ng spots 
(Figure 3-11), but mass chromatograms have not been successfully obtained at this 
level, since additional improvements in the sample preparation technique are required 
for this, as presented in chapter 5 of this thesis.
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The data further illustrate the poor mass resolution, and hence mass measurement 
accuracy, obtained in these early TLC-MALDI TOF MS experiments. These appeared 
to be quite poor in the chromatographic acquisition experiments, possibly due to the 
movement of the TLC plate, which is in essence now the MALDI target, over several 
millimetres, during the acquisition of each spectrum. The small variations in flight time 
that would be cause these phenomena, arising from the uneven nature of the TLC plate 
surface, would obviously be greater the larger the area of TLC plate surface that data 
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Figure 3-7. Mass chromatogram from m/z 440 to 460 for three replicate tetracycline spots of





Figure 3-8. Mass chromatogram from m/z 440 to 460 for three replicate tetracycline spots of 1
pg on silica gel substrate.
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Figure 3-9. A typical m ass spectrum obtained from scanning a 100 pg tetracycline (TC) spot. 
The matrix DHB was applied on the TLC plate using the electrospray deposition method.
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Figure 3-10. A typical m ass spectrum obtained from scanning a 1 pg tetracycline (TC) sp o t 
The matrix DHB was applied on the TLC plate using the electrospray deposition method.
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3-11. Mass spectrum obtained from a 1 ng spot of tetracycline (TC). The matrix a-CHCA was 
applied on the TLC plate using the electrospray deposition method.
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3.4 Conclusion
Three literature methods for TLC plate preparation for coupling to MALDI MS have 
been examined, i.e. pressing a previously prepared matrix layer into the TLC plate 
surface, the use of a reagent sprayer and an air-spray. Two new approaches have been 
also developed: brushing a supersaturated matrix solution and deposition of matrix 
material by electrospraying. All procedures gave TLC-MALDI targets, which on 
analysis produced mass spectra from analyte-doped matrix crystals. However, of the 
methods of matrix deposition into a TLC plate, only electrospray deposition has been 
shown to produce analyte signals from enough points on a sample spot to allow 
chromatographic information to be obtained from a TLC plate. By modifications of a 
commercial MALDI TOF mass spectrometer, and its control and acquisition software, 
chromatographic data from replicated spots of tetracycline at the 1 pg level could be 
obtained. The limit of detection is lower, about 1 ng (for localised signals). However, it 
is likely that a modified environment, which promotes more homogeneous 
crystallisation, is still needed in order to improve the ultimate limit of detection further, 
and hence allow the acquisition of chromatographic data at these lower levels. The data 
also highlighted problems with mass measurement accuracy and mass resolution 
obtained, when mass spectra were acquired directly from TLC plates.
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Chapter 4
Qualitative Determination of Pharmaceutical 




Some preliminary data was presented in chapter 3 on the development of methods for 
direct analysis of TLC plates by TLC-MALDI TOF MS. Electrospraying of the matrix 
solution onto the plate was described as a new method of preparing TLC plates for 
MALDI mass spectrometry. Mass spectra were directly obtained from plates, prepared 
in such a manner, and showed that modification of a commercial MALDI TOF mass 
spectrometer enabled chromatographic data to be obtained from such plates.
In this chapter the generation and characterisation of an impurity profile of a 
pharmaceutical compound by TLC-MALDI TOF MS is reported. UK-224,671 is a 
compound synthesised by Pfizer Global R&D, as part of a drug development program. 
A mixture of UK-224,671 and its known related substances was separated by TLC on 
silica gel, and the plate was prepared for TLC-MALDI by electrospraying the surface 
with a solution of a-CHCA. The identification of the main component and three major 
related substances was possible using mass chromatograms, recorded directly from the 
TLC plates. An increase in the signal intensities of the detected components in the 
recorded mass spectra was observed when each spot was wetted with methanol, before 
electrospray deposition of the matrix material. The mass spectra recorded contained 
mainly [M+H]+ ions. The degradation in mass measurement accuracy and mass 
resolution, observed in the TLC-MALDI experiments, described in chapter 3, has been 
corrected by utilising a software that recalibrates each mass spectrum acquired during a 
run by using a matrix ion or other selected ions as “lock masses”. Data acquired with, 
and without, the use of the “lock mass” are compared.
4.2 Experimental
4.2.1 Materials
UK-224,671 (C24H3 5CI2N5O3 S), a pharmaceutically active compound, and known 
related substances, UK-256,327 (C11H 17N3 O2 S), UK-253,501 (C20H26N4 O2 S) and UK-
260,489 (C19H2 3CI2NO3), were supplied by Pfizer Global R&D (Sandwich, U.K.). The 
structures of these compounds are shown in Figure 4-1. In all cases, the formula weight
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(FW) quoted is calculated using the isotopic-averaged atomic masses. A sample 
solution, containing 2.5 mg/ml of the pharmaceutically active compound and 2.5 mg/ml 
of each related substance, was prepared in methanol.
nh2v i N—S= 0
UK-224,671 (FW 544.6) UK-253,501 (FW 386.5)
N—S=0
UK-256,327 (FW 255.3) UK-260,489 (FW 384.3)
Figure 4-1. The structure of UK-224,671 (C24H35CI2N5O3S), a pharmaceutically active 
compound, and some of its known impurities, UK-256,327 (C11H17N30 2S), UK-253,501 
(C20H26N4O2S) and UK-260,489 (C^hbCbNOa).
The suitability of the following organic MALDI matrices for TLC-MALDI coupling of 
these compounds was examined: a-CHCA, HABA, DHB, CA and 3-HPA. These 
organic matrices were purchased from Sigma-Aldrich (Dorset, U.K.).
All solvents used (methanol, ethanol, tetrahydrofiiran and dichloromethane) were HPLC 
grade. Ammonia (35%) was prepared by dilution of a concentrated ammonia SG 0.88. 
The TLC plates employed were silica gel 60 F2 5 4 , 0.2 mm thickness and aluminium- 
backed (Merck, Germany).
4.2.2 TLC Separation
The TLC separation was carried out using the following procedure, which was adapted 
from an in-house method developed at Pfizer Global R&D. The silica gel plate was used
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as supplied, without any pre-treatment. The TLC development tank was lined with filter 
paper and saturated with the development solvent dichloromethane/methanol/ammonia 
(35%) at a volume ratio of 60:10:1 over night, prior to use. An aliquot of sample 
solution (10 pi) was applied to the plate with a syringe. The plate was developed to a 
distance of 7.0 cm, air dried at room temperature and the TLC spots were visualised 
under UV light (k=254 nm.).
4.2.3 Matrix Selection
For organic matrices, the analytes were dissolved in methanol (10 mg/ml). The organic 
matrices investigated (a-CHCA, HABA, DHB, CA and 3-HPA) were dissolved in a 
polar solvent, typically methanol at 10-100 mg/ml, depending on their solubility. TFA 
(AR grade) was added to the prepared matrix solution at a concentration of 0.1 % v/v. 
The analyte and matrix solutions were mixed in suitable ratios (typical ratios used were 
1:1 or 1:10 v/v, respectively). Approximately 1 pi of the mixture was spotted onto a 
stainless steel MALDI target. The target was then analysed.
4.2.4 Matrix Application
The method used to prepare the TLC plates for MALDI analysis was to electrospray the 
matrix onto the TLC plate, as described in chapter 3.
4.2.5 Mass Spectrom etry
The TOF mass spectrometer employed in these investigations was a modified LaserTOF 
1500 (SAI, Manchester, U.K.). The modifications to the instrument are described in 
detail in chapter 3. In collaboration with SAI new software was developed to allow 
recalibration of each mass spectrum, during the scanning of a TLC plate, based on the 
measured m/z values of one or more peaks in the recorded mass spectra. Its use in these 
experiments is extensively described in the discussion section of this chapter. Only the 
positive ion mode was used in this study.
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4.3 Results and Discussion
4.3.1 Matrix Selection
The selection of the organic matrix was based on an examination of their MALDI MS 
behaviour on stainless steel targets, as described in chapter 3. For UK-224,671 and 
related substances, a-CHCA was found to give the best results. Optimum matrix to 
analyte molar ratios were between 16:1 and 40:1.
4.3.2 Electrospraying MALDI M atrices onto TLC Plates
For UK-224,671 the best data from plates prepared by electrospray were obtained using 
a-CHCA as the matrix (20 mg/ml in methanol containing 0.1 % TFA). However, use of 
this matrix gave a mass spectral peak at m/z 379 [2M+H]+, which could interfere with 
signals from UK-253,501 (FW 386.5) and UK-260,489 (FW 384.3), if  adequate mass 
measurement stability/resolution were not achieved. However, instrumental resolution 
was adequate to separate the analyte and matrix related signals, as shown in Figure 4-4 
c-d and 4-6 c-d, respectively.
4.3.3 Acquisition of M ass Chrom atogram s and M ass Spectra
The TLC plate obtained from the separation of a mixture containing 25 pg of each of 
UK-224,671, UK-256,327, UK-253,501, and UK-260,489 is shown in Figure 4-2. The 
corresponding Rf values obtained by examination of the TLC plate under UV light are 
also presented in this figure. Chromatographic data have been successfully obtained 
from such a TLC plate, as shown in Figure 4-3. In these data the peaks, arising from the 
four TLC spots, are clearly visible. The software labels the x-axis with the distance, 
travelled from the origin by the spot, enabling Rf values to be readily calculated. From 
these data, the Rf values of UK-224,671, UK-256,327, UK-253,501 and UK-260,489 
were calculated as 0.36, 0.51, 0.57 and 0.75, respectively and correspond to the Rf 
values obtained by UV detection (Figure 4-2). The mass chromatogram of the parent 
compound UK-224,671 comes from a different run. The corresponding mass spectra 
obtained for each spot are shown as Figure 4-4. These non-background subtracted
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spectra show intense ions arising from the matrix, however the protonated molecular 
species for each analyte is clearly visible.
-------------Solvent front
-------------- UK-260,489 R f= 0.76
UK-253,501 Rf = 0.56 
UK-256,327 Rf = 0.50
-------------- UK-224,671 Rf = 0.36
•— •------ -Starting point
'BrrtiM
Figure 4-2. Typical TLC plate of a mixture of UK-224,671, UK-256,327, UK-253,501 and UK-
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Figure 4-3. Overlaid m ass chromatograms from the TLC-MALDI analysis of (A) UK-224,671 
(m/z 545-547), (B) UK-256,327 (m/z 255-257), (C) UK-253,501 (m/z 385-388) and (D) UK- 
260,489 (m/z 382-385). 25 pg per component was separated on a TLC plate and the matrix a- 





Figure 4-4. TLC-MALDI mass spectra of the peaks indicated in Figure 4-3, a) UK-224,671, b) UK-256,327, c) UK-253,501 and d) UK-260,489 (25 pg 
per component). The protonated molecular species of each component is labelled with an asterisk. The ions below 380 Da are a-CHCA matrix clusters.
The mass spectra were acquired without “lock m ass” corrections.
4.3.4 Extraction of Analytes from TLC plates
The analytes separated by TLC are presumably located up to 100-200 pm inside the 
plate [1]. To produce a MALDI MS signal, the analyte must be transferred from inside 
the silica gel to the surface, followed by electrospraying of matrix and crystallisation. 
The time for extracting an analyte from inside the TLC plate onto the surface is limited 
by the time of matrix crystallisation, which is less than ~ 10 minutes [1]. In this work, 
the extraction of analytes from the interior of the TLC plate was improved by the 
addition of an organic solvent, such as ethanol, tetrahydrofuran, methanol and 
methanol/water (1:1, v/v). The best results were obtained when methanol was applied 
onto each TLC spot. The addition of methanol may have increased the concentration of 
analyte molecules on the TLC surface, and/or led to a better co-crystallisation. An 
improved incorporation of analyte molecules into the matrix crystal layer was thus 
obtained. Figure 4-5 shows the overlaid mass chromatograms from the TLC-MALDI 
MS analysis of a mixture containing 25 pg of each of UK-224,671, UK-256,327, UK- 
253,501, and UK-260,489, using the described approach. The jagged nature of the 
chromatographic peaks is typically for the use of methanol, which causes some analyte 
spreading in such a manner that less concentration of the analyte is obtained in the spot 
centre. The amount of extraction solvent, deposited on each TLC spot, is critical. On the 
one hand the amount should be as high as possible to increase the absolute quantity of 
analyte close to the surface, and on the other hand lateral spreading should be 
minimised, as far as possible. It has been found ca. 1 pi of methanol is appropriate. The 
lateral spreading was typically in the range of 1-5 mm depending on the analyte. UK- 
256,327 showed even planar diffusion along the plate, without the application of an 
extraction solvent (see Figure 4-3). Figure 4-5 also illustrates that UK-256,327 and 
UK-253,501 could be found on the same position (37 mm from the starting point) due 
to the extraction procedure. The improvement of the sensitivity in the TLC-MALDI MS 
experiments carried out on UK-224,671 and related compounds by using methanol is 
demonstrated by: the increase in the ion intensity of the protonated molecular species by 
a factor of three for each substance observable in Figure 4-6 and also by the fact that all 
four analytes could be detected in a single experiment.
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Figure 4-5. Overlaid m ass chromatograms from the TLC-MALDI MS analysis of a mixture of (A) 
UK-224,671 (m/z 545-547), (B) UK-256,327 (m/z 255-257), (C) UK-253,501 (m/z 385-388) and 
(D) UK-260,489 (m/z 384-387). 25 pg per component was separated on a TLC plate and the 
matrix a-CHCA was applied by electrospray deposition. The data was acquired using methanol 
as an extraction solvent.
4.3.5 Recalibration of M ass Spectra
As shown in Figure 4-4 d, where the protonated molecular species of UK-260,489 (FW 
384.3) was observed at m/z 383.3 rather than at 385, there is some degradation of mass 
spectral resolution and mass measurement accuracy observed, when mass spectra are 
recorded directly from TLC plates. This effect was described in the previous chapter of 
this thesis, and has also been observed by Guittard et al. [2], even when a reflectron 
based MALDI mass spectrometer (capable of much higher resolution than the 
instrument used in this work) was employed. The author of this thesis attributes the 
effect of poor mass accuracy and mass resolution to the uneven nature of the TLC plate 
surface, which leads to deviations in the ion flight time. Hence, the use of a software 
“lock mass” was investigated.
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This software recalibrates each mass spectrum, acquired during the scanning of a TLC 
plate, based on the error in mass measurement observed, for one or more user defined 
m/z values. The “lock mass” correction is performed on individual spectra, before they 
are accumulated to enhance the signal-to-noise ratio. This has the effect of narrowing 
the peak width, and hence the resolution is significantly improved.
Initially two matrix ions were chosen for the recalibration, but it was found that one was 
sufficient. Thus, the [M+Na]+ ion of a-CHCA was typically chosen. The mass spectra, 
shown in Figure 4-6 were acquired using the “lock mass” software and illustrate that 
this approach presents a possible solution to the mass measurement accuracy issue. 
However, the mass spectral resolution achieved in the chromatographic acquisition 
experiments is still relatively poor compared to conventional MALDI applications. This 
is possibly due to the movement of the TLC plate over 0.125 mm during the acquisition 
of each spectrum.
4.4 Conclusion
Mass spectral and chromatographic data from a thin-layer chromatogram of a mixture of 
25 pg quantities of a pharmaceutical compound and some of its related substances has 
been successfully demonstrated. This is, to the authors knowledge, the first time that the 
acquisition of genuine chromatographic data from a TLC plate by MALDI TOF MS has 
been reported.
The role of an extraction solvent has been investigated in detail. It has been 
demonstrated that its use results in a higher extraction efficiency and a better co­
crystallisation and hence an increase in the intensity of ions from the compounds 
studied. It caused peak broadening in the chromatographic data obtained by TLC- 
MALDI MS. Therefore, in future TLC-MALDI experiments the solvent of the matrix 
will be selected carefully in order to improve the extraction of the analyte and its co­
crystallisation with matrix , but avoiding extensive analyte spreading as presented here.
The degradation in mass measurement accuracy, reported previously for TLC-MALDI 
TOF MS experiments in chapter 3, has been successfully overcome by internal 
recalibration on selected matrix ions.
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Chapter 5




Monitoring of the presence of ‘related substances’ is required in the development of 
pharmaceutical compounds. The term ‘related substance’ describes compounds, 
structurally similar to the drug, including synthetic impurities, degradation products, or 
impurities, arising from storage or manufacturing [1-2]. The analysis of related 
substances is performed on both, the bulk drug and the finished drug product. Planar 
chromatography [reviewed in 3-8] is often used in the pharmaceutical industry as an 
analytical method for monitoring these substances [9-11] in order to prevent unknowns 
being missed due to their non-elution from a HPLC column [12]. TLC is easy to 
perform, fast and inexpensive, e.g. for the assay and purity tests of phospholipids a cost 
reduction by a factor of 2.5, compared to an existing HPLC method, was calculated
[13]. In addition, other analytical methods can be carried out after the TLC separation 
by scraping off the purified parent compound from the stationary phase. However, TLC 
can lack sensitivity, since detection is often achieved by observing the absence of 
visible fluorescence at the excitation wavelength of 254 nm. Thus, it is necessary to 
apply large amounts of the parent compound onto the TLC plate to identify related 
substances at the 0.1% level. For example a sample of 400 pg of e.g. the bulk drug 
needs to be applied to detect ca. 0.4 pg of the related substances [14]. In this situation, 
TLC can be combined with mass spectrometry [15-16] to improve the sensitivity and to 
identify related substances by their molecular weight. Current methods of interfacing 
TLC to MS use the following soft ionisation techniques: FAB [17], LSI [18], MALDI 
[19], SALDI [20], and electrospray [21]. These techniques have been fully described in 
chapter 2. The work, described in chapter 3 of this thesis, indicates that TLC-MALDI 
has the advantages of minimal analyte spreading, compared to TLC-FAB and TLC-LSI, 
and a better sensitivity, compared to the early TLC-SALDI experiments.
The generation of an impurity profile of a pharmaceutical compound by TLC-MALDI 
was presented in chapter 4. 25 pg of each component was separated on a silica gel 60 
F254 TLC plate, and mass spectra as well as mass chromatograms could be obtained 
from such a plate.
Improvements to the sample preparation procedure are reported in this chapter and were 
achieved by modifying a commercial robotic x-y-z axis motion system to act as an 
electrospray deposition device. This modified commercial device enabled the detection
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of related substances at the 0.1% level by TLC-MALDI MS. UK-137,457, a compound 
synthesised by Pfizer Global R&D as part of a drug development program, and UK- 
124,912, one of its related substances, were chosen as examples to demonstrate this. 
The new electrospray deposition device produced matrix crystals with a higher degree 
of porosity, compared to the electrospray deposition device, used in previous 
experiments (chapters 3 and 4). Thus, mass chromatograms of the related substance 
UK-124,912 could be constructed down to 2.4 pmol spots.
One limiting factor in the sensitivity, achievable by TLC-MALDI analysis, is that the 
analyte spot is not uniformly distributed in the silica gel layer [22]. The concentration of 
the analyte is increased on the surface and the extraction of the analyte is depending on 
its adsorbent strength to the silica gel. When the matrix solution is electrosprayed onto 
the TLC plate, the solvent acts as an extraction solvent to facilitate the movement of the 
analyte, located in the silica gel layer to the surface. By reducing the silica gel layer 
thickness from 2 0 0  pm to 1 0 0  pm an enhancement of the analyte signals detected by 
MALDI might be expected. Commercially available Si 60 F254 HPTLC plates with a 
layer thickness of 1 0 0  pm were tested, but difficulties encountered by cutting the 
developed plates to the required size of 60 x 2 mm excluded their use. Hence, a special 
Si 60 F254 HPTLC-MALDI target was developed in collaboration with Merck KGaA 
(Darmstadt, Germany) and enabled the detection of the related substance UK-124,912 
in the high ftnol range.
5.2 Experimental
5.2.1 Materials
UK-137,457 (C3 1 H3 1NO5), a pharmaceutically active compound, and one known related 
substance UK-124,912 (C2 7H2 5NO3 ) were supplied by Pfizer Global R&D (Sandwich, 
U.K.). The structures of these compounds are shown in Figure 5-1. In both cases, the 
formula weight (FW) quoted is calculated using the averaged-isotopic atomic masses.
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HO
UK-137,457 (FW 497.6) UK-124,912 (FW 411.5)
Figure 5-1. Structures of UK-137,457 (C31H31N 05) a pharmaceutical active compound and one 
of its known related substance UK-124,912 (C27H25N 03).
The suitability of the following organic matrices for TLC-MALDI analysis of the two 
compounds was examined: a-CHCA, HABA, DHB, 3-HPA, and CA. These matrices 
were purchased from Sigma-Aldrich (Dorset, U.K.).
To enhance the sensitivity achievable in TLC-MALDI MS a special TLC-MALDI 
target was developed in collaboration with Merck KGaA (Darmstadt, Germany), as 
shown in Figure 5-2.
Figure 5-2. The Si 60 F254 HPTLC-MALDI target developed in collaboration with Merck KGaA.
A 100 pm thick layer of the silica gel 60 sorbent with a mean particle size of 5 pm was 
coated in the 60 x 2 mm recess of the MALDI target. Small amounts of a polymer 
binder and a fluorescence indicator were added to the sorbent. The adherence of the 
sorbent to the smooth stainless steel MALDI target was difficult and therefore thickness 
variations were obtained. Further improvements in the preparation of this layer are 
necessary, but it should be noted that the present work was undertaken to demonstrate 
the possibility of this approach.
5.2.2 TLC Separation
A method, developed at Pfizer Global R&D, was modified in order to improve the 
separation of both compounds. The mobile phase chloroform/methanol/glacial acetic 
acid at the volume ratio of 60:5:1 was saturated over night in a development chamber,
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which was lined with filter paper. Aliquots of the sample solutions, dissolved in 
acetonitrile, were applied to silica gel 60 F254 aluminium backed TLC plates (10 x 10 
cm) (Merck, Germany) and the plates were developed to a distance of 7.0 cm. After 
solvent evaporation at room temperature, the sample spots were visualised under UV 
light (k=254 nm). (The replacement of chloroform with the less hazardous solvent 
dichloromethane in the mobile phase resulted in analyte streaking along the TLC plate.)
TLC separation of the analyte mixture on a Si 60 F254 HPTLC-MALDI target has not 
been carried out yet, since the experiments are at an early stage.
5.2.3 Matrix Application
Before the matrix was deposited on the silica gel surface, a strip of the developed TLC 
plate (60 x 2 mm) was attached to a modified MALDI target with double sided tape. 
The organic matrix was applied to the silica gel surface of the TLC plate by electrospray 
using an in-house modified commercial robotic x-y-z-axis motion system (PROBOT, 







Replaced by external 
syringe driver
Figure 5-3. Commercial robotic x-y-z axis motion system  (Probot, BAI GmbH), modified to act
as  an electrospray deposition device.
Modifications to the instrument were conducted in order to use the apparatus as an 
electrospray deposition device. The alterations were as follows: a PTFE tube was used 
to transfer matrix solution from a 100 pi syringe to a PEEK Supelco coupling (Cat. no.: 
Z227242). The electrospray needle consisted of a 94 mm length of stainless steel 
capillary (0.5 mm OD, 0.11 mm ID, ASH Instruments, U.K.) and the seal to the PTFE
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tube was made within the PEEK Supelco coupling. The electrospray needle was 
threaded through a stainless steel Swagelock tee coupling (1/16” OD) and through a 
piece of stainless steel tubing (38 mm length, 1/16” OD, 0.75 mm ID, Jones 
Chromatography, U.K.). A gas line was attached to the tee to provide nitrogen (2 bar) 
coaxial to the spray to assist in gas nebulization if required. Nebulising gas was not used 
in these investigations, since rapid solvent evaporation occurred. This led to reduction in 
the extraction efficiency of the analytes from the silica gel layer. The syringe pump 
(Harvard microliter syringe pump) set at a flow rate of 0.6 ml/h delivered the matrix 
solution to the tip of the stainless steel capillary. To obtain a fine spray of the matrix 
solution ca. 2 kV was applied to the tee coupling using a high voltage supply. The metal 
plate ( 7x15  cm) was earthed and placed 2 mm from the end of the electrospray needle. 
The plate was then moved across in front of the spray at a rate of 25 mm/s. Typically an 
area of 60 x 2 mm on the TLC strip was covered with matrix crystals.
5.2.4 M ass Spectrom etry
The time-of-flight (TOF) mass spectrometer employed in these investigations was a 
modified linear LaserTOF 1500 (SAI, Manchester, U.K.). The modifications to the 
instrument and its software have been extensively described in chapters 3 and 4. Only 
the positive ion mode was used in these investigations. 16 single shot mass spectra were 
averaged to give a composite mass spectrum. Typically, a data set of 120 mass spectra 
was acquired for each sample. The [M+Na]+ ion of a-CHCA at the m/z value of 212 
was used as “lock mass”.
5.3 Results and Discussion
5.3.1 Matrix Selection
The selection of matrix was initially based on an examination of their MALDI MS 
behaviour on stainless steel targets, as described in chapter 3. CA as well as a-CHCA 
were found to give the best results, i.e. highest signal intensities of the compound 
studied and no interfering peaks arising from the matrix. However, electrospraying of 
CA (40 mg/ml in acetonitrile containing 0.1% TFA) did not yield a homogeneous
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crystal layer. Changing of the solvent system to e.g. methanol decreased the sensitivity 
of the analytes detected on the TLC plate. The solvent of the matrix acts as an extraction 
solvent and is required to assist in releasing the analyte from the stationary phase and in 
this case both analytes have got the highest solubility in acetonitrile. The concentration 
of CA was finally increased by changing the solvent system to acetonitrile/water 
containing 0.1% TFA (70/30, v/v). At a concentration of 80 mg/ml still areas of the 
TLC plate with no matrix crystals could be detected, by examination under a high 
magnification microscope. By increasing the concentration to 100 mg/ml blocking of 
the capillary tubing was obtained. Hence, a-CHCA (20 mg/ml in acetonitrile/water 
containing 0.1% TFA, 70/30, v/v) was used for further experiments.
5.3.2 TLC-MALDI Analysis
The experiments were started at the 1% level of the related substance UK-124,912, 
since the compound was observable at this level ( 1  pg loading) by fluoresence 
quenching on the TLC plate, as shown in Figure 5-4. The Rf-values of the parent 
compound and the related substance were calculated from the TLC plate as 0.48 and 
0.62, respectively.
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Figure 5-5. TLC-MALDI data obtained from the analysis of UK-137,457, containing UK-124,912 at the 0.1% level. The matrix a-CHCA was applied on the TLC plate 
with the new electrospray deposition device, (a) TLC separation, (b) Overlaid mass chromatograms obtained by MS scan of the TLC plate. The single m ass 
chromatograms were constructed by use of the [M+H]+ ion of UK-137,457 (m/z 498-499) and of UK-124,912 (m/z 412-413). (c) TLC-MALDI spectrum of the 100 pg 
spot of UK-137,457, (d) TLC-MALDI spectrum of the 100 ng spot of UK-124,912.
The photographic scan taken from the TLC plate (Figure 5-4) indicates that even with a 
loading of 100 pg of the parent compound the TLC plate is overloaded. Figure 5-5 a-d 
shows the data obtained from the analysis of UK-137,457 containing UK-124,912 at the 
0.1% level. In these data, although UK-124,912 is not observable in the UV data 
(Figure 5-5 a), it can be clearly seen in the mass chromatogram of m/z 412-413 (Figure
5-5 b) at an Revalue of 0.63. The protonated molecule at m/z 412.8 in the mass 
spectrum (Figure 5-5 d) correspond to the expected value of UK-124,912.
5.3.3 Im provem ents in Sensitivity
The sensitivity of the related substance UK-124,912 was assessed by spotting different 
amounts of it onto a TLC plate, followed by electrospraying of a-CHCA. The detection 
limit for the acquisition of mass chromatograms was determined as 1 ng (Figure 5-6). 
This is an improvement of a factor of 1000, when compared to the data for tetracycline 
described in chapter 3 of this thesis.
Intensity (%)
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Figure 5-6. Assessment of the detection limit of the related substance UK-124,912. The m ass 
chromatogram was constructed using the [M+H]+ ion of the compound (m/z 412-413).
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The question which arises is, if this improvement is only compound specific or is there 
any difference in the performance between the electrospray deposition device, described 
in chapters 3 and 4, and the new device. Initial examinations of the TLC plate surfaces 
by electron microscopy indicated that both devices gave similar good surface coverage 
of the MALDI matrix, as shown in Figure 5-7. However, by using a higher 
magnification, as shown in Figure 5-8, an obvious difference in the porosity of the 
matrix can be seen.
Figure 5-7. SEM pictures of a) blank silica gel TLC plate, and a-CHCA electrosprayed using b) 
the in-house build electrospray deposition device or c) the new modified commercial x-y-z axis
motion system  (magnification: 570).
b)
Figure 5-8. SEM pictures shown in Figure 5-7 b and c, but with a magnification of 11400.
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The new electrospray deposition device produces crystals with a much higher degree of 
porosity. These results support the hypothesis that the adsorption model between analyte 
and matrix does not depend on crystallinity [23]. The solvent-free sample preparation 
method, introduced by Skelton et a l [24], and further investigated by Trimpin et a l
[23], mixes matrix with analyte powder without the use of a solvent. This method does 
not require the co-crystallisation of analyte and matrix, which is commonly consider as 
the key factor for the success and quality of MALDI mass spectra. Trimpin et a l [23] 
concluded that the quality of the MALDI spectra is influenced by the homogeneity of 
the analyte/matrix mixture. The results presented here would imply that the porosity of 
the matrix plays an important role, when the matrix is electrosprayed. Whether the 
increase in the specific surface, obtained by the new electrospray deposition device, 
simply increases the number of accessible analyte molecules within the desorption area, 
or whether this also improves the analyte isolation on the surface, is not yet fully 
understood. Recently, Gliickmann et a l [25] concluded their discussion of the results, 
obtained from the solvent-free sample preparation method of different biopolymers, in 
the same way by leaving this question open.
The possibility that the new electrospray deposition device produces smaller crystals 
can not be excluded. However a higher flow rate (600 pl/h) and a smaller distance 
between thetip of the electrospray capillary and TLC surface (2 mm), compared to the 
electrospray deposition device, described in chapter 3 and 4, does not necessarly support 
this conclusion. Both parameters extend the evaporation time of the solvent.
Preliminary experiments, conducted with the Si 60 F25 4  HPTLC-MALDI target, showed 
further improvements in sensitivity. It was possible to detect 400 pg of UK-124,912, 
spotted onto the target, as shown in Figure 5-9. This is close to the limit of detection of 
the mass spectrometer, used in these investigations. The sensitivity lies, according to the 
instrument specifications, which can be found in the appendix of this thesis (chapter 
10), in the sub picomol range. At this very low concentration level reproducibility was 
not obtained; UK-124,912 was detected in one of two spots. Furthermore, the plotted 
chromatogram did not show a recognisable chromatographic peak for the analyte due to 
high background noise.
The sensitivity presented here is poorer than the sensitivity reported by Gusev et a l [26- 
28]. Detection limits in the low nano- or picogram range were reported for several 
compound classes studied: e.g. angiotensin II 200 pg [26], rhodamine B 50 pg [26], the
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pesticides avenage 4 pg [27] and glyodin 4 ng [27], and the nucleotide 
desoxyribonucleotide monophosphate 10 pg [28]. By using a hybrid TLC-MALDI plate 
detection limits in the range of 1 1  to 116 fmol for cyclic peptide spots were achieved by 
this group [29]. A matrix layer was created on the aluminium support of a 200 pm thick 
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Figure 5-9. Mass spectrum of a 400 pg spot (972 fmol) of UK-124,912 in a-CHCA, recorded on 
a Si 60 F254 HPTLC-MALDI target. The ions of a-CHCA are visible between 120 and 405 Da.
The analyte spots were then eluted to the matrix layer via capillary action. This 
procedure refocused the analyte spots, enhancing the analyte signals detected by 
MALDI. However, the chromatographic information contained in the TLC plate is lost 
in this technique and it seemed to be very time consuming to scrape off the silica gel 
layer in order to create a MALDI layer on it. The use of a Si 60 F254 HPTLC-MALDI 
target, where the matrix has only to be electrosprayed on the silica gel layer seemed to 
be more favourable and further improvements in the sensitivity could be obtained by 
using a smaller sample volume spotted (typically 1 pi volume was used), which would 
reduce the diameter of the analyte spot and would act as an concentration step.
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5.4 C onclusion
Using the modified commercial device mass spectra and chromatograms from a 
pharmaceutical compound and one of its related substance at the 0 .1 % level were 
successfully obtained. TLC-MALDI data down to 2.4 pmol (1 ng) spots were 
demonstrated and further improvements in the sensitivity were achieved by using a 
special Si 60 F2 54 HPTLC-MALDI target.
Furthermore, some aspects on the ion formation in MALDI were discussed, based on 
the TLC-MALDI findings. The porosity of the matrix might also be important, besides 
its crystallinity, which is commonly considered to be the key factor for a successful 
MALDI analysis. The role of the pores may be the separation of the analyte molecules 
from each other, which minimises their interactions, or maybe they simply increase the 
accessible surface area for analyte molecules to be desorbed by the laser pulse.
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Chapter 6
TLC-PALDI TOF MS of Tetracyclines
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6.1 Introduction
Matrix-assisted laser desorption/ionisation (MALDI) is a powerful and widely used 
mass spectrometric method for the analysis of biopolymers [1 ], as described in chapter 
2. The process of using a UV absorbing organic compound as matrix material to aid 
laser desorption of intact protein molecular ions was introduced by Karas and 
Hillenkamp [2]. Mass spectra of various proteins, such as albumin (67 kDa), were 
recorded by mixing the analyte with nicotinic acid. Since then, different classes of 
organic acids with pKa in the range of 2-4 have been considered as potential MALDI 
matrices [3-5]. Fitzgerald et a l [6 ] introduced a number of basic matrices derived from 
substituted pyrimidines, pyridines and anilines. Some of these matrices have proven to 
be excellent for observing non covalent complexes, because they allow samples to be 
prepared under non-denaturing conditions [7].
Substances other than solids, having a strong absorbance at the laser wavelength of 337 
nm, have also been shown to function as UV-MALDI matrices. Liquids, such as 3- 
nitrobenzyl alcohol or nitrophenyloctylether, have been used in UV-MALDI [8-9], since 
they circumvent some of the problems associated with solids. The “sweet spot” 
phenomenon, known for solid matrices, can be largely eliminated, because liquid 
matrices continuously refresh their surfaces.
Besides organic matrices, metal particles of different materials and sizes have been 
investigated as possible MALDI matrices. The major advantage of metal particles is the 
absence of matrix interference in the lower mass range (below 500 Da), hence allowing 
the analysis of low mass analytes. In 1988, Tanaka et a l [10] first demonstrated laser 
desorption/ionisation (LDI) spectra of proteins and polymers with molecular weights up 
to 25 kDa, using 30 nm diameter fine cobalt powder, suspended in a glycerol dispersant. 
Schurenberg et al. [11] were inspired by Tanaka’s work and investigated recently 
several nano-particles as matrices for the analysis of proteins and peptides. Mass spectra 
of cytochrome c and myoglobin were obtained by this research group using a 
suspension of titanium nitride (35 nm diameter) in glycerol. Sunner et a l [12] and Dale 
et a l [13-14] have investigated the use of micro-particles instead of nano-particles. In 
their experiments particles of 2-150 pm diameter of graphite and silicon, with a range of 
dispersants, including glycerol, were employed to ionise compounds such as peptides, 
proteins, oligosaccharides, synthetic polymers and anionic analytes. The term SALDI
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for surface-assisted laser desorption/ionisation was introduced by Sunner et al. [12] to 
distinguish this technique from MALDI employing organic matrices. Ho and Fenselau
[15] successfully analysed intact gram-negative and gram-positive bacteria by addition 
of a graphite or cobalt matrix, suspended in glycerol. Instead of using graphite particles, 
Kim et a l [16] demonstrated the use of a graphite plate to absorb and transfer UV 
energy for the analysis of low molecular weight polymers below 1000 Da. Kinumi et al.
[17] investigated commercially available metal and metal oxide micro-particles (Al, Zn, 
TiC>2 , ZnO etc.) as matrices for the analysis of PEG 200 and methyl stearate. Michalak 
et al. [18] reported that fullerene Ceo, with a diameter of a few micrometers, was a good 
matrix for protein analysis and Huang et al. [19] pursued this technique for the 
screening of diuretics in urine. More recently, laser desorption/ionisation (LDI) has 
been achieved without a matrix by depositing the analyte on a UV absorbing silicon 
substrate, a technique that has been called desorption/ionisation on porous silicon 
(DIOS) [20-23].
The coupling of thin-layer chromatography to mass spectrometry combines the 
simplicity of TLC with the selectivity and sensitivity of MS [24-25]. For the analysis of 
tetracycline antibiotics, as described in this chapter of this thesis, TLC-MS has the 
specific advantage that the non-volatile compound, disodium ethylene diamine tetra 
acetate, which is required to improve the separation, remains on the TLC plate and 
hence does not cause any of the problems, such as clogging of the interface and deposits 
in the ion source that have been reported in their analysis by LC-MS [26]. FAB-MS was 
successfully employed by Oka et al. [27] for the TLC-MS analysis of tetracyclines. 
However, the lateral analyte spreading, caused by the use of a liquid matrix in FAB, 
required the sample spots to be concentrated by “condensing” them using a solvent 
focusing technique [28]. The chromatographic information contained in the TLC plate is 
therefore lost in this technique.
The use of micro-particles in TLC-SALDI TOF MS has recently been described by 
Chen et al. [29-30]. The appropriate zone of the developed TLC plate was coated with a 
suspension of carbon powder (graphite or activated carbon particles) in glycerol and 
analysed. Using this approach spectra were obtained for a variety of peptides (e.g. 
bradykinin and angiotensin II) and low molecular mass organic compounds (e.g. 
hydrochorothiazide, prometryn, cytosine and PEG 400). By addition of the surfactant p- 
toluenesulfonic acid the signals of the analytes studied (ATP and methylephedrine)
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could be enhanced [31]. In their latest work [32], the graphite matrix is deposited onto 
the TLC plate before the analyte separation by using a pencil. Using this technique, 
improvements in the sensitivity of porphyrins were demonstrated. However, the 
porphyrin derivative meso-tetrakis(pentafluorophenyl)porphyrin is known to be a useful 
matrix for the analysis of small molecules [33]. Furthermore, even though enhancement 
in mass resolution were shown, it is still not comparable to the mass resolution, which is 
typically obtained by coupling TLC with MALDI TOF MS. The reasons for the reduced 
mass resolution were connected with the movement of the laser in order to obtain ions 
with a sufficient intensity and the possibly inhomogeneous distribution of the graphite 
matrix.
Limitations in analytical sensitivity and spectral quality led Han and Sunner [34] to 
create a carbon activated surface on the aluminium support of the TLC plate, so that the 
analyte could migrate towards the particle surface. The sensitivity as well as the mass 
resolution could be readily improved by this new methodology. A similar approach was 
used by Mehl and Hercules [35], who used organic matrices to create the activated 
surface. However, the chromatographic integrity of a separation is destroyed in this 
technique and hence there is no longer the possibility of ‘scanning’ the TLC plate to 
produce chromatograms or ‘imaging’ spots of the analyte.
In this chapter, results for the analysis of tetracyclines by combining TLC with particle- 
assisted laser desorption/ionisation time-of-flight mass spectrometry (PALDI TOF MS) 
are reported. Suspensions of micro-particles as well as nano-particles were examined for 
their suitability for TLC-PALDI MS. The term PALDI was introduced to take into 
account that a variety of particle materials and sizes can be employed by this technique, 
in opposite to SALDI (surface-assisted laser desorption/ionisation) [29-34], in which 
only carbon-glycerol suspensions are used. Furthermore, the pore size seemed to be an 
important factor in PALDI, whereas in SALDI it is possible to obtain spectra from 
nonporous surfaces [36].
The majority of the results were obtained for a suspension of graphite (1-2 pm 
diameter) in ethylene glycol, which was found to yield better sensitivity in comparison 
to the other tested materials and dispersants. Using this system, the major ion species 
observed in both positive and negative ionisation modes were fragment ions. 
Fragmentation did not occur to the same extent when organic matrices, such as DHB or
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a-CHCA, were used.
Extracted mass chromatograms were constructed from the scanned TLC plates. Using 
the extracted mass chromatograms, obtained from the TLC-PALDI analysis of different 
tetracyclines, it was possible to calculate the Rf-values of the detected analyte spots. 
These showed good agreement with the Revalues obtained by UV detection.
6.2 Experimental
6.2.1 Materials
Oxytetracycline (OTC), tetracycline (TC), chlortetracycline (CTC) and minocycline 
(MC) were purchased from Sigma-Aldrich (Dorset, U.K.). OTC was used as dihydrate, 
CTC and MC as hydrochloride. The structures of these compounds are shown in Figure 
6-1. In all cases the formula weight (FW) quoted is calculated using the mono-isotopic 
atomic masses. The five tested nano- and micro-particle powders of different materials 
and particle diameters are listed in Table 6-1. All chemicals were used as purchased 
from commercial suppliers.
CONH CONH
OH O OH O OH O OH O
Oxytetracycline (OTC, FW 460) Tetracycline (TC, FW444)
CONH CONH
OH O OH O OH O OH O
Chlortetracycline (CTC, FW478) Minocycline (MC, FW 457)
Figure 6-1. Structures of tetracyclines.
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Cobalt ultra fine powder (Co-UFP) black 20 nm Kratos, UK
TiN black 36 nm HC Starck GmbH, Germany, (kind gift by the supplier)
Ti02 white 1 pm Fluka, USA
Graphite black 1-2 pm Sigma-Aldrich, UK
Silicon grey 45 pm Sigma-Aldrich, UK
6.2.2 TLC Separation
The tetracycline antibiotics were separated using the procedure described by Naidong et 
al [37]. Pre-treatment of the aluminium-backed TLC plates, coated with 0.2 mm layers 
of silica gel 60 F2 5 4 (Merck, Germany), was necessary in order to avoid the formation of 
metal-tetracycline complexes and hence to improve the separation. The TLC plates (10 
x 10 cm) were sprayed with ca. 5 ml of an aqueous disodium EDTA solution (0.27 
mol/1, pH 8 ), air dried for 30 minutes in a horizontal position and then activated in an 
oven (120 °C) for another 30 minutes. The mobile phase dichloromethane 
/methanol/water (59/35/8, v/v) was saturated for 2 hours prior use. The plates were 
eluted over a distance of 7.0 cm, air dried and visualised under UV light (X=254 nm).
6.2.3 Matrix Application
In all experiments a 60 x 2 mm strip of the developed TLC plate was attached to a 
modified MALDI target with double sided tape, before the matrix was deposited onto 
the silica gel surface.
Particle matrix suspensions were prepared by dispersing powders of nano- or micro­
particles ( 1 0 - 1 0 0  mg/ml) in ca. 1 ml of ethanol/ethylene glycol (1 0 0 0 :1 , v/v) or 
methanol/ethylene glycol (1000:1, v/v). The suspensions were homogenised by 
sonication for 15 minutes and then applied (30 pi) to the developed TLC strip using a 
1 0  pi syringe.
Experiments with the crystalline chemical matrices DHB and a-CHCA were performed
for comparison. In these cases the matrix solutions (300 mg/ml DHB in ethanol/water
containing 0.1% TFA 80:20 v/v, or 20 mg/ml a-CHCA in methanol containing
0.1%TFA) were electrosprayed onto the TLC plates using the in-house modified
89
commercial robotic x-y-z-axis motion system (PROBOT, BAI, Germany), described in 
chapter 5. An area of 2 x 60 mm on the TLC strip was typically covered with matrix 
crystals. Good matrix coverage was obtained using the modified device, as shown in 
Figure 6-2. Note: Particle suspension matrices can not be successfully electrosprayed 
owing to capillary blockages.
Figure 6-2. SEM image of the crystalline chemical matrix DHB, electrosprayed onto a silica gel 
TLC plate. The TLC-MALDI mass spectrum and mass chromatogram obtained from this sample 
are shown in Figure 6-9 and 6-10, respectively.
6.2.4 M ass Spectrom etry
Mass spectra and mass chromatograms were recorded directly from the TLC plate with 
a modified linear LaserTOF 1500 mass spectrometer (SAI, Manchester, U.K.). The 
modifications to the instrument and its software for use in TLC-MALDI-MS have been 
described in chapters 3 and 4. The positive and negative ion mode was used in these 
investigations and the mass spectra acquired from the TLC surface were the results of 
the cumulative acquisition of 16 shots. The TLC strips were scanned over a distance o f 
60 mm and mass spectra were recorded each 0.5 mm. A data set of 120 mass spectra 
was obtained for each sample from which single mass chromatograms were constructed. 
The mass chromatograms presented in this chapter are smoothed, since appropriate 
software was developed in collaboration with SAI.
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6.3 Results and Discussion
6.3.1 Com parison of Particle Suspension  Matrices with Organic Matrices
For the PALDI-MS analysis of TC in a range of particle suspension matrices, mixtures 
containing equal volumes of particle suspensions ( 1 0 - 1 0 0  mg/ml in ethanol/ethylene 
glycol 1 0 0 0 :1 , v/v) and analyte solutions ( 1  mg/ml in methanol) were added to the 
stainless steel targets (typically 0.25 pi) and analysed.
The PALDI mass spectra obtained for TC using nano-and micro-particles are presented 
in Figure 6-3 and 6-4, respectively. The inorganic matrices showed the following 
characteristics, compared to the crystalline organic matrices DHB and a-CHCA (Figure
6-5). No protonated molecule of TC could be observed, except when silicon powder 
was used, as shown in Figure 6-4 c. However strong cationisation by sodium and 
potassium was typically obtained when particle suspension matrices were used. Hence, 
the molecular related ions of TC appeared as [M+Na]+ at m/z 467 and as [M+K]+ at m/z 
483. Fragment ions, which have been identified as [M+Na-NH3]+ at m/z 450, [M+K- 
NH3]+ at m/z 466 and [M+Na-NH3-H2 0 ]+ at m/z 432, could also be detected for TC. 
Furthermore, the ion intensity of the most abundant ions of TC was typically lower than 
that achieved when organic matrices were used (Figure 6-5). However the mass spectra 
were not dominated by complex signals at the lower mass range, as shown in Figure 6- 
3 and 6-4, respectively.
In order to get some idea of the relative sensitivity obtained from TLC-PALDI MS 
employing suspension matrices, in comparison to the sensitivity obtained from 
conventional targets, the same quantity of TC (lOpg) was analysed on both, silica gel 
TLC plates and stainless steel targets . Three samples were analysed on each substrate 
and the results were averaged. The suspension matrix used in this case was 40 mg/ml 
graphite, dissolved in methanol/ethylene glycol (1000:1, v/v). Comparison of the peak 
areas of the [M+Na-NH3]+ of TC at m/z 450 showed that the relative sensitivity 
obtained by PALDI MS from conventional targets was two times better than that 
obtained by TLC PALDI MS.
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6.3.2 Liquid D ispersants of Suspension  Matrices
Three different viscous liquids are generally described in the literature as particularly 
suitable for use as dispersants with particle suspension matrices, i.e. glycerol [1 0 ], 
ethylene glycol [38], and liquid paraffin [17]. The dispersant glycerol shows a 
characteristic background level in the low-mass region, and hence is in general not 
considered as a good choice for the analysis of low mass analytes [17]. Ethylene glycol 
showed in the studies presented here an advantage to paraffin, since the latter showed a 
degree of analyte suppression. Therefore, all data were collected by using ethylene 
glycol as dispersant.
The role of glycerol in supporting phase transition is well documented in FAB and LSI. 
It is not clear if the function of glycerol is the same in PALDI. Dale et al. [13] 
considered that the addition of glycerol to graphite particles fulfils several roles. Besides 
increasing the signal lifetime at a particular sample position, it acts as a proton source in 
the case of peptides and proteins. In the initial studies of the work, presented in this 
chapter, it was found that the absence of dispersant in graphite (or any other particle 
material) caused the ion intensity to rapidly decrease after firing the laser repeatedly at 
the same position. An increase of the concentration of ethylene glycol (from 0.1% to 1% 
in ethanol) caused an increase in the lifetime of the analyte signals obtained for TC. 
However, this also led to a faster contamination of the ion source extraction grid. As 
described earlier, typically no protonated signals of TC could be detected when 
particle/ethylene glycol systems were used (Figure 6-3 and 6-4). This was also the case 
when small peptides, such as Phe-Phe, Tyr-Tyr and Tyr-Tyr-Tyr were analysed (data 
not shown). This would appear to indicate that ethylene glycol does not function as a 
proton source, but simply serves to mobilise the analyte by remaining liquid under 
vacuum.
6.3.3 Surface Morphology of Particle Suspension  Matrices
No mass spectral peak of the antibiotic tetracycline could be obtained, when the analyte 
was spotted on the TLC plate and directly analysed without the addition of a matrix. 
This corresponds to the results reported by Wei et a l [20]. Obviously a pore size of 6  
nm of the silica gel on the TLC plate is too small to give a significant analyte signal.
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The importance of the pore size, when using silica gel particles as matrix, was recently 
reported by Zhang et al. [22]. Non-porous silica gel did not yield a mass spectral signal 
of the analyte. An increase in the pore size up to 30 nm showed an enhancement of the 
signal intensities of the analytes studied. The role of surface morphology in 
desorption/ionisation was recently studied for the relatively new technique DIOS [39]. 
The pore size as well as the overall porosity of the silicon wafers influenced the overall 
DIOS-MS performance.
The particle suspension matrices, employed in these investigations, showed pore sizes 
around 200 nm or greater. The surface morphology of Co-UFP and graphite, applied 
onto a silica gel TLC plate, are shown in Figure 6 - 6  a and b, respectively. These results 
imply that the pore size and moreover the overall porosity is an important factor in the 
desorption/ionisation process occurring at particle surfaces.
Figure 6 -6 . SEM images of particle suspension matrices (a) Co-UFP, and (b) graphite, applied
onto a silica gel TLC plate.
6.3.4 TLC-PALDI TOF MS of Tetracycline
From the whole range of particles studied, the TLC-PALDI mass spectra recorded from 
graphite suspensions showed the lowest background noise and the highest peak 
intensities. The peak intensities of TC obtained from graphite suspensions were even
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higher than the ones obtained when DHB was used (Figure 6-9 and the corresponding 
mass chromatogram is shown in Figure 6-10).
In TLC-PALDI TOF MS the extraction of the analyte from the TLC plate and its 
adsorption on the particle surface plays an important role. Micro-particles were found to 
be superior to nano-particles, in this case the particle size was of the same order as the 
particle size of the TLC silica gel layer (10 pm). However, if the particle diameter was 
higher than 10 pm, as in the case of silicon with a diameter of around 45 pm, the 
particles did not adhere to the silica gel layer after solvent evaporation. The addition of 
an additive, e.g. sucrose [29-32], can improve the adhesion between particles and silica 
gel layer, but this causes extra signals in the recorded mass spectra, which can interfere 
with the analyte peaks in the low mass range.
Figure 6-7 shows the TLC-PALDI mass spectra of TC (200 pg), developed on a TLC 
plate using graphite particles as matrix material. In the positive ion mode, several 
fragment ions and sodium adducts of TC were observed. In the negative ion mode, high 
intensity carbon clusters in the low mass range were present, and fragment ions were the 
dominant species. A level of 200 pg of analyte was chosen in order to detect all possible 
fragment ions in reasonable peak intensities, so that mass chromatograms of the 
corresponding analyte ions could be constructed with a low background noise level. 
Mass chromatograms of the identified analyte peaks were recorded in the positive and 
negative ion mode, as shown in Figure 6 -8 .
Since the absolute mass accuracy obtained was limited by thickness variations in the 
graphite film, an effect which has been observed by Zumbuhl et al. [40], and which 
results in a mass inaccuracy of ± 2  mass units, it was decided to employ a “lock mass” 
and to recalibrate each mass spectrum during acquisition. Initially three small peptides 
(Phe-Phe, Tyr-Tyr and Tyr-Tyr-Tyr) and mixtures containing two of the peptides were 
tested as internal calibration standards. Phe-Phe was found to give the best results: 
optimum signal response and no suppression of analyte signals, and hence was used in 
further experiments. Phe-Phe (3 mM in ethanol) was added to the graphite suspensions 
in order to recalibrate the TLC-PALDI mass spectra, acquired during a run. This was 
achieved by use of the [M+Na]+and [M-H+2Na]+ signals of the peptide as "lock 
masses" in the positive ion mode, and by use of the [M-H]' signal in the negative ion 
mode. The mass accuracy and mass resolution achievable by internal recalibration with 
Phe-Phe was comparable with that obtained in similar TLC-MALDI experiments
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Figure 6-7. TLC-PALDI m a s s  sp e c tr a  o f  te tracyc lin e  s p o t  (200 p g) u sin g  a  grap h ite  m atrix in (a )
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Figure 6 -8 . Smoothed m ass chromatograms of tetracycline (200 pg spot), developed on a TLC 
plate, using a graphite matrix from the experiments shown in Figure 6-7 a and b. In the positive 
ion mode the [M+Na-NH3]+ ion (m/z 449-451) and in the negative ion mode the [M-OH]* ion (m/z 
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Figure 6-10. Smoothed m ass chromatogram of tetracycline (200 pg spot) from the experiment 
shown in Figure 6-9. The [M+H]+ ion (m/z 444-446) was used to construct the m ass 
chromatogram.
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6.3.5 TLC-PALDI TOF MS of a Mixture of OTC, CTC, TC and MC
A typical chromatogram obtained for a mixture, containing 10 pg of OTC, CTC, TC 
and MC, using the mobile phase described earlier is shown in Figure 6-11. One 
unresolved spot for both CTC and TC (Rf = 0.17) was observed. From reference runs it 
was established that CTC has an Rf value of 0.16 and TC one of 0.18. The TLC-PALDI 
MS analysis of such a mixture confirmed this, as shown by the overlaid mass 




CTC and TC 
OTC
Rf= 0.39 
Rf = 0.17 
Rf = 0.15
Figure 6-11. TLC separation of a mixture of OTC, CTC, TC and MC (10 pg per component).
This demonstrates the potential of TLC-PALDI using a graphite suspension matrix for 
detecting unresolved analyte spots on a TLC plate. All four tetracycline antibiotics gave 
one characteristic fragment ion, [M+Na-NHs]+ in the TLC PALDI mass spectra 
recorded, as shown in Figure 6-14. Hence the [M+Na-NHs]+ was used for each 
tetracycline antibiotic to construct the corresponding mass chromatogram (Figure 6-12 
and 6-13). The detection limit of tetracyclines in TLC-PALDI MS employing graphite 
suspensions was found to be under 1 0  pg, however at lower levels the reproducibility 
was poor.
It should be noted that the present work was undertaken to demonstrate the applicability 
of particle suspension matrices to TLC-PALDI TOF MS. It is anticipated that 
improvements in sensitivity and reproducibility could be achieved by finding 
procedures with higher and more consistent extraction efficiency. One possibility is to 
wet the TLC plate with an appropriate extraction solvent and then to blot the TLC plate
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onto a graphite plate.
Increased in-source fragmentation of tetracyclines antibiotics was observed when 
particle suspension matrices were used, compared to crystalline organic matrices. The 
reasons for this are that higher peak temperatures are reached, when particles are 
employed. Zenobi and Knochenmuss [41] found that peak temperatures of 700-900 K 
could be reached in a few nanoseconds with 2  pm graphite/glycerol samples and 
Schurenberg et al. [11] has estimated that peak temperatures above 10 000 K are 
possible with 35 nm TiN particles. When a crystalline matrix is used, only temperatures 
of ca. 500 K are reached [42]. At this level, a thermal ionisation mechanism, is clearly 
not significant. Another factor, which leads to the consideration that thermal ionisation 
plays a key role in TLC-PALDI, is that higher laser fluences were required, compared to 
TLC-MALDI experiments, employing organic acid matrices.
Intensity (%)






Figure 6-12. Smoothed overlaid m ass chromatograms from the TLC-PALDI TOF MS analysis of 
OTC, CTC, TC, and MC (10 |jg per component). The [M+Na-NH3]+ ion of each tetracycline 











Figure 6-13. Smoothed single m ass chromatograms from the TLC-PALDI TOF MS analysis of 
OTC, CTC, TC, and MC (10 |jg per component). The single m ass chromatograms were 











Figure 6-14. TLC-PALDI mass spectra from the peaks indicated in Figure 6-12 and 6-13, (a) OTC, (b) CTC, (c) TC, and (d) MC (10 pg per component).
6.4 C onclusion
The acquisition of chromatographic as well as mass spectral data from eluted TLC 
plates via TLC-PALDI TOF MS, using different particle suspension matrices, for the 
analysis of tetracyclines has been successfully demonstrated. A suspension of graphite 
(1 - 2  pm) in ethylene glycol was found to yield superior data to the other tested matrices 
and dispersants. The mass accuracy on graphite films was improved by adding Phe-Phe 
as “lock mass” to the graphite/ethylene glycol suspensions in order to allow internal 
recalibration of the acquired TLC-PALDI mass spectra.
Furthermore, it could be shown that the specific detection capabilities of TLC-PALDI 
MS from graphite suspensions assisted in the analysis of the antibiotics CTC and TC in 
a mixture of OTC, CTC, TC and MC.
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Chapter 7




The quantitative determination of pharmaceuticals by TLC-MS has been the subject of 
several reports [1-6]. Caffeine was quantified by off-line TLC-SPE-APCI-MS in soft 
drinks [1]. On-line TLC-MS techniques, which have the advantage of allowing the 
generation of mass spectral as well as chromatographic information from the TLC spots, 
have been used for the quantification of the following drugs, pyridostigmine [2 ] and 
nicerogline [3] by TLC-LSI MS, the diuretic amiloride by TLC-FAB MS [4], 
imipragmine by TLC-two step laser mass spectrometry (L2 MS) [5], and cocaine by 
TLC-MALDI MS [6 ]. In most of the quantification experiments a chemical or stable 
isotope analogue was used as internal standard to enable quantification to be carried out 
directly on the separated TLC spots. TLC-FAB MS as well as TLC-LSI MS require a 
liquid matrix, which causes diffusion of the analyte after a certain time and hence makes 
the recording of a stable ion signal impossible. The two other soft ionisation techniques 
L2 MS and MALDI coupled to TLC show signal variations due to alterations from laser 
to laser pulse.
The non steroidal anti-inflammatory drug (NSAID) [7] piroxicam or 4-hydroxy-2- 
methyl-N-(2-pyridyl)-H-l,2-benzothiazine-3-carboxamide-1,1-di-oxide is widely used 
in the treatment of rheumatological disorders [8 ]. Several analytical methods have been 
described for the determination of piroxicam, including TLC [9-12], CE [13], 
spectrofluorometry [14], derivative spectrometry [15-17] and HPLC [18-21]. There 
appear to be no reports of the application of TLC-MALDI MS to the determination of 
this pharmaceutical. The main advantages, arising from the development of such a 
method, would be its simplicity, sensitivity and specificity.
Hence, the aim of the study, described in this chapter, was to develop and validate a 
quantitative TLC-MALDI TOF MS method for the analysis of piroxicam. Tenoxicam, a 
structural analogue of piroxicam, was used as internal standard to compensate for 
MALDI MS signal deviations and variations in the extraction efficiency of piroxicam 
from the TLC plate. To regulate the analyte signals, recorded directly from the TLC 
plate, the internal standard has to be located at the same positions as the analyte. 
Preliminary data, obtained by spotting mixtures, containing the internal standard and the 
analyte, on silica gel 60 F254 TLC plates proved that quantification of piroxicam with 
the chosen internal standard was possible. The next step was to find a suitable method
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of incorporating the internal standard on the TLC plate so that the development of the 
TLC plate was possible. Since the internal standard did not show the same Rf value as 
the analyte in the TLC analysis, the following approaches were tested: development of 
the TLC plate in the mobile phase to which the internal standard was added, and 
electrospraying of a solution of tenoxicam or a mixture with the matrix onto the TLC 
plate. The best precision for the standard calibration curve, between 400 and 800 ng of 
piroxicam, was obtained by incorporating the internal standard in the mobile phase (15 
to 63 % range errors, n = 4). The other methods investigated showed higher range errors 




Piroxicam (PX) and tenoxicam (TX) were obtained from Sigma-Aldrich (Dorset, U.K.). 
Their chemical structures are shown in Figure 7-1. In both cases, the formula weight 
quoted is calculated using the mono-isotopic atomic masses. All chemicals were used 
without further purification, as supplied by commercial suppliers.
Piroxicam (FW 331) Tenoxicam (FW 337)
Figure 7-1. Chemical structures of analyte and internal standard.
7.2.2 Instrum entation and Conditions
For the application of the MALDI matrix on the silica gel surface of the TLC plate an 
in-house modified commercial robotic x-y-z-axis motion system (PROBOT, BAI,
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Germany) was used. Modifications to the instrument have been described in chapter 5. 
Mass spectra were recorded directly from TLC strips with a modified linear LaserTOF 
1500 mass spectrometer (SAI, Manchester, U.K.). The modifications to the instrument 
and its software have been extensively described in chapters 3 and 4. Experiments were 
carried out using a 10 kV extraction voltage. Only the positive ion mode was used and 
the mass spectra, acquired from the TLC surface, were the results of the cumulative 
acquisition of 16 shots. The TLC strips were scanned over a distance of 50 or 55 mm 
and mass spectra were recorded every 0.5 mm. A data set of 100 or 110 mass spectra 
was obtained for each TLC strip.
7.2.3 Quantification M ethods
The section is divided into four sub-sections 1, 2, 3 and 4, which describe the different 
approaches for the incorporation of the internal standard, tenoxicam, into the TLC 
plate.
Method 1: Mixing of the internal standard to the analyte solution and spotting of the 
resulting mixture onto the TLC plate.
Method 2: Pre-development of the TLC plate in the mobile phase, to which the internal 
standard is added, followed by development of the analyte in the same mobile phase.
Method 3: Electrospraying of the internal standard prior matrix application.
Method 4: Mixing of the internal standard with the matrix solution and electrospraying 
of the resulting solution.
Calibration Standards
Method 1: Primary stock solutions of piroxicam (1 mg/ml) and tenoxicam (2 mg/ml) 
were prepared in hydrochloric acid (2.0 M), respectively. Five standard solutions of 
piroxicam (0.4, 0.5, 0.6, 0.7 and 0.8 mg/ml), with a constant concentration of tenoxicam 
(0.4 mg/ml), were obtained by combining aliquots of both primary solutions and 
diluting with HPLC-grade methanol.
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Method 2: Primary stock solution of the analyte piroxicam (1 mg/ml) was prepared in 
HPLC-grade dichloromethane and five standard solutions (0.4, 0.5, 0.6, 0.7 and 0.8 
mg/ml) were obtained by subsequent dilution of the primary stock solution.
Method 3 and 4: Five standard solutions of piroxicam (0.4, 0.5, 0.6, 0.7 and 0.8 mg/ml) 
were obtained by diluting the primary stock solution of piroxicam, prepared in method 
1, with HPLC-grade methanol.
Sample Preparation
Method 1: Aliquots of standard solutions (lpl) were applied to an aluminium-backed 
TLC plate coated with a 0.2 mm layer of silica gel 60 F25 4 (Merck, Germany) using 
disposable spotting pipettes (Camag, Switzerland). A distance of 10 mm between the 
analyte spots was chosen to keep them separate in order to be able to detect 5 spots in a 
single experiment. After UV detection (k = 254 nm) of the analyte spots, a strip of the 
TLC plate (2 x 50 mm) was cut out and attached to a modified MALDI target using 
double sided tape. The matrix a-CHCA (Sigma-Aldrich, Dorset, U.K.) was dissolved in 
HPLC-grade methanol containing 0.1% TFA. A solution of 20 mg/ml of a-CHCA was 
electrosprayed onto the silica gel TLC strip and the TLC sample was subjected to 
MALDI analysis after 30 minutes drying at room temperature.
Method 2: The TLC plate was pre-developed in 25.0 ml chloroform-methanol (9:1, v/v), 
in which tenoxicam was dissolved to a concentration of 0.4 mg/ml. The chamber was 
lined with filter paper and saturated for 30 minutes. The TLC plate was developed for 
17 hours in the mobile phase to obtain a homogeneous surface coverage of tenoxicam. 
After air drying, 1 pi aliquots of standard solutions were applied to the pre-developed 
TLC plate and the plate was developed again in the same mobile phase. The mobile 
phase was freshly prepared and saturated for one hour prior use. A typical TLC plate 
obtained by this procedure is shown in Figure 7-2. After the developed TLC plate was 
air dried, a-CHCA was electrosprayed onto the plate followed by MALDI-MS analysis, 
as described for method 1 .
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PX Rf= 0.63
m m m   position with highest concentration of TX
Figure 7-2. Typical TLC separation of 600 ng of piroxicam (PX), separated  on a pre-coated TLC 
plate, according to method 2. The grey colour throughout the TLC plate represents the surface 
coverage of tenoxicam (TX).
Method 3: Aliquots of standard solutions (lpl) were applied to the TLC plate, as 
described for method 1, and a 0.25 mg/ml solution of tenoxicam, dissolved in acetone, 
was electrosprayed on the TLC plate, followed by electrospraying of the matrix 
solution.
Method 4: Aliquots of standard solutions (lpl) were applied to the TLC plate, as 
described for method 1. A 0.1 mg/ml solution of tenoxicam, dissolved in 
dichloromethane, was mixed to the matrix solution in the volume ratio 1:1 and 
electro sprayed on the analyte spots.
C alib ra tion  C u rv es
Standard curves were constructed for samples spots containing 400 to 800 ng of 
piroxicam for each method. Peak responses of piroxicam and tenoxicam were measured 
in each of the mass spectra recorded. From these data mass chromatograms of 
Piroxicam (PX) and tenoxicam (TX) were generated for each sample (Figure 7-5). The 
piroxicam-to-tenoxicam ratio for each single spot on the TLC strip was calculated using 
the software package Origin (OriginLab Corporation). For each spot, represented in the 
mass chromatograms as a peak, the piroxicam-to-tenoxicam ratio was obtained by 
dividing the integrated area of the piroxicam signals by the integrated area of the
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tenoxicam signals at the same positions on the TLC plate. The piroxicam-to-tenoxicam 
ratios obtained by this methodology were plotted versus the corresponding piroxicam 
quantity. The calibration curves were determined by least-square linear regression 
analysis and the precision was evaluated on the range errors of the replicates. The 
calculated range errors are listed in the appendix of this thesis.
Method Validation
Method 1 and 2 were assessed by the following criteria [22]: accuracy, precision, 
specificity, limit of detection, limit of quantification, linearity and range of 
measurement. The robustness could not be determined, since the methodology is 
currently unique to this laboratory.
Accuracy and Precision: To evaluate the accuracy and precision of the proposed 
methods three quantities within the previously determined linear range (450, 600 and 
750 ng piroxicam) were selected and analysed. From each quantity ten determinations 
(method 1) or five determinations (method 2) were performed. The accuracy of the 
method was defined as the amount of piroxicam determined by TLC-MALDI MS, 
expressed as a percentage of the “true” amount of piroxicam in the sample spot. To be 
acceptable, measures should be within ± 15% at all concentrations [23]. The precision 
of the method was expressed as the relative standard deviation (RSD) of replicate 
analyses, carried out within one working day. To be acceptable, measures should be 
lower than + 15% at all concentrations [23].
Specificity: Six blank TLC plates were tested for the presence of interfering peaks, 
arising from the silica gel layer and the matrix.
Limit o f  Detection and Quantification: The limit of detection (LOD) was defined as the 
piroxicam amount, resulting in a peak area of three times the noise level. The limit of 
quantification (LOQ) was defined as the piroxicam amount, resulting in a peak area of 
ten times the noise level. The LOD and LOQ value were calculated from the 
constructed calibration curves [24], shown in Figure 7-6a and b.
Range: The range was determined by selecting three amounts of piroxicam (a lower, 
middle and upper amount) and demonstrating that the analyses could be obtained with a
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suitable level of precision, accuracy and linearity.
7.3 Results and Discussion
7.3.1 Matrix Selection
The suitability of the following MALDI matrices, a-CHCA, DHB, 3-HPA, and HABA, 
was studied for the quantitative analysis of piroxicam. The selection of the matrix was 
based on examination of their MALDI-MS behaviour on stainless steel substrates. The 
matrix a-CHCA was found to give the best results, based on the following criteria, i.e. 
absence of interfering peaks in the spectral region of interest and reproducible analyte 
signal intensity from laser spot to spot over the target (good crystal homogeneity).
7.3.2 Internal S tandard Selection
For quantitative MALDI analysis an internal standard is required to improve shot-to- 
shot and sample-to-sample reproducibility. The selection of an appropriate internal 
standard is critical for the success of such an analysis [25]. An isotopically labelled 
analogue is an ideal internal standard [26] in mass spectrometry, however these are 
seldom available and structural analogues are often employed, e.g. for the quantification 
of biomolecules [27] or small molecules [28] by MALDI mass spectrometry.
The selection of a suitable internal standard for quantification using TLC-MALDI was 
based on two important properties of the internal standard. Firstly, it needed to be 
chemically similar to the analyte so that similar extraction efficiencies out of the silica 
gel phase were achieved. Secondly, for these experiments a reasonable mass separation 
between analyte and internal standard signal was required since the mass spectrometer, 
employed in these investigations has a mass resolution of only -425 (FWHM) for 
piroxicam. For these reasons tenoxicam, a structural analogue of piroxicam, was 
chosen. Tenoxicam is, as well as piroxicam, a member of the N-heterocyclic 
carboxamide derivatives of benzothiazine- 1,2-dioxide and has been previously used as
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internal standard for the quantitative HPLC analysis of piroxicam [21]. Their mass 
difference of 6 mass units gave adequate resolution of their protonated molecules 
(Figure 7-3 and 7-4, respectively).
7.3.3 TLC-MALDI A nalysis
Method 1: Preliminary experiments, involving spotting mixtures containing 400 to 800 
ng of piroxicam and the same amount of tenoxicam (400 ng) on untreated silica gel 
TLC plates, were carried out to prove that quantification of piroxicam with tenoxicam 
as internal standard is possible by TLC-MALDI TOF MS and to show that the method 
could be validated. Typical TLC-MALDI mass spectra, obtained from the blank TLC 
plate and a 800 ng spot of piroxicam containing 400 ng of tenoxicam, are shown in 
Figure 7-3a and b, respectively. Since the primary stock solutions of analyte and 
internal standard were prepared in hydrochloric acid and diluted with methanol to obtain 
the required concentrations, typically no sodium adduct of the matrix (m/z 212) was 
obtained at the location of the TLC spots (Figure 7-3b). The mass chromatograms, 
obtained for the analyte (m/z range: 331-333) and the internal standard (m/z range: 337- 
339), using this approach, are presented in Figure 7-5a. Piroxicam showed a higher 
signal response compared to tenoxicam and appeared to give a better MALDI response. 
Although piroxicam was increased in the spots from the left to the right side in Figure 
7-5a, a steady increase in the recorded signal intensities was not obtained. Moreover, all 
five spots contained the same amount of tenoxicam, but the signal responses varied 
greatly. These variations are caused by local concentration changes of the compounds in 
the crystal structure [25]. The reason for these variations can be explained as follows. 
The solvent, in which the matrix is dissolved, acts as an extraction solvent of the 
compounds, spotted on the TLC plate (analyte and internal standard). The extraction 
efficiency of the solvent throughout the scanned TLC strip varies from position to 
position and causes these variations. This shows how important the use of an internal 
standard is to normalise MALDI signals from a TLC plate when attempting 
quantification.
An effect, where the signal from a less concentrated component is suppressed by that 
from a more concentrated one, has been described for MALDI-MS [25, 27, 29]. In the 
TLC-MALDI experiments presented here this effect lead to the limited linear range
(400 to 800 ng) obtained in the constructed calibration curve (Figure 7-6a).
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250 300Mass (m/z) 450
Figure 7-3. TLC-MALDI spectra of (a) blank sample, and (b) 800 ng of piroxicam (PX) 
containing 400 ng of tenoxicam (TX) (method 1).
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Figure 7-4. TLC-MALDI spectra of (a) blank sample, the internal standard tenoxicam (TX) is 
pre-developed on the TLC plate, and (b) 600 ng of piroxicam (PX) (method 2). The intercept 
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Figure 7-5. Mass chromatogram s obtained by different approaches of incorporating the internal 
standard: (a) method 1, (b) method 2, (c) method 3, and (d) method 4. The various m ethods are 
explained in the experimental section. A range of quantities of piroxicam (400-800 ng) w as 

























Figure 7-6. Standard calibration curves obtained for (a) method 1, (b) method 2, (c) method 3, and (d) method 4. The plotted data points are the
arithmetic means of three experiments, except for method 2 (n = 4).
When a higher concentration than 0.4 mg/ml of the internal standard was used, 
suppression of the analyte occurred. The analyte signal caused also suppression of the 
internal standard signal, if  a critical quantity was exceeded, e.g. a quantity of 3 pg of 
piroxicam suppressed 0.8 pg of tenoxicam.
Method 2: The mass chromatograms obtained by method 2 are presented in Figure 7- 
5b. Since tenoxicam has a smaller Rf value than piroxicam, pre-development of the 
silica gel TLC plate with the internal standard was necessary to achieve the same 
location for analyte and internal standard. The variation of the signal responses of the 
internal standard was 90% RSD from the averaged value, throughout the scanned TLC 
strip. However, only the surface coverage at the location of the piroxicam spot was of 
interest, and there the variation was in accordance to the one obtained by the analyte.
Even with the matrix electrospray deposition method, which has been shown to produce 
a homogenous layer compared to other methods of matrix application studied (chapter 3 
of this thesis), variation of the matrix signals throughout the scanned TLC plate is 
obtained. The variation of the signals of the internal standard is in accordance to this, as 
revealed by plotting the signal intensities of the sodium adduct of a-CHCA (m/z 212) 
and the protonated molecular signal of tenoxicam (m/z 338) against the position on the 
TLC plate (Figure 7-7).
The resulting calibration curve obtained by method 2 (Figure 7-6b) shows a four times 
smaller slope value (b = 0.0012), in comparison to method l(b = 0.0047) (Figure 7-6a).
Figure 7-4b shows the MALDI mass spectrum recorded at 45 mm of the scanned TLC 
plate with the [M+H]+ ion of piroxicam clearly visible at m/z 332 and that of tenoxicam 
at m/z 338. Three matrix peaks of a-CHCA, [M-H20+H]+ at m/z 172, [M+H]+ at m/z 
190, and [2M+H]+ at m/z 379, were used as “lock masses” to overcome the degradation 
in mass measurement accuracy and mass resolution observed in the previous TLC- 
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Figure 7-7. Plot of the signal intensities of the protonated molecular species of the internal 
standard tenoxicam (TX) (m/z 338) and the sodium adduct of the matrix a-CHCA (m/z 212)
against the position on the TLC plate.
Method 3: When the internal standard is electrosprayed on the analyte spots, care has to 
be taken that minimal planar spreading of the analyte is caused. This can be achieved by 
using a non-polar solvent, in which the analyte is only sparingly soluble, but which has 
reasonable solvating properties for the internal standard. This second criteria is difficult 
to achieve, due to the chemical similarity of analyte and internal standard. It was found 
that acetone is a suitable candidate, since its polarity index is 5.4 [30] and the solubility 
of tenoxicam is 2 mg/ml in it [31]. The concentration of tenoxicam in acetone was 
reduced from 0.4 to 0.25 mg/ml, since analyte suppression occurred at higher 
concentrations.
In the mass chromatograms shown in Figure 7-5c, the increase in the internal standard 
response at the analyte spots containing 600, 700 and 800 ng of piroxicam is significant. 
A possible explanation could be as follows. The internal standard molecules are located 
at a layer above the analyte molecules, and when the solvent of the matrix solution is 
extracting the analyte molecules from the inner part of the silica gel layer to the surface, 
they have to pass through the layer of the internal standard molecules. An increase in
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the concentration of the analyte molecules possibly causes an increase of internal 
standard molecules desorbed on the TLC plate surface.
The variation of the internal standard signals along the TLC strip varied around 102 % 
from the average value. The calibration curve (Figure 7-6c), showing an error range of 
86 % for the lowest amount of piroxicam (400 ng), spotted on the TLC plate, and one of 
32 % for the highest amount (800 ng), discounts this method for validation.
Method 4: Since electrospraying of the internal standard with the matrix solution caused 
a high degree of analyte suppression, the concentration of tenoxicam was reduced from 
0.25 to 0.05 mg/ml in a-CHCA. Even at this level suppression effects could not be 
prevented (Figure 7-5d and slope value of calibration curve in Figure 7-6d). However, 
at lower levels the internal standard signal was not detected in a high number of mass 
spectra required, during the scan. The high variation of the internal standard signal in 
the recorded mass spectra is shown in Figure 7-5d (values vary from 0 to 53, which 
corresponds to an RSD of 111 %). This method, like method 3, was not considered as 
suitable for the quantitative analysis of piroxicam, since range error values of 130 % for 
the lowest and 55 % for the highest point of the calibration curve were obtained (n = 3) 
(Figure 7-6d).
Comparing all four methods of incorporating the internal standard into the TLC plate, 
the question arises why methods 3 and 4 are not suitable for the quantification of 
piroxicam by TLC-MALDI TOF MS. A possible explanation lies in the MALDI 
process itself. The incorporation of the analyte into the matrix crystals is not a 
requirement, but improves the overall MALDI performance [32]. In methods 3 and 4 
the location of the internal standard and analyte molecules differ from each other, and 
hence the same incorporation process dos not occur. This highlights how important it is 
that both, the analyte and the internal standard, are applied on the TLC plate in the same 
manner, i.e. by spotting (method 1) or by TLC development (method 2).
7.3.4 Method Validation
Specificity: The specificity of method 1 and 2 was tested on six blank TLC-MALDI 
samples, respectively. The corresponding mass spectra (Figure 7-3a and Figure 7-4a)
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showed no interfering peaks between m/z 330 and 340.
Linearity and range: Both methods exhibited linearity between the response (y) and the 
corresponding amount of piroxicam (x), over the range of 400 to 800 ng (Figure 7-6a 
and b). The mean correlation coefficient was 0.9992 (n = 3, method 1) or 0.9969 (n = 4, 
method 2), respectively.
Limit o f  detection (LOD) and limit o f  quantification (LOQ): The LOD for piroxicam 
was calculated as 16 ng and the LOQ as 53 ng (method 1). Method 2 showed two fold 
higher values, LOD = 39 ng, and LOQ = 131 ng. The latter values are similar to the 
ones, described for the quantitative HPTLC determination of piroxicam (LOD = 40 ng, 
and LOQ =150 ng) [11].
Accuracy and precision: Table 7-1 summaries the assay results for the analysis of three 
different quantities of piroxicam. Good accuracy and precision were obtained for both 
methods.




Method 1 Method 2
Detected RSD Accuracy Detected RSD Accuracy
[ng]a [%] [%] [ng]6 [%] [%]
450 438 ±28 6.4 2.7 457 ±41 8.9 1.5
600 617 ±32 5.2 2.8 586 ± 20 3.5 2.3
750 728 ± 23 3.2 2.9 745 ±10 1.3 0.7
Values are mean of te n a or fiveb determinations ± S.D.
7.4 Conclusion
Four methods for quantification by TLC-MALDI TOF MS have been compared. The 
drug piroxicam could be successfully quantified by TLC-MALDI mass spectrometry,
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when the internal standard was mixed into the mobile phase of the TLC analysis. The 
results of the method validation demonstrated that good accuracy, precision, linearity 
and sensitivity could all be obtained using this method.
The simplicity of pre-developing the TLC plate with an appropriate internal standard to 
perform quantification in TLC-MALDI MS makes this technique particularly attractive 
to the pharmaceutical industry, where TLC is a standard analytical method for quality 
control samples (QC samples).
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Chapter 8
TLC-PSD MALDI TOF MS of Small Drug Molecules
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8.1 Introduction
The use of post-source decay (PSD) in combination with MALDI MS has become a 
widely used technique for peptide sequencing [1-5], since its introduction in the early 
1990s [6]. Compared to the large amount of work that has been carried out using PSD- 
MALDI for the analysis of biomolecules, little work has been conducted on the 
structural elucidation of low molecular weight compounds. Recently, Cheng and 
Hercules [7] demonstrated the use of collision-induced dissociation, post-source decay 
matrix-assisted laser desorption/ionisation (CID-PSD MALDI) mass spectrometry for 
the analysis of pesticides. LeRiche et a l [8] compared product ion spectra of 4- 
quinolone antibiotics produced by PSD- and PSD-CID MALDI mass spectrometry with 
electrospray ion-trap MSn. The possibility of recording PSD MALDI spectra directly 
from membranes was investigated by Guittard et a l [9]. In this work glycolipid samples 
were separated on a TLC plate followed by heat transfer to a membrane. More 
information about the latter technique can be found in chapter 2 of this thesis.
The structural analysis of small drug molecules by directly coupling TLC with PSD 
MALDI mass spectrometry is reported in this chapter. The applicability of this 
techniques is shown using two examples: (i) the TLC-PSD MALDI analysis of two 
representatives of non steroidal anti-inflammatory drugs (NSAIDs), tenoxicam and 
piroxicam, and (ii) the analysis of the pharmaceutically active compound UK-137,457 
and one of its related substances UK-124,912. The matrices a-CHCA and graphite were 
used to investigate the effect of the precursor ion selection on the TLC-PSD MALDI 
spectra of the drug molecules studied. While a-CHCA enhances the [M+H]+ ion 
formation, graphite produces in general only sodium adducts. Structural differentiation 
of tenoxicam and piroxicam was only possible by selecting the sodium adduct of both 
drug molecules as precursor ions. In the case of the TLC-PSD MALDI analysis of UK- 
13 7,457 and its related substance UK-124,912 at the 1% level, the PSD spectra obtained 
in a-CHCA, by selecting the protonated adduct of the small molecules as precursor 
ions, showed distinguishable dissociation patterns containing structurally significant 
information. Since a-CHCA showed matrix ions, which could not be eliminated from 
the PSD spectra in the case of tenoxicam and piroxicam due to the low resolution of the 
ion gate, the use of a quadrupole TOF instrument (q-TOF) was investigated for TLC- 




The small drug molecules, tenoxicam (C13H 11N3O4 S2) and piroxicam (C15H 13N3O4 S) 
were obtained from Sigma-Aldrich (Dorset, U.K.). UK-137,457 (C31H31NO5), a 
pharmaceutically active compound, and one of its related substance UK-124,912 
(C2 7H25NO3) were supplied by Pfizer Global R&D (Sandwich, U.K.). The chemical 
structures of these compounds are shown in chapter 7 and 5, respectively. The matrices 
a-CHCA and graphite (1-2 pm) were purchased from Sigma-Aldrich (Dorset, U.K.). 
Methanol, acetonitrile, chloroform and dichloromethane were all HPLC grade.
8.2.2 Sam ple Preparation
Stock solutions of tenoxicam and piroxicam (2 mg/ml) were dissolved in 
dichloromethane. A mixture of both oxicam derivatives, with a concentration of 1 
mg/ml of each component, was obtained by combining aliquots of both stock solutions.
Stock solutions of UK-137,457 (20 mg/ml) and UK-124,912 (1 mg/ml) were dissolved 
in acetonitrile. A mixture containing 10 mg/ml of UK-137,457 and 0.1 mg/ml of UK-
124,912 was prepared by mixing both stock solutions in an appropriate ratio and 
diluting with acetonitrile to get the final concentrations.
8.2.3 TLC Separation
Appropriate aliquots of the mixture were applied to an aluminium-backed TLC plate (10 
x 10 cm), coated with 0.2 mm layers of silica gel 60 F254 (Merck, Germany), using a 10 
pi syringe. The development chamber was lined with filter paper and saturated with the 
corresponding mobile phase. For the separation of tenoxicam and piroxicam the mobile 
phase chloroform/methanol (9/1, v/v) [10] was used and saturated for one hour before 
development of the plate. UK-137,457 was separated from its related substance UK-
124,912 employing the mobile phase chloroform/methanol/glacial acetic acid (60/5/1, 
v/v/v), which was saturated over night. The TLC plates were developed to a distance of 
7.0 cm. After solvent evaporation at room temperature, the sample spots were visualised
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by illumination with UV light at A,=254 nm.
8.2.4 Matrix Application
Before the matrix was deposited on the silica gel surface, a strip of the developed TLC 
plate (60 x 2 mm) was attached to a modified MALDI target with double sided tape. 
The organic matrix a-CHCA was applied to the silica gel surface of the TLC plate by 
using an in-house modified commercial robotic x-y-z-axis motion system (PROBOT, 
BAI, Germany), described in chapter 5.
The inorganic matrix suspension of graphite was prepared by dispersing 80 mg graphite 
in 1 ml of methanol/ethylene glycol (1000:1, v/v). The suspension was homogenised by 
sonication for 15 minutes and then applied to the developed TLC strip using a 10 pi 
syringe, as described in chapter 7 of this thesis. Typically 30 pi of the graphite 
suspension was used to cover an area of 60 x 2 mm.
8.2.5 M ass Spectrom etry
A LT3 mass spectrometer (SAI, Manchester, U.K.), equipped with a nitrogen laser 
(A,=337 nm), was employed for this study. Further information about this instrument can 
be found in the appendix of this thesis (chapter 10). Modifications to the instrument and 
its software are the same as described for the linear LaserTOF 1500 mass spectrometer, 
which can be found in chapters 3 and 4 of this thesis.
TLC-MALDI analysis was performed in linear or reflectron positive ion mode with an 
accelerating voltage of 10 or 20 kV. 16 shots/spectrum were accumulated. The TLC 
strip was scanned over a distance of 60 mm and spectra were recorded every 0.5 mm. A 
data set of 120 mass spectra were obtained, from which mass chromatograms of the 
studied compounds were constructed. The mass chromatograms enabled the location of 
the highest analyte signals on the TLC strip (“sweet spots”). Note: The mass 
chromatograms presented here were smoothed.
TLC-PSD MALDI analysis was performed at these “sweet spots” using an accelerating 
voltage of 20 kV, and a focus mass applicable to the mass of the analyte. The gate was
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set to include the analyte of interest +/- 2 Da. Since this instrument uses a curved-field 
reflectron [11] full PSD spectra could be recorded without the need to combine small 
spectra segments.
TLC-MALDI MS-MS analysis was performed on a Q-Star hybrid quadrupole TOF 
mass spectrometer, fitted with an orthogonal MALDI source (Applied Biosystems-MDS 
Sciex, Toronto, Canada) [12]. (The mass spectrometric analysis was not performed by 
the author of this thesis, since the laboratory was not equipped with this instrument, 
when this work was carried out.)
8.3 Results and Discussion
8.3.1 TLC-MALDI Analysis
Figure 8-1 a shows typical overlaid mass chromatograms of tenoxicam ([M+H]+, m/z 
338) and piroxicam ([M+H]+, m/z 332), obtained from a TLC-MALDI experiment in 
reflectron positive ion mode with an acceleration voltage of 20 kV. Two pg of both 
drug compounds were separated on a silica gel TLC plate and the organic matrix a- 
CHCA (20 mg/ml in methanol containing 0.1% TFA) was electrosprayed on the eluted 
TLC plate.
The phenomenon of “donut shaped” analyte spots, normally occurs when polar solvents 
are used to apply the analyte spot on the TLC plate, prior to TLC analysis [13-14]. In 
TLC-MALDI analysis bimodal responses, as illustrated in Figure 8-1 a, were due to the 
electrospray deposition of the matrix, which was carried out in the polar solvent 
methanol. Both drug molecules have a solubility of < 1 mg/ml in methanol [15]. This is 
necessary to ensure sufficient analyte extraction. However, solubility sufficient to give 
good analyte extraction from the silica gel layer also causes some analyte spreading, 
indicated as peak broadening in Figure 8-1 a. Although the limit of detection of 
piroxicam is 39 ng when a-CHCA is employed as MALDI matrix, as determined in 
chapter 7 of this thesis, 2 pg quantities of both drug compounds were chosen in order to 
allow scanning of the TLC plate and PSD analysis to be carried out on the same sample. 
A high analyte concentration was particularly required when graphite was used as
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matrix since fast signal decrease occurred when the laser was targeted on the same TLC 
position.
The generation of an impurity profile of UK-137,357 is presented in Figure 8-1 b. The 
overlaid mass chromatograms of the parent compound UK-137,457 ([M+H]+, m/z 498) 
and its related substance UK-124,912 ([M+H]+, m/z 412) at the 1% level were 
constructed from a TLC-MALDI analysis in linear positive ion mode using an 
acceleration voltage of 10 kV. One hundred pg of the parent compound was separated 
from 1 pg of the related substance on a silica gel TLC plate and the organic matrix a- 
CHCA (20 mg/ml in acetonitrile/water containing 0.1% TFA in the volume ratio 7:3) 
was electrosprayed onto the eluted TLC plate. To obtain a sufficient signal of the related 
substance for the following PSD analysis a 1% level was chosen, even though the 
sensitivity of the related substance is below 1 ng, as presented in chapter 5 of this thesis. 
With a quantity of 100 pg of the parent compound the TLC plate is overloaded, as 
indicated in Figure 8-1 b.
8.3.2 TLC-PSD MALDI Analysis
The mass chromatograms obtained from the TLC-MALDI analysis (Figure 8-1) 
enabled the location of the highest analyte signals on the TLC strip, and TLC-PSD 
MALDI analyses were performed at these positions.
Two matrices were chosen for the TLC-PSD MALDI analysis of tenoxicam and 
piroxicam, the organic matrix a-CHCA and the particle suspension matrix graphite, a- 
CHCA is classified as a “hot” matrix in MALDI, because of the high dissociation level 
induced [16]. The use of graphite for PSD experiments has not been previously 
reported. However, previous studies of graphite for the TLC-PALDI analysis of 
tetracyclines showed high in-source fragmentation rates in the linear positive and 
negative ion mode, as described in chapter 6 of this thesis.
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Figure 8-1. Overlaid, smoothed m ass chromatograms from the TLC-MALDI determination of (a) 
tenoxicam ([M+H]+, m/z 338) and piroxicam ([M+H]+, m/z 332) (2 pg of each component), and 
(b) UK-137,457 ([M+H]+, m/z 498) (100 pg) and its known related substance UK-124,912 
([M+H]+, m/z 412) at the 1% level. In both analyses the small molecules were separated on a 
silica gel TLC plate and a-CHCA was used as matrix, as described in the experimental section.
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The recorded TLC-PSD-MALDI spectrum of tenoxicam in a-CHCA is presented in 
Figure 8-2 a. The protonated molecular species of tenoxicam at m/z 338 was selected 
as precursor ion. An interference peak of a-CHCA, indicated as M* in the spectrum, is 
observed at m/z 335 . a-CHCA with a molecular weight of 189 Da, forms a dimer [2M- 
C02+H]+ at m/z 335 [17], which passes through the ion gate and enters the mass 
analyser. For piroxicam the protonated molecular species at m/z 332 was chosen as 
precursor ion. The corresponding TLC-PSD MALDI spectrum of piroxicam in a- 
CHCA is shown in Figure 8-2 b. The interfering peak of the matrix (indicated as M*) is 
observed in low abundance. To ensure that the detected product ions in Figure 8-2 a 
and b are not arising from dissociated ions of a-CHCA, TLC-PSD MALDI analysis 
was carried out on TLC plate positions, at which no analyte was located, i.e. matrix only 
was present in this position. No product ions with m/z values shown in Figure 8-2 a and 
b were detected.
The oxicam derivatives tenoxicam and piroxicam form mainly sodium adduct ions in 
TLC-MALDI analysis using graphite as matrix, since sodium is believed to be a major 
contaminant in graphite. Hence, TLC-PSD MALDI analysis in graphite was performed 
on the [M+Na]+ ion of tenoxicam at m/z 360 and of piroxicam on the [M+Na]+ at m/z 
354. The resulting TLC-PSD MALDI spectra of both drug molecules are shown in 
Figure 8-2 c and d, respectively. A comparison of the TLC-PSD MALDI spectra of 
tenoxicam and piroxicam obtained in graphite (Figure 8-2 c and d) with a-CHCA 
(Figure 8-2 a and b), shows that a lower noise level is obtained when the latter matrix is 
employed.
To improve the mass accuracy obtained on a TLC plate, which is limited by the porosity 
of the silica gel surface (see chapters 3 and 4), the instrument was re-calibrated using 
the selected precursor ion in the positive reflectron ion mode at the TLC position from 
which the TLC-PSD MALDI spectra were recorded. Comparison of the m/z values of 
the product ions obtained on the silica gel surface with the normal stainless steel surface 
showed no differences.
Possible structures for the product ions of tenoxicam and piroxicam are proposed in 
Table 8-1. It could be clearly seen that the selection of the protonated species as 
precursor ion for tenoxicam and piroxicam in the organic matrix a-CHCA produces the 
same product ions for both drug molecules, since dissociation presumably occurs from
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the thiophene or benzene-group, which represent the only structural difference between 
both molecules (Table 8-1 column 1). In contrast, the selection of the sodium adduct as 
precursor ion for both oxicam derivatives, in experiments conducted using the particle 
suspension matrix graphite, generates distinguishable dissociation patterns. All product 
ions observed (Table 8-1 column 2) are believed to be sodium adducts. Dissociation is 
believed to occur from both sides of the drug molecules, the thiophene or the benzene- 
group and the pyridine-group. The structural information obtained by selection of the 
sodium adduct as the precursor ion is complementary to the protonated adduct, and 
hence the combination of both precursor ions enables a more complete structural picture 
of the test analytes.
It is interesting to note that the PSD analysis of cationised peptides was reported to be 
less efficient than PSD of protonated species [5]. Cationised ions were found to be 
much more stable. This does obviously not apply to pharmaceutical compounds, such as 
tenoxicam and piroxicam.
The addition of sodium chloride to a-CHCA was tried in order to produce sodium 
adducts of the drug molecules. However, the generated sodium adducts of tenoxicam 
and piroxicam were of low abundance and the protonated ions were still the dominant 
species. Despite this, when the sodium adducts were selected as precursor ions for PSD 
analysis the same dissociation patterns were obtained as those when graphite was used 
as the matrix. The PSD spectrum of piroxicam is presented in Figure 8-3. The sodium 
adduct of piroxicam with the m/z value of 354 was produced by adding an appropriate 
aliquot of a 30 mg/ml solution of sodium chloride, dissolved in methanol/water (1/1, 
v/v), to the sample. These data prove that the degree of dissociation of the drug 









Figure 8-2. TLC-PSD MALDI spectra of tenoxicam (2 pg) and piroxicam (2 pg), separated on silica gel TLC plates using different matrices. Mass spectra of (a) 
tenoxicam and (b) piroxicam were acquired using a-CHCA as matrix, and mass spectra of (c) tenoxicam and (d) piroxicam were acquired using graphite as matrix.
when the [M+Na] ion was used.
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Figure 8-3. PSD-MALDI spectrum of piroxicam obtained in a-CHCA by addition of sodium 
chloride to produce the [M+Na]+ ion at m/z 354.
For the TLC-PSD MALDI analysis of UK-137,457 in a-CHCA the protonated 
molecular species at m/z 498 was selected as the precursor ion. The corresponding PSD 
spectrum is shown in Figure 8-4 a. The [M+H]+ ion of the related substance UK- 
124,912 was detected at m/z 412 and was used as precursor ion for PSD analysis 
(Figure 8-4 b). In both TLC-PSD MALDI spectra, a-CHCA does not show interfering 
peaks. Possible structures of the recorded product ions are summarised in Table 8-2. 
The important species are those of m/z 230 and 341 for UK-137,457 and m/z 144 and 
255 for UK-124,912. As can be seen from Table 8-2, the difference in m/z value of 86 
between corresponding ions is the RMM of the side chain group of the pyrrole ring of 
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Figure 8-4. TLC-PSD MALDI spectra of (a) UK-137,457 (100 pg), and (b) its related substance 
UK-124,912 at the 1% level. The related substance UK-124,912 (1 pg) was separated on a 









Table 8-2. Proposed structures of the product ions observed in the TLC-PSD MALDI m ass
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8.3.3 TLC-MALDI MS-MS Analysis
The organic matrix a-CHCA shows one peak at m/z 335, as discussed under point 8.3.2 
of this chapter, which could not be eliminated due to the low resolution of the ion gate 
in the reflectron TOF instrument. To compensate this, a q-TOF instrument was 
employed for tandem MS analysis. Figure 8-5 shows the MS-MS spectrum of 
piroxicam obtained by spotting 800 ng of it on a silica gel TLC plate followed by 
electrospray deposition of a-CHCA. The mass accuracy and mass resolution were 
excellent using this instrument, as shown in Figure 8-5. Re-calibration of the precursor 
ion on the TLC spot was not necessary, since precursor ion selection was performed 
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Figure 8-5. TLC-MALDI MS-MS spectrum of 800 ng of piroxicam using a-CHCA as matrix.
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8.4 Conclusion
TLC-PSD MALDI spectra of the drug analogues tenoxicam and piroxicam and the 
pharmaceutically active compound UK-137,457 and its related substance UK-124,912 
have been successfully obtained, and the effect of the precursor ion selection on this 
technique was evaluated. The extent of PSD of these small molecules was determined 
by the selection of the precursor ion. A high degree of PSD activation and 
distinguishable product ions were only obtained for tenoxicam and piroxicam when the 
sodium adduct was chosen as precursor ion. a-CHCA showed the disadvantage of 
generating matrix ions, which could not be eliminated from the PSD spectra due to the 
low resolution of the ion gate. Hence, the feasibility of employing a q-TOF instrument 
for TLC-MALDI MS-MS experiments was tested to overcome this matrix interference 
and to enhance the mass accuracy and mass resolution.
In the TLC-PSD MALDI analysis of UK-137,457 and its related substance UK-124,912 
in a-CHCA, differentiation in the PSD spectra was achieved when the protonated ion of 
both molecules was selected. It was possible to obtain TLC-PSD MALDI data from 
UK-124,912 at the 1% level which allowed its structural characterisation.
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Chapter 9
Conclusions and Future Perspectives
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In recent years has been an increased interest in the use of MALDI MS for the direct 
analysis of TLC plates [1]. However, there are several issues, which have to be 
addressed for successful TLC-MALDI coupling. The first is concerned with the method 
used for the deposition of the MALDI matrix onto the TLC plate. The matrix facilitates 
the ionisation of the analyte molecules separated on the TLC plate. The application of 
the matrix directly onto the TLC plate is crucial to the success of such analysis. The 
matrix application has to be carried out in such a manner that analyte spreading along 
the silica gel layer is avoided. This maintains the chromatographic integrity of the 
analyte spots. The second issue is the requirement for efficient extraction of the analyte 
from the interior of the silica gel layer to enhance sensitivity. The porosity o f the silica 
gel layer, can also lead to problems, ions starting from different points in the surface can 
have a slight variation in their flight times and hence lead to a decrease in the mass 
resolution and mass accuracy of spectra recorded, if a TOF analyser is used. Finally, for 
the analysis of low molecular weight compounds, such as pharmaceuticals, strong 
matrix peaks can interfere and suppress analyte signals.
In this thesis the direct TLC-MALDI analysis of pharmaceutical compounds was 
evaluated. The issues described above for the direct coupling o f TLC with MALDI mass 
spectrometry have been fully investigated and discussed. The study was started by 
comparing several approaches for the application of the matrix for TLC-MALDI 
coupling, including a newly developed electrospray matrix deposition (chapter 3). The 
electrospray method was found to be superior to the other techniques studied. It 
produced a stable signal, minimised analyte spreading and hence allowed the scanning 
of a TLC plate to obtain chromatographic as well as mass spectral data. To enhance the 
signals recorded directly from a TLC plate the use of an extraction solvent prior the 
matrix application was explored (chapter 4). Further improvements in sensitivity was 
obtained by alterations of the electrospray deposition step and by reducing the silica gel 
layer to a thickness of 0.1 mm (chapter 5). The mass measurement inaccuracies 
observed commonly in TLC-MALDI TOF MS could be corrected by internal 
recalibration on selected matrix ions, during the scanning of a TLC plate (chapter 4). 
Quantification in TLC-MALDI MS was achieved by pre-development of the TLC plate 
in the mobile phase to which an internal standard was added (chapter 7). Other work 
that has been described in this thesis was the use of PSD-MALDI to aid the 
identification of compound spots (chapter 8) and a study of the minimisation o f matrix
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interference by applying suspensions of particles of different materials and sizes (Co- 
UFP, TiN, TiC>2 , graphite and silicon) onto eluted TLC plates (chapter 6).
For TLC-MALDI mass spectrometry to be more widely used, e.g. in industrial 
applications, ftiture developments would be necessary to enhance sensitivity, mass 
resolution, reproducibility and to decrease the presence of abundant matrix-related ions 
in the low-mass range.
The reduction of the thickness o f the silica gel layer below 100 pm would presumably 
improve the sensitivity, and hence would enable the detection of low femtomoler 
amounts of material. Another possible approach would be to employ an IR laser for the 
desorption and ionisation of analytes, separated on the TLC plate. At present the 
MALDI sensitivity, shown in this study, is limited to the confined penetration depth of 
the nitrogen laser beam inside the TLC plate. The feasibility of direct IR-MALDI mass 
spectrometry for the analysis o f gangliosides from TLC plates has already been 
demonstrated [2]. Suitable IR matrices, such as frozen water [3] and glycerol [4] would 
make TLC-IR MALDI MS very attractive for the growing area of proteomics. Glycerol 
is commonly used as a stabiliser for fluorescence zones on the TLC plate [5], and hence 
its use would address both issues: to act as a matrix and to store fluorescence. Lasers of 
other wavelength, such as VIS laser radiation would be also of interest for direct TLC- 
MALDI mass spectrometry. Only little work has been carried out using VIS-MALDI 
MS due to the lack of suitable matrices. Preliminary studies have been reported using 
dye molecules, such as rhodamine 6G [6] and indocyanine green [7] as matrices. In this 
situation, it would be challenging to investigate ninhydrine as a suitable matrix for TLC- 
VIS MALDI, since the dye molecule is commonly used as spray reagent for 
derivatisation purposes on TLC plates.
The TLC-MALDI experiments presented in this thesis were conducted on a liner TOF 
instrument with delayed extraction. Hence, the porosity of the silica gel layer caused 
peak broadening to a certain extent and with this correlated mass inaccuracies. These 
problems can mainly be overcome by employing a FTICR or q-TOF instrument, in 
which the mass analyser does not require the TOF time o f the ions. Initial experiments, 
carried out on the latter instrument, were presented in this thesis, highlighting the 
potential of this approach. Thus, determinations of small organic molecules by TLC- 
MALDI MS and tandem MS with a q-TOF instrument may be pursued further.
148
The search for new UV matrices to suppress the matrix background is an area of 
ongoing research [8]. Recently, meso-tetrakis(pentafluorophenyl)porphyrin has been 
studied as a replacement for an organic matrix [9], and also the addition of the 
surfactant cetrimonium bromide to an organic matrix [10] has been investigated. Both 
approaches seemed to be interesting for the TLC-MALDI analysis of small molecules, 
such as pharmaceuticals. Alternatively, the use of porous silicon from silicon wafers, 
which have been investigated by Wei et al. [11] maybe another promising path. First 
attempts to use porous silicon as a microscale chromatographic platform have been 
presented recently [12]. Thus, the first steps in this direction have already succeeded, 
and it seems a promising area for further research.
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10.1 List of Abbreviation
AP atm ospheric p ressu re
ATP ad enosine  triphosphate
CA trans-cinnam ic acid
CE capillary electrophoresis
a-CHCA a-cyano-4-hydroxy cinnam ic acid
Cl chem ical ionisation
CID collision-induced dissociation
Co-UFP cobalt ultra fine pow der
CTC chlortetracycline
Da dalton
DE delayed  extraction
DHB 2,5-dihydroxy benzoic acid
DHBs mixture of 2,5-dihydoxy benzoic acid and  2-hydroxy-5-m ethoxy
benzoic acid in the  volum e ratio 9:1 
DIOS desorption/ionisation on porous silicon
EDTA ethylenediam inetetraacetic  acid
El electron ionisation
ESI e lectrospray  ionisation
FAB fast atom  bom bardm ent
FEL free-electron laser
FT fourier transform
FTICR fourier transform  ion cyclotron resonance
FW formula weight
FWHM full width at half maximum
HABA 2-(4-hydroxyphenylazo) benzoic acid
HMB 2-hydroxy-5-m ethoxy benzoic acid
3-HPA 3-hydroxy picolinic acid
HPLC high-perform ance liquid chrom atography




L2 MS two s tep  laser m ass  spectrom etry
LC liquid chrom atography
B
LD lase r desorption
LDI lase r  desorption/ionisation
LOD limit of detection
LOQ limit of quantification
LSI liquid secondary  ionisation
m /z m ass-to -charge  ratio
MALDI m atrix-assisted laser desorption/ionisation
MC minocycline
MS m ass  spectrom etry
MS-MS tandem  m ass  spectrom etry
Nd:YAG neodym ium  yttrium alum inum  garnet
NSAID non steroidal anti-inflammatory drug
O PO optical param etric oscillator
OTC oxytetracycline
PALDI particle-assisted  lase r desorption/ionisation
PSD post-source decay
PX piroxicam
q-TOF quadrupole time-of-flight instrum ent
R2PI resonance-tw o-photon ionisation
REMPI R esonance-enhanced  multi-photon ionisation
Rf retardation factor
RSD relative standard  deviation
SALDI su rface-assis ted  lase r desorption/ionisation
SD standard  deviation




T i0 2 titanium dioxide
TLC thin-layer chrom atography






10.2 MALDI TOF Mass Spectrometers
10.2.1 SAI LaserTOF 1500 (LT1500)
Perform ance
Resolution: ca. 540 (FWHM) on UK-124,912 
Mass Accuracy: 0.03% RMS (internal calibration)
Mass Range: greater than 500,000 Da.
Sensitivity: sub picomol
Laser
Type: pulsed nitrogen laser 337 nm (LSC Inc.)
Spot size: elliptical 101 x 41 pm
(The laser spot size w as determ ined by m easuring the size o f  
bummarks on thermal paper using a high resolution m icroscope. 








(i) Reflectron mode: <12,000 (FWHM) ACTH 
(MH+2465)
(ii) Linear mode: 4,000 (FWHM) ACTH (MH+2465)
(iii) Precursor ion selection: 100 (FWHM)
Mass Accuracy:
(i) External calibration: <100ppm RMS
(ii) Internal calibration: <15ppm RMS 
Mass Range: greater than 500,000 Da.
Sensitivity: less than 1fmol
Laser
Type: pulsed nitrogen laser 337 nm (LSC Inc.)
More information about both MALDI m ass spectrom eters 
can be found under http://www.saiman.demon.co.uk.
E
10.3 Calculation of Range Errors
In chapter 7 the precision of the constructed calibration curves is evaluated on the range 
errors obtained for the replicate TLC-MALDI analysis (method 1,3,4 n=3 and method 2 
n=4) of each piroxicam quantity.
The range errors were calculated according to the following equation:
Xjj = highest piroxicam-to-tenoxicam ratio at given piroxicam quantity 
x h ~  X1 . j  0 0 %  X1 = l°west piroxicam-to-tenoxicam ratio at given piroxicam quantity
X x = mean o f piroxicam-to-tenoxicam ratios at given piroxicam quantity
Table 10.1 gives a summary of the calculated range errors for the corresponding 
quantities o f piroxicam.
Table 10.1. Range errors of the five calibration points in the four different TLC-MALDI methods
for the determination of piroxicam.
PX amount
[ng]
Method 1 Method 2 Method 3 Method 4
400 25% 63% 86% 130 %
500 21 % 50% 70% 125 %
600 16% 22% 74% 69%
700 13% 22% 41 % 59%
800 2.0 % 15% 32% 55%
F
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Matrix-assisted Laser Desorption/Ionisation Time-of-flight/Thin Layer Chromatography/ Mass Spectrometry—A Rapid Method for 
Impurity Testing
Siew Mowthorpe1, Malcolm R. Clench1*, Anna Cricelius1, Don S. Richards2, Vic Parr3 and 
Lee W. Tetler1
'Division of Chemistry, School of Science and Mathematics, Sheffield Hallam University, Pond Street, Sheffield, SI 1WB, UK 
2Pfizer Central Research, Ramsgate Road, Sandwich, Kent CT13 9NJ, UK 
3SAI Ltd, New Elm Lane, Manchester M3 4JW, UK
Thin layer chromatography/matrix-assisted laser desorption/ionisation mass spectrometry (TLC/MALDI- 
MS) has been previously used to obtain mass spectra from a variety of compounds, principally peptides. For 
pharmaceutical compounds, which are often of relatively low molecular weight, it is important that any 
matrix materials employed do not interfere with the mass spectra obtained. The key step to successful TLC/ 
MALDI-MS is hence the preparation of the TLC plate prior to mass spectrometry. Crucial to this is the 
deposition of matrix material into the plate to promote co-crystallisation with the analyte. In this work we 
have examined the literature methods for plate preparation and developed two new approaches. The first 
involves brushing the TLC plate with a supersaturated solution of matrix and the second involves 
electrospraying the TLC plate with a matrix solution. Data are presented from the direct analysis of 
tetracycline and its impurities. Using the electrospray method the limit of detection for tetracycline is 1 ng 
from a TLC plate. A commercial MALDI-TOF mass spectrometer has been modified to allow the 
acquisition of chromatographic data from TLC plates. Chromatograms from replicate spots of 100 and 1 p,g 
of tetracycline are shown. Copyright ©  1999 John Wiley & Sons, Ltd.
Received 20 September 1998; Revised 14 November 1998; Accepted 15 November 1998
Thin layer chromatography (TLC) is a w idely used, 
relatively low technology method for the examination o f  
compound purity. How ever it provides little information 
about compound identity and is not quantitative. In this 
situation, after initial examination by TLC, high perfor­
mance liquid chromatography (HPLC) methods must then 
be developed in order to identify and quantify unknown 
species observed on TLC plates. Hence the ability to 
exam ine a TLC plate and obtain mass spectral information 
directly would be advantageous to a variety o f industries 
(particularly the pharmaceutical industry) who utilise TLC 
to examine product purity . 1 2
Several methods have been developed for the coupling o f  
TLC to mass spectrometry (M S). These have included the 
extraction o f spots from TLC plates with subsequent 
analysis o f the extract by fast atom bombardment,34’ 
2/'52C f  plasma desorption , 5  and laser desorption follow ed  
by laser ionisation mass spectrometry directly from TLC  
plates . 6  Each o f these techniques suffers from either 
sensitivity limitations or requires com plex and expensive 
MS instrumentation. R ecently, work by Gusev et a l.7 has 
demonstrated the use o f  matrix-assisted laser desorption/ 
ionisation (M ALDI) for the direct analysis o f TLC plates. 
The method o f plate preparation developed by Gusev et al. 
involves pressing a previously prepared layer o f matrix
*Correspondence to: M. R. Clench, Division of Chemistry, School of 
Science and Mathematics, Sheffield Hallam University, Pond Street, 
Sheffield SI 1WB, UK.
Contract/grant sponsor: Pfizer Ltd., UK.
crystals into the TLC plate. U sing this method, im aging o f  
TLC spots o f  guinea green B, rhodamine and bradykinin 
have been reported.
In this work w e are interested in developing methods o f 
TLC/M ALDI-TOFM S that w ould allow  the scanning o f  a 
full TLC plate in order to obtain chromatographic as w ell as 
mass spectral data.
It is also an objective o f this project that the method  
developed for matrix deposition should be capable o f  being  
automated to allow routine use o f the technique. Hence 
alternative methods to the matrix pressing method have 
been investigated. Bristow et a l . 8  reported TLC /M A LDI- 
M S o f dyestuffs using plates prepared by spraying the 
matrix solution onto the plate with a TLC reagent sprayer. 
Som e preliminary work carried out in our laboratory 
showed that this approach led to the TLC spots spreading 
to an unacceptable degree on the TLC plate, and w ould  
therefore not be suitable for the acquisition o f  chromato­
graphic data. Electrospraying M ALDI matrices has been 
reported for the direct analysis o f biological sam ples , 9  and, 
since it was felt that the fine spray droplets produced by 
electrospray would lead to minimal spreading, this techni­
que w as chosen for extensive investigation.
EXPERIM ENTAL
M ateria ls and instrum entation. The analyte tetracycline 
(com pound (i), free base, FW 444.4) w as purchased 
from Sigm a-Aldrich (Dorset, UK), sam ples o f  known
CCC 0951—4198/99/040264-07 $17.50 Copyright ©  1999 John Wiley & Sons, Ltd.
0)
(ii)
Tetracycline (FW 444 4)
TLC coupling: a-cyano-4-hydroxycinnam ic acid (aC H C A ), 
2-(4-hydroxyphenylazo)benzoic acid (H A B A ) and 2,5- 
dihydroxybenzoic acid (D H B). aC H C A , H A BA  and D H B  
were purchased from Sigm a-Aldrich (Dorset, UK). The 
solvents acetone, methanol, ethanol and dichloromethane 
used were all HPLC grade. Trifluoroacetic acid (TFA) (AR  
grade) was typically added at 0 . 1 % to the matrix solutions.
The TLC plates em ployed were silica gel 6 OF2 5 4 , 0 .2  mm  
thickness and aluminium-backed (Riedel-de-H aen).
The tim e-of-flight (TOF) laser mass spectrometer 
em ployed in these investigations w as a modified LaserTOF  
1500 (Scientific Analytical Instruments, Manchester, UK). 
This is a linear TOF instrument with a nitrogen laser (337  
nm). The sample holder o f this instrument was m odified to 
allow  TLC strips o f  approximately 65 x 2 mm to be fitted  
into a recessed slot. The sam ple probe and software were 
also m odified to allow  free m ovem ent along the z (vertical) 
axis, and software w as developed that allowed the 
construction o f TIC and m ass chromatograms from the 
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Figure 1. Structures of tetracycline and some of its known impurities.
manufacturing impurities, epitetracydine (com pound (ii), 
FW 444.4), anhydrotetracycline (compound (iii), FW 426.4) 
and compound (iv) (FW  412.4) were supplied by Pfizer 
Central Research, Sandwich, Kent, UK. The structures of 
these compounds are as shown in Fig. 1. In all cases the 
formula w eight (FW ) quoted is the m olecular mass 
calculated using the isotope-averaged atomic masses.
The follow ing M ALDI matrices were used for M A LDI/
(i) D eposition  o f  m atrix m ateria l into the TLC p la te  by  
pressing. On an aluminium plate (25 x 25 mm ) saturated 
solutions o f a-cyano-4-hydroxycinnam ic acid in acetone 
were deposited in 50 pL aliquots in order to create a 
hom ogenous crystal layer.
Sample spots cut from the TLC plate were wetted with an 
extraction solution (ethanol or methanol/water, 1:1). The 
previously prepared matrix layer on the aluminium plate 
was then pressed into the TLC plate for at least 2 minutes 
using a small press. After transfer the aluminium plate was 
removed and the thus coated TLC spots w ere stuck to a 
conventional M ALDI target using double-sided tape.
(ii) D eposition  o f  m atrix m ateria l in to the TLC p la te  by  
brushing with supersaturated  solutions. A  65 x 2 mm strip 
of a developed (or uneluted) alum inium-backed TLC plate 
was mounted onto a conventional M ALDI target with  
double-sided tape. An extraction solvent (ethanol) w as 
applied to the TLC spots. A  hot supersaturated slurry o f the 
matrix (aC H C A ) in acetone w as then dabbed onto the TLC  
plate with a stiff brush. The prepared target w as dried at 
room temperature for at least 1 0  m inutes before analysis.
(iii) D eposition  o f  m atrix m ateria l in to the TLC p la te  by  
elec trospraying  m atrix solutions. For sam ple preparation 
via electrospray, a hom e-m ade device w as constructed. This 
consisted o f a syringe pump (Harvard 11) fitted with a 25 or 
100 pL syringe w hich was connected via PTFE/PEEK  
tubing to a HPLC zero dead volum e fitting to a capillary  
steel needle, to w hich a high voltage (2-A  kV) w as applied. 
The capillary needle w as further threaded through a HPLC  
T -piece zero dead volum e fitting through w hich dry nitrogen 
could be applied coaxial to the capillary tube. The TLC  
plate was earthed and held horizontally during spraying and 
set at a distance o f  ca. 3 -5  mm from the spray needle. The 
voltage and distance between the capillary needle tip and the 
TLC plate were adjusted such that a stable Taylor cone w as 
visible and remained stable.
A 65 x  2 mm strip o f  a developed (or uneluted) 
aluminium-backed TLC plate w as stuck onto a conventional 
M ALDI target with double-sided tape. An extraction
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Figure 2. Mass spectrum of epitetracydine, TLC /Rvalue of 0.11.
solvent (ethanol) was applied to the TLC spots, when 
required. Matrix concentrations used were between 10- 
100 mg/mL depending on the matrix solubility. Two solvent 
systems were tested; Solvent system A, methanol/0.1% TFA 
and Solvent system B, methanol/water (1:1, v/v)/0.1% TFA. 
Typically, a 25 pL syringe was filled with a matrix solution 
and electrosprayed at a rate of 2.5 pL/min while the TLC 
plate was moved at ca. 0.6 cm/min. The voltage applied to 
the capillary needle of the electrospray device was typically 
2.5-3.0 kV.
TLC separation
Tetracycline and its impurities were separated according to 
the procedure described by Weng et al.9 Before use the 
silica gel plates were sprayed with an aqueous solution of 
disodium ethylenediaminetetraacetic acid (10% w/w, ad­
justed to pH 9.0), dried horizontally at room temperature for 
half an hour and then at 120 °C for ca. half an hour. The TLC 
development tank was lined with filter paper and saturated 
with development solvent dichloromethane/methanol/water 
(59:35:6, v/v) for an least an hour prior to use. Typically, an 
aliquot (10 pL) of a sample solution (20 mg/mL, methanol) 
was applied to a plate with a micropipette. The plate was 
developed to a distance of 7 cm, air dried at room 
temperature and visualisation of the TLC spots was by 
ultraviolet (UV) light at 254 nm.
RESULTS AND DISCUSSION 
Selection of matrix
The selection of matrix was initially based on an examina­
tion of their behaviour during MALDI-MS on stainless steel 
targets.10,11 A  premixed solution of a matrix solution and 
sample solution (1-2 pL) in a series of matrix to analyte 
ratios was pipetted onto a stainless steel target. The matrix 
was selected on the following criteria: absence of interfering 
peaks in the spectral regions of interest, and reproducible
analyte signal intensity from laser spot to spot over the 
target (i.e. good crystal homogeneity). For tetracycline, all 
three matrices, (aCHCA, HABA and DHB) appeared 
suitable based on the normal MALDI sample preparation 
procedure. However the lower solubility of HABA (10 mg/ 
mL in methanol) excludes its use for electrospray deposi­
tion. aCHCA showed possible interfering peaks at m/z 423 
[2M — H +  2Na]+ and 439 [2M — H +  Na +  K]+ which 
made its use as a matrix difficult since mass spectral 
resolution appears to slightly deteriorate on TLC/MALDI 
coupling. This effect may be due to the uneven nature of the 
TLC plate surface although it is not at present completely 
understood.
Optimum matrix to analyte (tetracycline) molar ratios 
varied from 5:1 (HABA), 100:1 (aCHCA) to 700:1 (DHB). 
This small excess of matrix to analyte is a reflection of the 
low molecular mass of the analyte species in contrast with 
the situation for large molecular weight analytes such as 
biopolymers where very large matrix excess is used.12 The 
mass spectrum obtained with the use of aCHCA at a molar 
ratio to tetracycline of 100:1 showed considerable matrix 
suppression effects as observed by other workers.13
Comparison of different methods of deposition of matrix 
material
(a) Pressing. The indirect means of matrix deposition by 
pressing a predeposited matrix layer into a wetted TLC plate 
has been reported to work successfully by Gusev et al. In 
our hands, the procedure was found to be extremely 
difficult, only small sections of silica gel plate could be 
handled. Therefore a developed TLC plate was cut up into 
small sections of 1.5 x 1.5 cm. The silica gel plate was quite 
fragile and frequently cracked during the procedure. Mass 
spectrometric analysis of successfully prepared TLC spots 
showed areas of localised analyte-doped matrix crystals, but 
the number of points from which analyte signals were 
obtained was insufficient to allow chromatographic infor­
mation to be obtained from a spot.













500100 150 200 250 Mass (m/z) 400 450300 350
Figure 3. Mass spectrum of tetracycline, TLC /?/ value of 0.25.
(b) Brushing. Deposition of matrix material by brushing a 
supersaturated solution of matrix into a TLC plate showed 
some incorporation of analyte-doped crystals and did yield 
analyte mass spectra. Figures 2-5  show mass spectra from 
TLC spots obtained from the analysis of tetracycline and 
some of its known manufacturing impurities. The TLC 
procedure was as described in the experimental section. 
Figure 2 shows the mass spectrum obtained from epitetra- 
cycline retardation factor (Rj) = 0.11. The (MH+) ion can be 
clearly observed at m/z 444.8. Figure 3 shows the mass 
spectrum of tetracycline, itself (Rj) value = 0.25, MH+ at 
m/z 445.3), and two unknown impurities at Rj) values of
0.34 and 0.60 are shown in Figs 4 and 5 respectively. The 
pre-treatment of the TLC plate with disodium ethylenedi- 
aminetetraacetic acid solution was necessary for the 
separation of tetracycline from the impurities. Without this 
pre-treatment, streaking was observed on the plate, due to 
the interaction of the basic moieties of tetracycline with 
metallic impurities in the silica. However, this procedure 
frequently contributed to the enhancement of signals from 
sodium and potassium adducts of tetracycline (m/z 467 and 
483, respectively) and its impurities which complicates the 
interpretation of the mass spectra. Because of cation 
adduction, the close range of molecular weights of potential
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Figure 4. Mass spectrum of unknown impurity in tetracycline, TLC Rf value of 0.34.
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Figure 5. Mass spectrum of unknown impurity in tetracycline, TLC value of 0.60.
impurities, and deterioration of resolution on TLC MALDI 
coupling, unambiguous identification of the impurities on 
the basis of assignment of MH+ mass peaks proved 
challenging. In such a situation, only the use of good 
quality impurity reference standards would enable con­
clusive identification.
The procedure worked well only with very volatile 
solvents such as acetone, and in such cases lateral spreading 
of analyte species was minimal. MALDI-MS analysis 
targets prepared in this way showed analyte signals from
localised areas on the TLC plate. However, it was difficult 
to produce consistent results in terms of signal intensity 
since the procedure did not yield a consistent loading of 
matrix onto the plate. Since the analyte signals from TLC 
plates prepared by the brushing method are localised they 
are not obtained from a sufficient number of points on the 
plate to generate chromatographic information from TLC 
spots. A  degree of skill is needed to prepare a good plate, 
and the method does not seem to lend itself to automation. 
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Figure 6. Summed ion chromatogram from m/z 440 to 460 for 3 replicate tetracycline spots of 100 pg on silica gel 
substrate.
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Figure 7. Summed ion chromatogram from mtz 440 to 460 for 3 replicate tetracycline spots of 1 pg on silica gel 
substrate.
(c) Electrospraying. For tetracycline the best data from 
plates prepared by electrospray were obtained using DHB as 
the matrix (lOOmg/mL in Solvent system B). It was found 
that a single spray pass was sufficient. A  second pass 
showed either no improvement in signal intensity or a 
deterioration in the signal obtained, possibly because the 
initial layer of crystals which is co-crystallised with analyte 
would be redissolved by the second pass of matrix solution.
Using the modified instrument, chromatographic data 
were successfully obtained from TLC plates directly spotted 
with three replicate tetracycline spots each of 100 and 1 pg, 
prepared using the electrospray method. Figures 6 and 7 
show summed ion chromatograms over the range m/z 440-
460 for 3 tetracycline spots of 100 pg (Fig. 6) and 1 pg (Fig.
7). Typical mass spectra obtained from 100 and 1 pg 
tetracycline spots are shown in Figs 8 and 9, respectively. 
The ultimate limit of detection for tetracycline (localised 
signals) is, however, much lower at 1 ng, but so far we have 
not attempted scanning at these levels. These data further 
illustrate the poor mass resolution, and hence mass 
measurement accuracy, obtained in the TLC/MALDI-MS 
experiments to date. These appear to be quite poor in the 
chromatographic acquisition experiments, possibly due to 
the movement of the TLC plate, which is in essence now the 
MALDI target, over several millimetres during the acquisi­
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Figure 8. A typical mass spectrum obtained from scanning a 100 pg tetracycline spot.
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Figure 9. A  typical mass spectrum obtained from scanning a 1 pg tetracycline spot.
that would cause these phenomena arising from the uneven 
nature of the TLC plate surface, would obviously be greater 
the larger the area of TLC plate surface that data has been 
acquired from in order to produce one spectrum. However, 
as previously stated, this effect is not at present fully 
understood.
ultimate limit of detection further and hence allow 
acquisition of chromatographic data at these lower levels.
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CONCLUSIONS
We have examined the two literature methods for TLC plate 
preparation for coupling to MALDI-MS, i.e. pressing a 
previously prepared matrix layer into the TLC plate surface 
and the use of a reagent spray. We have also developed two 
new approaches; brushing a supersaturated matrix solution 
and deposition of matrix material by electrospraying. All 
procedures gave prepared TLC/MALDI targets which on 
analysis produced mass spectra from analyte-doped matrix 
crystals. However, of the three methods of matrix deposition 
into a TLC plate only electrospray deposition has been 
shown to produce analyte signals from enough points on a 
sample spot to allow chromatographic information to be 
obtained from a TLC plate. By modification of a 
commercial MALDI-TOF mass spectrometer, and its 
control and acquisition software, we have succeeded in 
obtaining chromatographic data from replicate spots of 
tetracycline at the 1 ug level. This is, to the best of our 
knowledge, the first time that the acquisition of chromato­
graphic data from a TLC plate by MALDI-MS has been 
successfully demonstrated. The limit of detection is lower, 
about 1 ng (for localised signals). However it is likely that a 
modified environment which promotes more homogeneous 
crystallisation is still needed in order to improve the
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Sum m ary
We have previously reported some preliminary data on the devel­
opment of methods for the direct analysis of TLC plates by matrix- 
assisted laser-desorption ionization-tim e of flight mass spectrom­
etry (TLC-M ALDI-TOFM S). In that paper we described the elec­
trospraying of matrix solutions on to the plate a new method of 
preparing TLC plates for M ALDI-MS. We demonstrated that 
mass spectra could be obtained directly from plates prepared in 
such a manner and showed that modification of a commercial 
MALDI-TOF mass spectrometer enabled chromatographic data to 
be obtained from such plates.
In the work presented here, we report for the first time, the gener­
ation and characterization of an impurity profile of a pharmaceu­
tical compound by TLC-M ALDI-TOFM S. UK-224,671 is a com­
pound synthesized, by Pfizer Ltd as part of a drug-development 
program. A mixture of UK-224,671 and its known related impuri­
ties was separated by TLC on silica gel and the plate was prepared 
for TLC-M ALDI-TOFM S by electrospraying the surface with a 
solution of a-cyano-4-hydroxycinnamic acid (a-CHCA) by means 
of an electrospray deposition device. A modified SAI Ltd Laser 
TOF 1500 instrum ent was then used to record mass chro­
matograms directly from the TLC plate; this enabled identification 
of the main component and three major related substances. Higher 
extraction efficiency was observed when each spot was wetted with 
methanol before electrospraying of the matrix. The mass spectra 
obtained contained mainly [M + H ]+ ions. The degradation in 
mass-measurement accuracy observed in our previous TLC-M ALDI- 
MS experiments has been corrected by use of newly developed soft­
ware that recalibrates each mass spectrum acquired during a run 
by using a matrix ion or other selected ion as a ‘lock m ass’. Data 
acquired with and without the use of the ‘lock m ass’ are compared.
A. Crecelius and M.R. Clench, Division of Chemistry, School of Science and 
Mathematics, Sheffield Hallam University, Pond Street, Sheffield; D.S. 
Richards, Pfizer Central Research, Ramsgate Road, Sandwich, Kent; and 
J. Mather and V. Parr, SAI Ltd, New Elm Lane, Manchester, UK.
1 Introduction
Although thin-layer chromatography (TLC) is widely used 
for the rapid qualitative examination of compound purity 
[1,2], the amount of qualitative information is limited to the 
retention factor ( RF) of the components. Coupling of TLC 
with mass spectrometry (MS) provides confirmatory evi­
dence of components which are subsequently identified by 
comparison of their values with those of reference stan­
dards on the thin layer chromatogram.
Several methods have been developed for coupling TLC 
with MS [3,4], These include both indirect and direct m eth­
ods. In indirect methods, TLC is often used for purification 
and the spots are usually visualized under UV illumination. 
Subsequently the components of interest are excised from 
the TLC plate and analyzed by fast-atom bombardment 
(FAB) or liquid secondary-ion mass spectrometry (LSIMS)
[5,6]. Further development in this direction led to systems 
whereby the sample introduction inlet was modified to 
enable direct insertion of the TLC plate. This approach has 
been used for 1- and 2-dimensional acquisition of thin layer 
chromatograms by TLC-FABMS [7-9], One of the draw­
backs of this technique is the unsuitability of liquid matrices 
such as glycerol and thioglycerol. If the chromatographic 
resolution of the TLC plate is to be maintained the MS 
experiment must be performed within ca 10 min of matrix 
application.
TLC-M S has also been accomplished by the use of laser 
desorption followed by laser ionization directly from the 
TLC plate [10]. More recent work by G usev  et al. [11] has 
demonstrated the use of matrix-assisted laser-desorption 
ionization (MALDI) for the direct analysis of TLC plates. 
The method of plate preparation developed by G usev  et al. 
involves pressing a previously prepared layer of matrix crys-
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tals into the TLC plate. This method has been used for 
imaging of TLC spots of guinea green B, rhodamine, and 
bradykinin.
We are interested in developing TLC-M ALDI-TOFM S 
methods that enable the scanning of a complete TLC plate 
to obtain both chromatographic and mass spectral data. It is 
also an objective of this work that the method developed for 
matrix deposition should be capable of automation to 
enable routine use of the technique. Hence, alternative 
methods to matrix pressing have been investigated. 
Electrospraying of MALDI matrices has been reported for 
the direct analysis of biological samples [12] and for imag­
ing experiments conducted by MALDI [13].
We have recently reported some preliminary data from the 
preparation of TLC plates for MALDI by electrospraying 
of matrix solution [14]. In this work we were able to show 
that chromatographic information could be acquired from 
a plate prepared in this manner and were able to acquire 
data from replicate spots of 1 |ig tetracycline. In this work 
we commented on errors in mass measurement observed in 
mass spectra acquired by TLC-M ALDI-M S. In the work 
presented here, we report for the first time the generation 
of an impurity profile of a pharmaceutical compound and 
some of its related substances by TLC-M ALDI-TOFM S 
entailing direct acquisition of data from a developed TLC 
plate. We also describe some results from the use of a soft­
ware ‘lock mass’ to correct for mass-measurement inaccu­
racies observed in TLC-M ALDI-M S.
2 Experim ental
2.1 Chemicals
UK-224,671 (C24H,5C12N50 ,S ), a pharmaceutically active 
compound, and known related substances UK-256,327 
(C „H 17N30 2S), UK-253,501 (C20H 26N4O 2S) and UK- 
260,489 (C 19H 23C12N 0 3), were supplied by Pfizer Central 
Research, Sandwich, Kent, UK The structures of the com ­
pounds are shown in Figure 1. In all cases the relative 
molecular mass (R M M ) quoted is calculated by using the 
mono-isotopic atomic masses for the most abundant iso­
topes.
The suitability of the organic MALDI matrices a-cyano-4- 
hydroxycinnamic acid (a-C H C A ), 2-(4-hydroxyphenyl- 
azo)benzoic acid (HABA), 2,5-dihydroxybenzoic acid 
(DHB), rran.v-cinnamic acid (CA), and 3-hydroxypicolinic 
acid (3-HPA) (Sigma-Aldrich, Dorset, UK) for M ALDI- 
TLC coupling was examined.
M ethanol, ethanol, tetrahydrofuran , and dichloro- 
methane were all HPLC grade. Ammonia (35%) was pre­
pared by dilution of a concentrated ammonia SG 0.88. 
Water was deionized MilliQ water generated in-house 
(> 10  M£2). TLC was performed on aluminum-backed 
plates coated with 0.2 mm layers of silica gel 60F254 
(Merck, Germany).
X, /  \  T 2
N N — S = 0
\  /  1  / O
U K -2 2 4 ,6 7 1 R M M : 5 4 4 .5 5  D a.
U K -2 5 6 ,3 2 7 R M M : 2 5 5 .3 4  Da.
nh2
•N
U K -2 5 3 ,5 0 1 R M M : 3 8 6 .5 2  Da.
Cl
U K -2 6 0 ,4 8 9 R M M : 3 8 4 .3 0  D a.
Figure 1
The structures of UK-224,671 (C24H35Cl2N50 3S), a pharmaceutically active com­
pound, and some of its known impurities UK-256,327 (C ^H ^N g O gS ), UK-253,501 
(C20H26N4O2S) and UK-260,489 (C 19H23CI2N 0 3).
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2.2 TLC Separation
TLC separation was conducted by a procedure adapted 
from an in-house method developed at Pfizer Ltd. Silica gel 
plates were used as supplied without pretreatm ent. The 
TLC development tank was lined with filter paper and sat­
urated overnight with the mobile phase, dichloromet- 
hane-m ethanol-am m onia (35%), 60 + 1 0 + 1  before use. 
Sample solutions (10 pL) were applied to the plates with a 
syringe. Plates were developed to a distance of 7.0 cm, dried 
in air at room tem perature, and visualization of the TLC 
spots was by UV light at A = 254 nm.
2.3 Matrix Selection
For organic matrices, the analytes were dissolved in 
methanol (10 mg m L '). The organic matrices investigated 
(a-CHCA, HABA, DHB, CA and 3-HPA) were dissolved in 
a polar solvent, typically methanol, at 10-100 mg mL-1 
depending on solubility. Trifluoroacetic acid (TFA; A R 
grade; 0.1%, v/v) was added to the prepared matrix solution. 
The analyte and matrix solutions were mixed in suitable 
ratios (typically 1:1 and 1:10 v/v, respectively). Approxi­
mately 1-2 pL of the mixture was spotted on to a stainless 
steel MALDI target which was then analyzed.
2.4 MALDI Sam ple Preparation
The method used to prepare the TLC plates for MAL- 
DI-M S was to electrospray the matrix on to the plate. A 
‘home made’ electrospray deposition device was construct­
ed from a syringe pump (Harvard 11) fitted with a 25-pL 
syringe which was connected via PTFE/PEEK tubing and an 
HPLC ‘zero dead volume’ fitting to a capillary steel needle, 
to which a high voltage (1-4 kV) was applied. The capillary 
needle is further threaded through a ‘zero dead volume’ 
HPLC T-piece through which dry nitrogen could be applied 
coaxial to the capillary tube. The TLC plate was earthed 
and held horizontally during spraying, at a distance of ca 
2-4 mm from the spray needle. The voltage and distance 
between the capillary needle tip and TLC plate were adjust­
ed such that a stable Taylor cone was visible and remained 
stable.
In all the experiments a 65 mm x 2 mm strip of the devel­
oped aluminum-backed TLC plate was attached to the 
modified M ALDI target with double-sided tape. Typically, 
a 25 pL syringe was filled with matrix solution which was 
electrosprayed at a rate of 150 pL h_1 while the TLC plate 
was moved at ca 0.6 cm min-1. The voltage applied to the 
capillary needle of the electrospray device was usually ca
1.5 kV.
2.5 M ass Spectrom etry
The time-of-flight (TO F) laser mass spectrom eter 
employed in these investigations was a modified Laser TOF 
1500 (Scientific Analytical Instruments, Manchester, UK), a 
linear TO F instrument with a nitrogen laser (A =  337 nm). 
The sample holder of this instrument has been modified to
enable TLC strips of approximately 65 mm x 2 mm to be fit­
ted into a recessed slot. The sample probe and software 
have been modified to enable free movement along the z  
(vertical) axis, and software has been developed that 
enables the construction of total ion (TIC) and mass chro­
matograms from the acquired data sets. ‘Lock mass’ soft­
ware has been developed to enable recalibration of each 
mass spectrum during the scanning of a TLC plate on the 
basis of measured m/z values of one or more peaks in the 
recorded mass spectra. Its use in these experiments is 
described more fully in Section 3.5. The positive ion mode 
only was used in this study.
3 R esu lts  an d  D iscussion
3.1 Matrix Selection
Selection of the organic matrix was based on examination of 
M ALDI-M S behavior on stainless steel targets. A  premixed 
solution of a matrix solution and sample solution (1-2 pL) 
in a range of matrix-to-analyte ratios was pipetted on to a 
stainless steel target. The matrix was selected on the basis of 
the solubility of the matrix and the analyte in similar sol­
vents, the absence of interfering peaks in the spectral 
regions of interest, and reproducible analyte signal intensi­
ty from laser spot to spot over the target (i.e. good crystal 
homogeneity). By use of these criteria for UK-224,671 and 
related substances, a-CHCA was found to give the best 
results. Optimum matrix-to-analyte molar ratios were 
between 16:1 and 40:1. This small excess of matrix to ana­
lyte reflects the low molecular mass of the analyte species, 
in contrast to large molecular weight analytes such as 
biopolymers, for which a very large matrix excess is used 
[15].
3.2 Electrospraying MALDI M atrices on to TLC plates
For UK-224,671 the best data from plates prepared by elec­
trospraying were obtained by use of a-CHCA as the matrix 
(20 mg mL-1 in methanol containing 0.1% TFA). Use of this 
matrix, however, gives a mass spectral peak at m/z 379 [2M 
+ H ]+ which can interfere with signals from UK-253,501 
{RMM 386.52 Da.) and UK-260,489 {RMM 384.3 Da.) if 
adequate mass measurement stability and resolution are not 
achieved. Instrumental resolution was, however, adequate 
for separation of analyte- and matrix-related signals, as 
shown in Figures 3c, d and 5c, d, respectively.
3.3 Acquisition of M ass Chrom atogram s and M ass Spectra
By use of the modified instrument chromatographic data 
were successfully obtained from a thin-layer chromatogram 
of a mixture containing 25 pg of each of UK-224,671, UK-
256,327, UK-253,501, and UK-260,489. The overlaid ion 
mass chromatograms are shown in Figure 2. In these data, 
the peaks arising from the four TLC spots are clearly visible. 
The software labels the x-axis with the distance traveled 
from the origin by the spot, enabling ready calculation of RF
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Figure 2
Overlaid ion chromatograms from TLC -M A LD I-M S analysis of a mixture of: 
(a) UK-224,671, (b) UK-256,327, (c) UK-253,501, and (d) UK-260,489 (25 pg per 
component).
values. From these data the R F values o f U K-224,671, UK-
256,327, U K-253,501, and UK -260,489 w ere calculated as
0.36, 0.51, 0.57, and 0.75, respectively, in accord with the R F 
values obtained by U V  detection. The ion mass chro­
matogram o f the parent com pound UK-224,671 com es from  
a different run. The corresponding mass spectra obtained  
for each spot are shown in Figure 3. A lthough these non­
background-subtracted spectra show intense ions arising 
from  the matrix, the protonated m olecular species from 
each analyte is clearly visible.
3.4 Extraction of Analytes from TLC plates
A nalytes separated by TLC are presum ably located  up to 
100-500 pm inside the plate. To produce a M A L D I-M S  
signal, the analyte must be transferred from inside the sili­
ca gel to the surface, and this must be fo llow ed by e lectro ­
spraying o f the matrix, and crystallization. T he tim e avail­
able for extraction o f  an analyte from inside the TLC plate 
on to the surface is lim ited by the tim e o f  matrix crystal­
lization, w hich is less than ca 10 min [16]. In this work 
extraction o f the analytes from  the interior o f  the TLC  
plate was im proved by addition o f  an organic solvent, for 
exam ple eth an o l, tetrahydrofuran, m eth an o l, and 
m ethanol-w ater, 1:1, (v/v). T he best results w ere obtained  
w hen m ethanol was applied to each TLC spot. Figure 4 
show s the overla id -ion  m ass chrom atogram s from  
T L C -M A L D I-M S  analysis o f  a mixture contain ing 25 pg 
o f each o f  U K -224,671, U K -256,327, U K -253,501, and UK- 
260,489, using the approach described. T he jagged nature 
o f the chrom atographic peaks is a typical characteristic o f  
the use o f  m ethanol, which causes analyte spreading in a 
m anner such that the concentration o f  the analyte at the 
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Figure 3
TLC-M ALDI mass spectra of the peaks indicated in Figure 2: (a) UK-224,671, (b) UK-256,327, (c) UK-253,501, and (d) UK-260,489 (25 pg per component).
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Figure 4
Overlaid ion chromatograms from TLC-MALDI-MS analysis of a mixture of: (a) 
UK-224,671, (b) UK-256,327, (c) UK-253,501, and (d) UK-260,489 (25 tig per com­
ponent). The data were acquired after use of methanol as extraction solvent.
deposited on each TLC spot is critical -  the amount should 
be as high as possible to increase the absolute quantity of 
analyte close to the surface but lateral spreading should be 
minimized as far as possible. It has been found that ca 1 pL 
methanol is appropriate. Lateral spreading was typically in 
the range 1-5 mm, depending on the analyte. Planar diffu­
sion of UK-256,327 along the plate occurred even without
application of an extraction solvent (Figure 2). Figure also 
illustrates that UK-256,327 and UK-253,501 could be found 
at the same position (37 mm from the starting point) 
because of the extraction procedure. The improvement of 
the sensitivity of TLC -M A LD I-M S experiments p er­
formed on UK-224,671 and related compounds by use of an 
extraction solvent is dem onstrated by the increase in the 
ion intensity of the protonated molecular species for each 
substance, observable in Figure 5, and also by the detection 
of all four analytes in a single experiment.
3.5 Recalibration of each M ass Spectrum
As shown in Figure 3d, in which the protonated molecular 
species of UK-260,489 (.RMM 384.30 Da.) was observed at 
m/z 383.3 rather than at 385 Da., degradation of mass spec­
tral resolution and mass measurement accuracy is observed 
when mass spectra are recorded directly from TLC plates. 
We have previously reported this effect [14], and others 
have observed such degradation even when reflectron based 
M ALDI-M S (capable of much higher resolution than the 
instrument used in this work) was employed [17]. Because 
we attribute this effect to the uneven nature of the TLC 
plate surface, the use of a software ‘lock mass’ was investi­
gated. This software recalibrates each mass spectrum 
acquired during the scanning of a TLC plate, on the basis of 
the error in mass measurement observed for one or more 
user-defined m/z values. Initially two matrix ions were cho­
450 50010 150 200 400 550 600
Figure 5
TLC-MALDI mass spectra of the peaks indicated in Figure 4: (a) UK-224,671, (b) UK-256,327, (c) UK-253,501, and (d) UK-260,489 (25 pg per component)
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4sen for the recalibration, but we have found that that one is 
sufficient. Thus, the [M + Na]+ ion of a-CHCA was typi­
cally chosen. The mass spectra shown in Figure 5 were 
acquired by use of the ‘lock-mass’ software and illustrate 
that this approach is a possible solution of mass measure­
ment inaccuracy, although the mass spectral resolution 
achieved in the chromatographic acquisition experiments is 
still relatively poor compared with conventional MALDI 
applications. This is possibly because of the movement of 
the TLC plate over a distance of 0.125 mm during the acqui­
sition of each spectrum.
4 C onclu sions
We have succeeded in obtaining mass spectral and chro­
matographic data from a thin layer chromatogram of a mix­
ture of 25 pg quantities of a pharmaceutical compound and 
some of its related substances. This is, to the best of our 
knowledge, the first time that the acquisition of genuine 
chromatographic data from a TLC plate by MALDI-MS 
has been successfully demonstrated.
The role of an extraction solvent has been investigated in 
detail. It has been demonstrated that its use results in a 
higher extraction efficiency and hence in an increase in the 
intensity of ions from the compounds studied. It also leads 
to planar spreading, however, which leads to broader chro­
matographic peaks in the chromatographic data obtained by 
TLC-M ALDI-M S. The degradation in mass measurement 
accuracy that we previously reported in TLC-M ALDI-M S 
experiments has been successfully overcome by the use of a 
software ‘lock mass’.
We now intend to investigate further modification of the 
sample procedure to prom ote more homogeneous crys­
tallization of matrix and analyte. This should enable 
acquisition of chrom atographic data at lower levels. We 
will also examine the use of cobalt ultra fine powder (Co- 
UFP) as a matrix to reduce the background ions present 
in the mass spectrum which can interfere with the analyte 
ions.
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The Possible use of Filter Paper as a Concentrating 
Medium in TLC
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Sum m ary
This paper describes the possibility of applying mixtures of sub­
stances to TLC plates by use of different types of filter (chromato­
graphic) paper as concentrating zones. The resolution of chro­
matographic systems has been compared after use of different 
modes of solute application -  applicator (point and linear applica­
tion), micropipet, use of plates with concentrating phase, and use 
of different types of filter paper as the concentrating phase.
The effect of the method of solute application on the Rv values of the 
chromatographed substances was also tested. The proposed use of 
paper as a concentrating zone increases the resolution of a chromato­
graphic system in comparison with systems in which a micropipet is 
used; resolution is comparable with that obtained on commercially 
available plates with concentrating phase. The use of the concentrat­
ing zone affects the migration of individual components of the solute. 
The effect depends on the kind of concentrating zone and on the 
adsorption of a given substance on the adsorbent surface.
1 In troduction
T he basic problem  in chrom atography is the efficiency o f  
the separation o f  mixtures. A  m easure o f this efficiency is 
the resolution o f  chrom atographic systems, /?s, which is 
defined  by the relationship [1
2(Rfi — ^ 2)RS = ( w, +  w 2) (1)
V.G. Berezkin, AJ5. Makarov, and R.G. Mardanov, A.V. Topchiev Institute 
of Petrochemical7Synthesis of the Russian Academy of Sciences, 29 Leninsky 
Pr., 11-79-12 Moscow, Russia; and I. Mainowska and J.K. Ro^yi), Faculty of 
Chemistry, Departm ent of Adsorption and Planar Chromatography, M. 
Curie-Sklpdowska University, M. Curie-Sklodowska Sq. 3, 20-031 Lublin, 
Poland.
w here R Fi a n d  R F2 are the R F values o f two adjacent sub­
stances and tv, and w2 are the widths o f the respective spots, 
m easured in the direction o f migration o f the m obile phase.
R f valups depend on substance identity and on the nature o f  
the absorbent and m obile phase. T he broadening o f a spot 
o f achrom atographed substance depends not only on these  
factors but also on the size o f the solute spot at the origin o f  
■a chrom atogram , i.e. on the m ethod o f application o f the  
substance. T he sm aller the size o f  a spot at the origin o f a 
chrom atogram , the sm aller the spots o f  the chro­
m atographed substances on the developed chrom atogram , 
i.e. the m ethod o f application o f substances to a TLC plate 
influences the resolution obtained w hen the mixture is sep ­
arated. Correct application o f a solute can thus be a m eans 
o f im proving the resolution and efficiency o f a chrom ato­
graphic system.
Solute application in planar chrom atography can be per­
form ed by a variety o f different m ethods. The m ethod used  
is crucial for mixtures o f  com ponents which are difficult to  
separate and the spots are situated close one to another. 
T he oldest and most w idely used m ethod o f  sam ple applica­
tion is the use o f a m icropipet -  a calibrated capillary or 
autom atic equipm ent with the possibility o f changing the 
volum e. The major advantages o f the m ethod are its sim ­
plicity and speed. Sam ple spots applied in this way are cir­
cular at the origin, the diam eter o f the spot depending on  
the volum e o f solute applied.
O ne m ethod o f improving the resolution o f  a chrom ato­
graphic system is band (linear) application. The chro­
m atographed substance or mixture is applied to the origin, 
either manually or autom atically in the form o f a band. 
Manual application is tim e-consum ing and requires consid­
erable skill -  an uneven band is often obtained.
Bands can also be obtained by m eans o f a special procedure 
entailing evaporation o f  solvent from the plate; the proce-
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Abstract
Particle suspension matrices have been successfully utilized for the analysis of tetracycline antibiotics by thin-layer 
chromatography-matrix-assisted laser desorption ionisation-time-of-flight mass spectrometry (TLC-MALDI-TOF-MS). 
Particles of different materials and sizes have been investigated (Co-UFP, TiN, T i02, Graphite and Silicon) by applying 
particle suspensions to eluted TLC plates. Mass spectra and mass chromatograms have been recorded directly from the TLC 
plates. Strong cationization by sodium and potassium was obtained in the positive ion mode, with [M+Na-NH3]+ ions 
being the predominant signals. The TLC-MALDI mass spectra recorded from graphite suspensions showed the lowest 
background noise and the highest peak intensities from the range of suspension matrices studied. The mass accuracy from 
graphite films was improved by adding the peptide Phe-Phe to the graphite suspensions. This allowed internal recalibration 
of the TLC-MALDI mass spectra acquired during a run. One major potential advantage of TLC-MALDI-TOF-MS has 
been demonstrated in the analysis of chlortetracycline and tetracycline in a mixture of oxytetracycline, chlortetracycline, 
tetracycline and minocycline. Examination of the TLC plate prior to MALDI analysis showed only an unresolved spot for 
chlortetracycline and tetracycline. However by investigation of the MALDI mass spectra and plotting of single ion 
chromatograms separate peaks for chlortetracycline and tetracycline could be obtained. © 2002 Elsevier Science B.V. All 
rights reserved.
Keywords: Particle suspension matrix; Mass spectrometry; Inorganic matrix; Matrix-assisted laser desorption ionisation; 
Chlortetracycline; Tetracycline
1. In tro d u c tio n
Matrix-assisted laser desorption/ionisation
‘ Corresponding author. Tel.: +44-11-4225-3072; fax: +44-11- 
4225-3066.
E-mail address: m.r.clencli@shu.ac.uk (M.R. Clench).
(MALDI) is a powerful and widely used mass 
spectrometry method for the analysis o f  biopolymers. 
The process o f using a UV absorbing organic com­
pound as matrix material to aid laser desorption o f 
intact protein molecular ions was introduced by 
Karas and Hillenkamp [1], Mass spectra o f various 
proteins, such as albumin (67 kDa), were recorded
0021-9673/0 2 /S  -  see front matter © 2002 Elsevier Science B.V. All rights reserved. 
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by mixing the analyte with nicotinic acid. Since then, 
different compounds, including cinnamic acid deri- 
vates and aromatic carbonyl derivates, have been 
considered as potential MALDI matrices [2].
Besides organic matrices, metal particles of differ­
ent materials and sizes have been investigated as 
possible MALDI matrices. The major advantage of 
metal particles is the absence o f matrix interference 
in the lower mass range (below 500 Da) hence 
allowing the analysis o f low mass analytes. In 1988, 
Tanaka et al. [3] first demonstrated laser desorption/ 
ionisation (LDI) spectra o f proteins and polymers 
with molecular masses up to 25 kDa, using 30 nm 
diameter fine cobalt powder, suspended in a glycerol 
dispersant. Schiirenberg et al. [4] were inspired by 
Tanaka’s work and investigated recently several 
nano-particles as matrices for the analysis o f proteins 
and peptides. Mass spectra of cytochrome c and 
myoglobin were obtained by this research group 
using a suspension o f titanium nitride (35 nm 
diameter) in glycerol. Sunner et al. [5] and Dale et al.
[6,7] have investigated the use o f micro-particles 
instead o f nano-particles. In their experiments par­
ticles o f 2 -150  p,m diameter o f graphite and silicon 
with a range o f dispersants including glycerol were 
employed to ionise compounds such as peptides, 
proteins, oligosaccharides, synthetic polymers and 
anionic analytes. The term SALDI for surface-as­
sisted laser desorption/ionisation was introduced by 
Sunner et al. to distinguish this technique from 
MALDI employing organic matrices. Kinumi et al. 
[8] investigated commercially available metal and 
metal oxide micro-particles (Al, Zn, T i0 2, ZnO, etc.) 
as matrices for the analysis o f PEG 200 and methyl 
stearate. Michalak et al. [9] reported that the ful- 
lerene C60 with a diameter o f a few micrometers was 
a good matrix for protein analysis and Huang et al. 
[10] pursued this technique for the screening of 
diuretics in urine. More recently, laser desorption/ 
ionisation has been achieved without a matrix by 
depositing the analyte on a UV absorbing silicon 
substrate (DIOS) [11-14].
The coupling o f thin-layer chromatography (TLC) 
to mass spectrometry (MS) combines the simplicity 
of TLC with the specific detection capabilities o f MS 
[15,16]. Unlike other hypemated techniques, e.g. 
liquid chromatography (LC-M S), solvent consump­
tion is low and additionally the TLC plate can act as
a storage device for samples and chromatograms. In 
TLC, unknowns, which might be missed in LC due 
non-elution from the column, are readily detected as 
spots that have not moved from the origin. For the 
analysis o f tetracycline antibiotics, a further advan­
tage, is that the non-volatile compound, disodium 
ethylenediaminetetraacetate, which is required to 
improve the separation, remains on the TLC plate 
and hence does not cause any o f the problems such 
as clogging of the interface and deposits in the ion 
source, that have been reported in their analysis by 
LC -M S [17]. Fast atom bombardment-mass spec­
trometry (FAB-MS) was successfully employed by 
Oka et al. [18] for the TLC -M S analysis o f tetra­
cyclines. However, the lateral analyte spreading 
caused by the use o f a liquid matrix in FAB, required 
the sample spots to be concentrated by “ condens­
ing” them using a solvent focusing technique [19]. 
The chromatographic information contained in the 
TLC plate is therefore lost in this technique.
The use o f micro-particles in T L C -SA L D I-T O F- 
MS has recently been described [20-22]. The appro­
priate zone of the developed TLC plate was coated 
with a suspension o f activated carbon particles in 
glycerol and analysed. Using this approach spectra 
were obtained for a variety o f peptides (bradykinin, 
angiotensin II) and low molecular mass organic 
compounds (hydrochorothiazide and prometryn). 
Limitations in analytical sensitivity and spectra 
quality led Han and co-workers [22] to create a 
carbon activated surface on the aluminium support of 
the TLC plate, so that the separated analytes could 
migrate towards the particle surface after elution. 
The sensitivity as well as the mass resolution could 
be readily improved by this new methodology, (a 
similar approach was used by Mehl et al. [23] who 
used organic matrices to create the activated surface). 
However, the chromatographic integrity o f a sepa­
ration is destroyed in this technique and hence there 
is no longer the possibility o f “ scanning” the TLC 
plate to produce chromatograms or “ imaging” spots 
o f the analyte.
In this paper, results for the TLC -M A LD I-TO F­
MS analysis o f tetracyclines using different particle 
suspensions are reported. Micro-particles as well as 
nano-particles were examined for their suitability for 
TLC-M A LD I-M S. The majority o f the results were 
obtained for a suspension o f graphite (1 -2  |xm
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diameter) in ethylene glycol which was found to 
yield better sensitivity in comparison to the other 
tested materials and dispersants. Using this system 
the major ion species observed in both positive and 
negative ionisation modes were fragment ions. Frag­
mentation did not occur to the same extent when 
organic matrices, such as DHB or a-CHCA, were 
used.
Extracted ion chromatograms have been con­
structed from the scanned TLC plates. Using the 
extracted ion chromatograms, obtained from the 
TLC-M ALDI analysis o f different tetracyclines, it 
was possible to calculate the 7?f-value o f the detected 
analyte spots. These showed good agreement with 
the /?f-values obtained by UV detection.
2. Experimental
2.1. Materials
Oxytetracycline (OTC, MW 460), Tetracycline 
(TC, MW 444), Chlortetracycline (CTC, MW 478) 
and Minocycline (MC, MW 457) were purchased 
from Sigma-Aldrich (Dorset, UK). OTC was used 
as dihydrate, CTC and MC as hydrochloride. The 
five tested nano- and micro-particle powders of 
different materials and particle diameters are listed in 
Table 1. All chemicals were used as purchased from 
commercial suppliers.
2.2. TLC separation
The tetracycline antibiotics were separated using 
the procedure described by Naidong et al. [24]. 
Pre-treatment o f the aluminium-backed TLC plates 
coated with 0.2 mm layers o f silica gel 60 F254 
(Merck, Germany) was necessary in order to avoid
the formation o f metal-tetracycline complexes and 
hence to improve the separation. The TLC plates 
(10X10 cm) were sprayed with ca. 5 ml o f an 
aqueous disodium EDTA solution (0.27 mol /l, pH
8), air dried for 30 min in a horizontal position and 
then activated in an oven (120 °C) for another 30 
min.
The mobile phase dichloromethane-m ethanol- 
water (59:35:8, v /v) was saturated for 2 h prior to 
use. The plates were eluted over a distance o f 7.0 
cm, air dried and visualised under UV light (254 
nm).
2.3. Matrix application
In all experiments a 60X2 mm strip o f the 
developed TLC plate was attached to a modified 
MALDI target with double sided tape before the 
matrix was deposited on to the silica gel surface.
Particle matrix suspensions were prepared by 
dispersing powders of nano- or micro-particles (1 0 - 
100 m g/m l) in ca. 1 ml o f ethanol-ethylene glycol 
(1000:1, v /v) or methanol-ethylene glycol (1000:1, 
v/v). The suspensions were homogenised by sonica- 
tion for 15 min and then applied (30 |xl) to the 
developed TLC strip using a 10 |xl syringe. Experi­
ments with the crystalline chemical matrices 2,5- 
dihydroxybenzoic acid (DHB) and a-cyano-4-hy- 
droxy cinnamic acid (a-CHCA) were performed for 
comparison. In these cases the matrix solutions (300 
m g/m l DHB in ethanol-water containing 0.1% TFA 
(80:20, v /v) or 20 m g/m l a-CHCA in methanol 
containing 0.1%TFA) were electrosprayed on to the 
TLC plates using an in-house modified commercial 
robotic x -y -z-ax is  motion system (PROBOT, BAI, 
Germany). The instrument was modified to act as an 
electrospray deposition device by connection o f a 
0 -6  kV power supply to the sample needle (110 |xm
Table 1






Cobalt ultra fine powder (Co-UFP) Black 20 nm Kratos, UK
TiN Black 36 nm HC Starck GmbH, Germany, (kind gift by the supplier)
T i02 White 1 p.m Fluka, USA
Graphite Black 1-2 |xm Sigma-Aldrich, UK
Silicon Grey 45 |xm Sigma-Aldrich, UK
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I.D.) and adding an earthed metal plate (7X15 cm) to 
the sample table. The matrix solutions were electro­
sprayed on to the silica gel surface with a flow-rate 
o f 10 |xl/min, as the sample table was moved with a 
speed o f 0.25 m m /s. An area o f 2X60 mm on the 
TLC strip was typically covered with matrix crystals 
and a good matrix coverage was obtained using this 
modified device. Note: Particle suspension matrices 
cannot be successfully electrosprayed owing to capil­
lary blockages.
2.4. Mass spectrometry
Mass spectra and ion mass chromatograms were 
recorded directly from the TLC plate with a modified 
linear Laser TOF 1500 mass spectrometer (SAI, 
UK), equipped with a nitrogen laser (A=337 nm). 
The modifications to the instrument and its software 
for use in TLC-M A LD I-M S have been previously 
described by this group [25]. The positive and 
negative ion mode was used in these investigations 
and the mass spectra acquired from the TLC surface 
were the results o f the cumulative acquisition o f 16 
shots. The TLC strips were scanned over a distance 
o f 60 mm and mass spectra were recorded each 0.5 
mm. A data set o f 120 mass spectra was obtained for 
each sample, from which single ion mass chromato­
grams were constructed.
3. Results and discussion
3.1. Comparison o f  particle suspension matrices 
with organic matrices
For the M ALDI-M S analysis o f TC in a range of 
particle suspension matrices, mixtures containing 
equal volumes of particle suspensions (10-100 m g/ 
ml in ethanol-ethylene glycol (1000:1, v/v)) and 
analyte solutions (1 m g/m l in methanol) were added 
to the stainless steel targets (typically 0.25 |xl) and 
analysed.
The MALDI mass spectra obtained for TC using 
nano- and micro-particles are presented in Fig. 1. 
The inorganic matrices showed the following charac­
teristics, compared to the crystalline organic matrices 
DHB and a-CHCA. No protonated molecule o f TC 
could be observed, except when silicon powder was
used, as shown in Fig. le. However strong cat- 
ionisation by sodium and potassium was typically 
obtained when particle suspension matrices were 
used. Hence the molecular related ions of TC 
appeared as [M + N a]+ at m /z  467 and as [M +  K] + 
at m lz  483.
Fragment ions, which have been identified as 
[M + N a-N H 3] + at m /z  450, [M + K -N H 3] + at m /z 
466 and [M + N a-N H 3- H 20 ] + at m /z 432, could 
also be detected for TC. Furthermore, the ion 
intensity o f the most abundant ions o f TC was 
typically lower than that achieved when organic 
matrices were used. However the mass spectra were 
not dominated by complex signals at the lower mass 
range, as shown in Fig. 1.
In order to get some idea o f the relative sensitivity 
obtained from TLC -M A LD I-M S employing sus­
pension matrices in comparison to the sensitivity 
obtained from conventional targets the same quantity 
of TC (10 |xg) was analysed on both silica gel TLC 
plates and stainless steel targets, (three samples were 
analysed on each substrate and the results averaged). 
The suspension matrix used in this case was 
40 m g/m l graphite, dissolved in methanol-ethylene 
glycol (1000:1, v/v). Comparison o f the peak areas 
o f the [M + N a-N H 3] + o f TC at m/z 450 showed 
that the relative sensitivity obtained by M ALDI-M S 
from conventional targets was two times better than 
that obtained by TLC-M A LD I-M S.
3.2. Liquid dispersants o f  suspension matrices
Three different viscous liquids are generally de­
scribed in the literature as particularly suitable for 
use as dispersants with particle suspension matrices,
i.e. glycerol [3], ethylene glycol [26] and liquid 
paraffin [8]. The dispersant glycerol shows a charac­
teristic background level in the low-mass region, and 
hence is in general not considered a good choice for 
the analysis o f low mass analytes [8]. In our studies, 
ethylene glycol showed an advantage to paraffin, 
since the latter showed a degree o f analyte suppres­
sion. Therefore, all data were collected by using 
ethylene glycol as dispersant.
The role o f glycerol in supporting the phase 
transition is well documented in fast atom bombard­
ment (FAB) and liquid secondary ion mass spec­
trometry (LSIMS). It is not clear if  the function of
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Fig. 1. MALDI mass spectra o f tetracycline using nano- and micro-particles as suspension matrices, (a) Co-UFP, (b) TiN, (c) T i02, (d) 
Graphite and (e) Silicon.
glycerol is the same in particle assisted desorption/ 
ionisation. Dale et al. [6] considered that the addition 
of glycerol to graphite particles fulfils several roles. 
Besides increasing the signal lifetime at a particular
sample position, it acts as a proton source in the case 
o f peptides and proteins. In our initial studies we 
found that the absence o f dispersant in graphite (or 
any other particle material) caused the ion intensity
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to rapidly decrease after firing the laser repeatedly at caused an increase in the lifetime o f the analyte
the same position. An increase o f the concentration signals obtained for TC. However, this also led to a
o f ethylene glycol (from 0.1 to 1% in ethanol) faster contamination o f the ion source extraction























grid. As described earlier, typically no protonated 
signals o f TC could be detected when particle- 
ethylene glycol systems were used (Fig. 1). This was 
also the case when small peptides, such as Phe-Phe, 
T yr-Tyr and T yr-T yr-T yr were analysed (data not 
shown).
This would appear to indicate that ethylene glycol 
does not function as a proton source, but simply 
serves to mobilize the analyte by remaining liquid 
under vacuum.
3.3. TLC-M ALDI-TOF-M S o f  tetracycline
From the whole range o f particles studied, the 
TLC-M ALDI mass spectra recorded from graphite 
suspensions showed the lowest background noise and 
the highest peak intensities. The peak intensities of 
TC obtained from graphite suspensions were even 
higher than the ones obtained when DHB was used 
(Fig. 3 and the corresponding ion mass chromato­
gram is shown in Fig. 4).
In TLC -M A LD I-TO F-M S the extraction o f the 
analyte from the TLC plate and its adsorption on the 
particle surface plays an important role. Micro-par­
ticles were found to be superior to nano-particles, in
this case the particle size was o f the same order as 
the particle size o f the TLC silica gel layer (10 |xm). 
However, if  the particle diameter was higher than 10 
|xm, as in the case of silicon with a diameter o f 
around 40 fim, the particles did not adhere to the 
silica gel layer after solvent evaporation. The addi­
tion of an additive, e.g. sucrose [20,21], can improve 
the adhesion between particles and silica gel layer. 
But this causes extra signals in the recorded mass 
spectra, which can interfere with the analyte peaks in 
the low mass range.
Fig. 2 shows the TLC-M ALDI mass spectra of 
TC (200 |xg) developed on a TLC plate using 
graphite particles as matrix material. In the positive 
ion mode several fragment ions and sodium adducts 
of TC were observed. In the negative ion mode, high 
intensity carbon clusters in the low mass range were 
present and fragment ions were the dominant 
species. A level o f 200 |xg o f analyte was chosen in 
order to detect all possible fragment ions in reason­
able peak intensities, so that mass chromatograms of 
the corresponding analyte ions could be constructed 
with a low background noise level. Mass chromato­
grams o f the identified analyte peaks were recorded 
in the positive and negative ion mode.
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Fig. 2. TLC-MALDI mass spectra of tetracycline (200 pg) using a graphite matrix in: (a) positive; and (b) negative ion mode.
Since the absolute mass accuracy obtained was 
limited by thickness variations in the graphite film 
(this effect has been observed by Zumbuhl et al. 
[27], resulting in a mass inaccuracy o f ± 2  mass 
units), it was decided to employ a “ lock mass” and
to recalibrate each mass spectrum acquired. Initially 
three small peptides (Phe-Phe, T yr-T yr and T y r- 
Tyr-Tyr) and mixtures containing two o f the pep­
tides were tested as internal calibration standards. 
Phe-Phe was found to give the best results: optimum


















445 [M + N a]+
467
315 [M +H -N H 3]+
. k — —.■ L.—-viu—.—
350 4(X)300 Mass (m/z)
|  [M -H + 2 N a]4
f. P 4f
450 500








20 25 40 50 55
Distance (mm)
Fig. 4. The smoothed ion mass chromatogram of tetracycline (200 pg) from the experiment shown in Fig. 3. The [M +  H]+ ion (m/z 
444-446) was used to construct the ion mass chromatogram.
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Fig. 5. Smoothed single ion mass chromatograms from the TLC-MALDI-TOF-MS analysis of OTC, CTC, TC and MC (10 jig per 
component).
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signal response and no suppression o f analyte signals 
and hence was used in further experiments.
Phe-Phe (3 mM  in ethanol) was added to the 
graphite suspensions in order to recalibrate the T L C - 
MALDI mass spectra acquired during a run. This 
was achieved by use o f the [M + N a]+ and [M -H  +  
2Na]+ signals o f the peptide as “ lock masses” in the 
positive ion mode and by use o f the [M -H] ~ signal 
in the negative ion mode. The mass accuracy and 
mass resolution achievable by internal recalibration 
with Phe-Phe was comparable with that obtained in 
similar TLC -M A LD I-TO F-M S experiments em­
ploying DHB (Fig. 3 and also Fig. 4).
3.4. TLC-M ALDI-TOF-M S o f  a mixture o f  OTC, 
CTC, TC and MC
A typical chromatogram obtained for a mixture 
containing 10 |xg o f OTC, CTC, TC and MC, using 
the mobile phase described earlier, showed one 
unresolved spot for both CTC and TC (/?f=0.17). 
From reference runs it was established that CTC has 
an Rf value o f 0.16 and TC one o f 0.18. The 
TLC-M A LD I-M S analysis o f such a mixture con­
firmed this, as shown by the single ion mass chro­
matograms (Fig. 5). This demonstrates the potential 
o f TLC-M ALDI using a graphite suspension matrix 
for detecting unresolved analyte spots on a TLC 
plate. All four tetracycline antibiotics gave one 
characteristic fragment ion, [M + N a-N H 3] + in the 
TLC-M ALDI mass spectra recorded. Hence the 
[M + N a-N H 3] + was used for each tetracycline 
antibiotic to construct the corresponding ion mass 
chromatogram (Fig. 5). The detection limit o f tetra­
cyclines in TLC-M A LD I-M S employing graphite 
suspensions was found to be under 10 fig, however 
at lower levels the reproducibility was poor.
It should be noted that the present work was 
undertaken to demonstrate the applicability o f par­
ticle suspension matrices to TLC-M A LD I-TO F­
MS. It is anticipated that improvements in sensitivity 
and reproducibility could be achieved by finding 
procedures with higher and more consistent extrac­
tion efficiency.
Increased in-source fragmentation of tetracyclines 
antibiotics was observed when particle suspension 
matrices were used, compared to crystalline organic 
matrices. The reasons for this are probably that
higher peak temperatures are reached when particles 
are employed. Zenobi et al. [28] found that peak 
temperatures o f 700-900 K  could be reached in a 
few nanoseconds with 2 fim graphite-glycerol sam­
ples and Schiirenberg et al. [4] has estimated that 
peak temperatures above 10 000 K are possible with 
35 nm TiN particles.
4. Conclusion
The acquisition o f chromatographic as well as 
mass spectral data from eluted TLC plates via T L C - 
M A LD I-TO F-M S using different particle suspen­
sion matrices for the analysis o f tetracyclines has 
been successfully demonstrated. A suspension of 
graphite (1 -2  |xm) in ethylene glycol was found to 
yield superior data to the other tested matrices and 
dispersants. The mass accuracy on graphite films was 
improved by adding Phe-Phe as “ lock mass” to the 
graphite-ethylene glycol suspensions in order to 
allow internal recalibration o f the acquired T L C - 
MALDI mass spectra.
Furthermore, it could be shown that the specific 
detection capabilities o f TLC -M A LD I-M S from 
graphite suspensions assisted in the analysis o f the 
antibiotics CTC and TC in a mixture o f OTC, CTC, 
TC and MC.
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